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INFECTIOUS DISEASES
INTRODUCTION
In 1969, the United States Surgeon General declared that
infectious diseases had been conquered and the time had come
to focus on chronic diseases like cancer and heart disease In
its 1996 annual report, the World Health Organization (WHO)
reported that infectious diseases were the world's leading
cause of death.2 WHO's annual report demonstrated that the
demise of infectious diseases predicted twenty-six years earlier
was premature. Instead, WHO believes that infectious dis-
eases now constitute a "world crisis. 3 Since 1969, infectious
diseases have returned to the international public health
agenda. New diseases have appeared, triggering global epi-
demics; old diseases, once thought under control, returned to
cause sickness and death worldwide. WHO and national pub-
lic health authorities in developed and developing countries
are scrambling to deal with emerging and reemerging infec-
tious diseases. Pestilence, the fourth horseman of the apoca-
lypse, is firmly in the saddle spreading sickness and death.4
Infectious diseases have caused illness and death in hu-
mans from the beginning of human history. 5 Historians of all
civilizations have recorded horrible epidemics of infectious dis-
eases.6 Physicians and citizens raised in the era of antibiotic
treatments have, however, no memory of life and a society con-
stantly under threat of infectious diseases. 7 For these genera-
1 See Emerging Infections: A Significant Threat to the Nation's Health:
Hearings Before the Senate Committee on Labor and Human Resources, 104th
Cong. 1 (1995) [hereinafter Emerging Infections Hearings] (statement of Sena-
tor Kassebaum, Chairman, Committee on Labor and Human Resources).
2. WORLD HEALTH ORGANIZATION, WORLD HEALTH REPORT 1996:
FIGHTING DISEASE, FOSTERING DEVELOPMENT 1 (1996) [hereinafter WORLD
HEALTH REP. 1996]. WHO has 190 member states. Id. at 113.
3. Id. at 105.
4. In June 1996, Vice President Al Gore asserted that "there is no more
menacing threat to our global health today than emerging infectious dis-
eases." Al Gore, Address Before the National Council for International Health
2 (June 12, 1996); see also Dennis Pirages, Microsecurity: Disease Organisms
and Human Well-Being, WASH. Q., Autumn 1995, at 5, 11 ("Infectious dis-
eases are potentially the largest threat to human security lurking in the post-
cold war world.").
5. For an account of infectious diseases in history, see generally
WILLiAM H. McNEILL, PLAGUES AND PEOPLES (1977).
6. See generally WILLIAM H. MCNEILL, PLAGUES AND PEOPLES (1977).
7. Cf LAURIE GARRETT, THE COMING PLAGUE: NEWLY EMERGING
DISEASES IN A WORLD OUT OF BALANCE 11 (1994) (noting that today's physi-cians are ill-equipped to diagnose "an old scourge like yellow fever or dengue,
much less spot an entirely new microbe"). Garrett is widely recognized as an
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tions, the "end of history" for infectious diseases seemed en-
tirely plausible. Nevertheless, the struggle between mankind
and the microbial world continues as emerging and reemerging
infectious diseases challenge international, national, and local
public health authorities.
An important feature of the latest chapter in mankind's
struggle with infectious diseases is that the threat of emerging
and reemerging infectious diseases is global in scope;8 a threat
which WHO believes requires a global, coordinated response.
9
The transboundary effects of infectious diseases are not new,
because microbes have for centuries spread to new regions
from their original locations.10 The need for international co-
operation in infectious disease control is not novel either, as
states have long cooperated to halt the spread of disease.11 The
threat of emerging and reemerging infectious diseases stresses
what history has frequently recorded: microbes do not recog-
nize borders, and states are compelled to cooperate when
dealing with infectious diseases.
Although infectious diseases are not unique threats his-
torically, current aspects of the problems they pose are novel.
The "global village" metaphor is apt because the unprece-
dented scale of global travel and commerce today makes any
disease outbreak in the world a threat to virtually every other
country.12 Infectious diseases spread through the links created
by an interdependent world.13  Globalization provides infec-
expert on emerging infectious diseases. The Coming Plague was a best-seller
in 1995, and Garrett won a Pulitzer Prize in 1996 for her reporting on the
Ebola outbreaks in Zaire. Rita Ciolli, 2 Newsday Pulitzers for Science, Relig-
ion, NEWSDAY, Apr. 10, 1996, at A03, available in LEXIS, Nexis Library,
Curnws File.
8. See David P. Fidler, Globalization, International Law, and Emerging
Infectious Diseases, 2 EMERGING INFECTIOUS DISEASES 77, 77 (1996).
9. See Communicable Disease Prevention and Control: New, Emerging,
and Re-Emerging Infectious Diseases-Report by the Director-General, World
Health Organization, WHO Doc. A48/15 at 2 (Feb. 22, 1995) [hereinafter Re-
port of the WHO Director-General].
10. See MCNEILL, supra note 5, at 176-207 (recounting the history of the
intercontinental spread of infectious diseases).
11. See Fidler, supra note 8, at 78.
12. See Emerging Infections Hearings, supra note 1, at 20 (statement of
Dr. James W. LeDuc, Medical Officer, Communicable Diseases Division,
World Health Organization).
13. See INSTrITE OF MEDICINE, EMERGING INFECTIONS: MICROBIAL
THREATS TO HEALTH IN THE UNITED STATES 77-84 (1992) [hereinafter IOM
REP.] (citing international travel and commerce as factors in infectious dis-
ease emergence).
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tious diseases with opportunities to infect human populations
across the planet almost as easily as infecting the family next
door. Just as companies today create global strategies, public
health authorities must view the health of their citizens from a
global perspective.
The global dimension of emerging and reemerging infec-
tious diseases brings into focus international efforts to control
them. As with other transnational problems, such as environ-
mental protection, international law plays an important role in
the international attempts to deal with infectious diseases.
WHO recognizes the importance of international law in its in-
ternational legal strategy for coping with the threat of emerg-
ing and reemerging infectious diseases. 14  In this strategy,
WHO acknowledges the historical role of international law on
infectious disease control as well as its future role in contain-
ing and preventing outbreaks of infectious diseases.
This Article is the first attempt to analyze international
law and emerging and reemerging diseases comprehensively.
The Article has six objectives. First, it looks at emerging and
reemerging infectious diseases to answer basic questions: what
are they, and what causes them? Defining emerging and ree-
merging infectious diseases and identifying their causes dem-
onstrates how complicated and troubling the return and con-
trol of infectious diseases are. Second, the Article analyzes the
reasons why emerging and reemerging infectious diseases cre-
ate such problems for international relations. Examining in-
fectious diseases in connection with the nature of international
relations clarifies that the emergence and reemergence of in-
fectious diseases pose threats of the most serious magnitude.
Third, the Article analyzes the current plans for dealing
with emerging and reemerging infectious diseases proposed by
WHO and United States federal agencies. These plans share
fundamental objectives and can be interpreted as manifesta-
tions of a common strategy. Fourth, the Article examines exist-
ing international law on infectious disease control. Much of
current international law on infectious disease control is in-
adequate in light of the nature of the new challenges of
emerging and reemerging infectious diseases and the ambi-
tious contents of the international action plans.
14. See World Health Assembly Resolution on Communicable Diseases
Prevention and Control: New, Emerging, and Re-Emerging Infectious Dis-
eases, WHO 48.13, World Health Org. (May 12, 1995) [hereinafter WHA Reso-
lution] (proposing revision of the International Health Regulations).
1997] 775
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Fifth, the Article explores WHO's proposed strategy to im-
prove international law on infectious disease control. I con-
clude that current WHO proposals for revising existing inter-
national law on infectious disease control are inadequate to
meet the existing challenges from emerging and reemerging in-
fectious diseases. Finally, the Article offers one alternative le-
gal strategy to WHO's proposals-an approach that suggests
the framework treaty/protocol approach used in other areas of
international law-and a brief critique of this alternative in
order to explore further the complexity of the issues and the
potential international law has in this area. The presentation
of an alternative strategy seeks to stimulate thinking about
various ways international law might more directly confront
the problems of emerging and reemerging infectious diseases.
I. EMERGING INFECTIOUS DISEASES
A. IDENTIFYING EMERGING INFECTIOUS DISEASES
1. Basic Infectious Disease Concepts
A basic grasp of the concepts used by public health offi-
cials, scientists, and physicians will help in analyzing whether
international law can deliver what these experts deem neces-
sary.
The sources for infectious diseases are found in four types
of agents: bacteria,1 5 viruses, 16 parasites,17 and fungi." Such
disease agents reside in or on a host, which is the organism
that carries the agent.19 Many infectious agents have no ad-
verse effects on their natural host populations. 20 Infectious
15. For example, the bacterium Yersinia pestis causes the plague. See
IOM REP., supra note 13, at 16.
16. AIDS is caused by a virus that weakens the human immune system.
See WORLD HEALTH REP. 1996, supra note 2, at 31.
17. Malaria is a disease caused by parasites. See id. at 47.
18. Candidiasis is a fungal disease that can affect the gastro-intestinal
tract, vagina, and mouth. See IOM REP., supra note 13, at 41.
19. Sometimes the host for an agent cannot be located, making the epi-
demiology of the disease mysterious. For example, the host and/or vector for
the Ebola virus is still not known. World Health Organization, Ebola Case
Confirmed in C6te D'Ivolre, WHO Press Release, WHO/89, Dec. 8, 1995,
<http://www.who.cb/press/1995/pr95-89.htn>.
20. For example, the parasite that causes malaria has no effect on the
mosquitoes that carry it. See GARRETT, supra note 7, at 39. Influenza carried
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disease spreads when a host organism transmits the agent to a
new organism. 21  Transmission can occur in many ways:
through air, water, direct contact with bodily fluids of a host
(e.g., urine, feces, saliva, and blood), sexual activity, and in-
termediary organisms or vectors (e.g., insects),2 Once a new
host is infected with the agent, it can also transmit the disease
and thus widen the spread of the infection, as long as the in-
troduction of the agent survives the new host's natural de-
fenses against infectious invaders.23
The keys to treating and controlling infectious diseases in
humans are identifying the agent, understanding how it works,
figuring out how the human host was initially infected, exam-ining how it causes illness in humans, and discovering how the
disease can be transmitted to other humans. 24 For new dis-
eases, each of these steps often proves difficult and expensive
because of the nature of the agent, political obstacles, the lack
of an obvious natural host, or lack of adequate research funds.
Once the biology and epidemiology of a disease agent are
understood, public health authorities can implement treatment
and control measures. Antimicrobial drugs are commonly used
to kill pathogenic microbes or to prevent them from reproduc-
ing. Some disease agents do not respond to existing antimi-
crobial drugs, though, so public health authorities concentrate
on controlling the spread of the disease by closing off trans-
mission opportunities.25 Treatment and control of an infectious
by waterfowl cause no illness in such birds. See Anita Manning, Scientists
Say New Virus Could Cause Pandemic, USA TODAY, Jan. 17,1996, at 1A.
2L See WORLD HEALTH REP. 1996, supra note 2, at 23 (noting that infec-
tious diseases spread from the reservoir organism to a susceptible host).
22. See id. at 24 (breaking down selected infectious diseases by different
modes of transmission).
23. See, e.g., Bernard N. Fields, Pathogenesis of Viral Infections, in
EMERGING VIRUSES 69, 70 (Stephen S. Morse ed., 1993) ("A virus needs to cir-
cumvent or subvert host defenses if it is to be a successful pathogen.").
24. Each of these tasks falls within the science of epidemiology, which has
been defined as "[t]he mother science of public health" because it involves "the
systematic, objective study of the natural history of disease within popula-
tions and the factors that determine its spread." INSTrUTE OF MEDICINE, THE
FUTURE OF PUBLIC HEALTH 40 (1988) [hereinafter IOM, FUTURE OF PUBLIC
HEALTH].
25. For example, "no drug has been developed that can prevent or cure
HIV infection." IOM REP., supra note 13, at 57. Public health officials thus
have to respond by trying to reduce opportunities for transmission of 1IV to
uninfected persons. See WORLD HEALTH REP. 1996, supra note 2, at 36-37(discussing HIV prevention strategies such as adopting safe sex practices, in-
creasing condom availability, and education).
7771997]
MINNESOTA LAW REVIEW
disease requires public health authorities to be able both to
identify an outbreak of a disease and to mobilize resources to
treat the infection and control its spread.
The preceding rudimentary description of infectious dis-
eases suggests that pathogenic microbes pose serious chal-
lenges to scientific, medical, and political institutions. Pains-
taking research must be done; complicated epidemiological
field work must be undertaken; funding must be found for re-
search and fieldwork; antimicrobial pharmaceuticals must be
developed; medical personnel must be trained to administer
treatment and to participate in disease surveillance; funding
must be supplied to maintain surveillance for future outbreaks;
and actors in the political arena must support work on infec-
tious diseases. All these activities consume considerable re-
sources. But, as the threat of emerging and reemerging infec-
tious diseases demonstrates, infectious diseases constantly
challenge the scientific creativity, financial resources, and
vigilance of even the most wealthy nation.
2. Definition and Examples of Emerging Infectious Diseases
Leading international and national public health authori-
ties usually label emerging and reemerging infectious diseases
as "emerging infectious diseases" (EIDs) and define EMs as
"diseases of infectious origin whose incidence in humans has
increased within the past two decades or threatens to increase
in the near future."2  This definition includes diseases never
before identified as well as previously known diseases that
have reemerged in traditional locations or in new regions.
Hereinafter, the acronym EIDs refers to both emerging and
reemerging infectious diseases.
One category of EMs contains diseases identified for the
first time in human populations during the last two decades.
The United States government interagency Working Group on
Emerging and Reemerging Infectious Diseases (CISET Work-
ing Group) listed twenty-nine examples of new infectious dis-
eases identified since 1973.28 The emergence of approximately
26. U.S. CENTERS FOR DISEASE CONTROL AND PREvENTION, ADDRESSING
EMERGING INFECTIOUS DISEASE THREATS: A PREVENTION STRATEGY FOR THE
UNITED STATES 1 (1994) [hereinafter CDC STRATEGY]; WORLD HEALTH REP.
1996, supra note 2, at 15.
27. See WORLD HEALTH REP. 1996, supra note 2, at 15.
28. See NATIONAL SCIENCE AND TECHNOLOGY COUNCIL COMMITTEE ON
INTERNATIONAL SCIENCE, ENGINEERING, AND TECHNOLOGY WORKING GROUP
[Vol. 81:771778
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thirty new infectious diseases within thirty years of the pro-
claimed conquest of infectious diseases provides sobering evi-
dence of the power of the microbial world.
The second category of EIms constitutes known infectious
diseases that have in the last twenty years reemerged as public
health problems. Reemerging infectious diseases fall into one
or more of three categories: (1) infectious diseases that have
flared up in regions in which they historically appeared; (2) in-
fectious diseases that have expanded into new regions where
they were not present before; and (3) infectious diseases that
have developed resistance to antimicrobial treatments and
have spread through traditional and/or new regions because of
such resistance.
29
Tuberculosis is a reemerging infectious disease that falls
into each of the three categories noted above. Tuberculosis is
an old disease that has reemerged as a major health problem
in regions where it has historically occurred. According to the
Institute of Medicine of the U.S. National Academy of Science
(Institute of Medicine), tuberculosis "kills more people world-
wide than any other infectious disease."30 Experts predict 90
million new cases of tuberculosis worldwide during the 1990s
and 30 million deaths by the year 2000.31 Tuberculosis has re-
turned as a problem in both developing and developed coun-
tries. For example, tuberculosis haunted major American cit-
ies, like New York, during the nineteenth century.32 In the
1980s and 1990s, New York City public health officials waged a
ON EMERGING AND RE-EMERGING INFECTIOUs DISEASES, INFECTIOUS
DISEASES-A GLOBAL HEALTH THREAT 14 (1995) [hereinafter CISET REP.].
The CISET Working Group list includes Ebola hemorrhagic fever (1977), Le-
gionnaires' disease (1977), toxic shock syndrome (1981), Lyme disease (1982),
acquired immunodeficiency syndrome (ADS) (1983), and Brazilian hemor-
rhagic fever (1994). See id. Before 1973, other scientists identified Argentine
hemorrhagic fever (1958), Bolivian hemorrhagic fever (1959), and Marburg
disease (1967) as new infectious diseases. See Robert E. Shope & Alfred S.
Evans, Assessing Geographic and Transport Factors, and Recognition of New
Viruses, in EMERGING VIRUSES 109, 113 (Stephen S. Morse ed., 1993); see also
GARRETr, supra note 7, at 13-29 (describing search for Bolivian hemorrhagic
fever) and 53-59 (describing initial outbreak of Marburg virus in Germany).
29. The CISET Working Group identified 20 reemerging infections, in-
cluding rabies, dengue and dengue hemorrhagic fever, yellow fever, malaria,
schistosomiasis, plague, diphtheria, tuberculosis, and cholera. See CISET
REP., supra note 28, at 15.
30. IOM REP., supra note 13, at 30-31.
31. See Mario C. Raviglione et al., Global Epidemiology of Tuberculosis:
Morbidity and Mortality of a Worldwide Epidemic, 273 JAMA 220, 220 (1995).
32. See GARRETT, supra note 7, at 241.
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battle to contain a reappearance of the disease.33 One of the
causes of the reemergence of tuberculosis in New York City
was immigration of tuberculin-infected persons from develop-
ing countries,34 which makes tuberculosis an infectious disease
that has expanded from places where the disease is fairly
common to a new environment relatively free from the disease.
Finally, certain strains of tuberculosis have developed antimi-
crobial resistance to traditional pharmaceutical treatments
35
making some cases in New York City even harder to handle.
3. Growth of Awareness of the EID Problem
EIIs have been on the march for the last three decades.
Yet it was only five years ago that alarm over the EID threat
motivated international and national public health authorities
to take action. The public health communities internationally
and in the United States recognize the 1992 report of the Insti-
tute of Medicine entitled Emerging Infections: Microbial
Threats to Health in the United States37 as the call for action
against EmDs. 38 Why it took so long for public health authori-
ties to understand the EID threat is a controversial story; but,
as will be examined later, the inertia had much to do with the
complacency about infectious diseases that followed the prema-
ture triumphalism of the late 1960s and early 1970s. One
thing however, is clear: the worldwide AIDS pandemic shat-
tered all illusions that science had laid infectious diseases to
rest. The AIDS pandemic brought home the vulnerability of
every society to infectious diseases. By the year 2000, between
30 million and 110 million people worldwide will be infected
with the human immunodeficiency virus (HIV). 39 AIDS made
33. See Emerging Infections Hearings, supra note 1, at 33-35 (statement
of Dr. Margaret H. Hamburg, Health Commissioner of New York City).
34 See Anthony S. Fauci, New Science Aimed at an Ancient Killer, 274
JAMA 786, 786 (1995); Tuberculosis Morbidity-United States, 1994, 274
JAMA 788, 788 (1995).
35. See Raviglione et al., supra note 31, at 224.
36. See Emerging Infections Hearings, supra note 1, at 33-35 (statement
of Dr. Margaret H. Hamburg, Health Commissioner of New York City).
37. IOM REP., supra note 13.
38. See GARRETT, supra note 7, at 5-7 (discussing origins of the IOM re-
port).
39. See U.S. DEP'T OF STATE, PuB. 10296, UNITED STATES INTERNATIONAL
STRATEGY ON HIV/AIDS 2 (1995) [hereinafter U.S. INTL STRATEGY ON
HIV/AIDS] (citing estimates from WHO and the Global AIDS Policy Coalition
at the Harvard School of Public Health). According to the UN Chronicle, the
AIDS pandemic "is a calamity whose dimensions are scarcely comprehensi-
[Vol. 81:771
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clear the urgent need for national and international scientific,
medical, and public health policy communities to regroup to
create a strategy to deal with their resurgent foe.
Emerging Infections as well as two earlier reports by the
Institute of Medicine demonstrate that "the ability of the U.S.
public health system and our health professionals to deal with
emerging infectious diseases is in jeopardy."40 Emerging Infec-
tions focused on the EID threat to American and global health,
stressed the need to overcome years of complacency on infec-
tious diseases in the United States, and made recommenda-
tions for federal and state agencies to follow in addressing the
threat.' Since the publication of Emerging Infections, the EID
threat and the need for global action have become subjects of
extensive discourse for international and national public
health authorities, in the legislative and executive branch of
the United States government, in international meetings of
leading industrial countries, and in popular culture.
As the leading agency in the United States public health
service, the Centers for Disease Control and Prevention (CDC)
responded to Emerging Infections by developing an action plan
for the CDC specifically and the United States generally. In
1994, the CDC's Emerging Infections Working Group pub-
lished Addressing Emerging Infectious Disease Threats: A Pre-
vention Strategy for the United States.42 The CDC also began
publishing a new journal, Emerging Infectious Diseases, de-
signed "to promote the recognition of emerging and reemerging
infectious diseases and improve the understanding of factors
involved in disease emergence, prevention, and elimination."43
ble." Confronting a Calamity: To Combat the World's Most Menacing Epi-
demic, the UN Mounts a New Joint Programme, 31 UN CHRONICLE 48 (June
1994), available in LEXIS, Nexis Library, Arcnws File [hereinaftr Confront-
ing a Calamity]. For many, AIDS "represents the great new plague of this
century." Seth F. Berkley, AIDS in the Global Village: Why U.S. Physicians
Should Care About HIV Outside the United States, 268 JAMA 3368, 3369
(1992).
40. CDC STRATEGY, supra note 26, at 3. The first report issued in 1987
addressed the weaknesses of American public health abilities to handle tropi-
cal infectious diseases, such as Lassa fever, Ebola hemorrhagic fever, and
drug-resistant malaria. See INSTITUTE OF MEDICINE, THE U.S. CAPACITY TO
ADDRESS TROPICAL INFECTIOUS DISEASE PROBLEMS (1987). In 1988, the sec-
ond Institute of Medicine study criticized the American approach to public
health as ineffective and expensive. See IOM, FUTURE OF PUBLIC HEALTH, su-
pra note 24, at 5-6, 170.
41. See generally IOM REP., supra note 13.
42. CDC STRATEGY, supra note 26.
43. Emerging Infectious Diseases Homepage (visited Feb. 5, 1997)
1997]
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Internationally WHO also responded to the 1992 Institute
of Medicine report. In April 1994, WHO convened an inter-
national meeting to discuss the EID threat. At this meeting,
participants agreed that "WHO should be encouraged to take a
leadership role in implementing and coordinating global ef-
forts" against EIDs.45 The Director-General of WHO produced
a report in February 1995 in which he discussed the back-
ground of the EID situation, causes of EIDs, and specific steps
"to ensure that a global plan is established to combat emerging
infectious diseases." 46 After considering the Director-General's
report, the World Health Assembly47 adopted a resolution in
May 1995 urging WHO member states to take action against
EIDs, urging international and nongovernmental organizations
to cooperate in EID control efforts, and requesting the Director-
General to develop a global WHO action plan to combat the
threat of EIDs.
48
Concern about EI)s emerged in the United States Senate
as well. In hearings held by the Senate Committee on Labor
and Human Resources on "Emerging Infections: A Significant
<http'/www.cdc.gov/ncidod/EID/eid.htm>. CDC Director Satcher stated that
he believed Emerging Infectious Diseases "is the first scientific journal to be-
gin online with Internet." Emerging Infections Hearings, supra note 1, at 9
(statement of Dr. David Satcher). The CDC published the first issue of
Emerging Infectious Diseases in early 1995. In that issue, Satcher argued
that the "need for implementing CDC's plan is urgent, given the extremely
dynamic nature of disease trends and the complexity of factors contributing to
disease emergence" and that Emerging Infectious Diseases "is part of the
overall strategy to draw worldwide attention to emerging infections and im-
prove communication." David Satcher, Emerging Infections: Getting Ahead of
the Curve, 1 EMERGING INFEcTIOUs DISEASES 1, 4-5 (1995).
44. WHO recognized that the IOM report had been a catalyst for interna-
tional and national discussions of EIDs. See Emerging Infectious Diseases:
Memorandum from a WHO Meeting, 72 BuLL. WORLD HEALTH ORG. 845, 845
(1994) [hereinafter WHO Meeting Memorandum].
45. Id. at 848.
46. Report of the WHO Director-General, supra note 9, at 3.
47. The World Health Assembly is one of the three bodies created in the
WHO Constitution to carry out WHO's work. WHO CONST. art. 9. The World
Health Assembly determines policies, adopts regulations in specific areas, and
has the authority to adopt conventions or agreements with respect to any
matter within WHO's competence. See id. at arts. 19, 21.
48. W&A Resolution, supra note 14, at 2-3. Following WHO's lead, the
Pan American Health Organization (PAHO) adopted a resolution on EDs in
September 1995, recommending to PAHO member states that they improve
the infrastructure supporting infectious disease surveillance, prevention, and
control. See New, Emerging, and Re-emerging Infectious Diseases, Res.
CD38.R12, Pan Am. Health Org. (Sept. 28, 1995), compiled in 115th and 116th
Meetings of the PAHO Executive Committee, at 101, PAHO Doc. 1276 (1996).
[Vol. 81:771
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Threat to the Nations Health,"49 Senator Nancy Kassebaum,
Chair of the Committee, used the language of war to describe
the EID threat: "New strategies for the future begin with in-
creasing the awareness that we must re-arm the Nation and
the world to vanquish enemies that we thought we had already
conquered."50 The efforts of the U.S. interagency CISET Work-
ing Group indicated that concern about the EID threat perme-
ated many levels of the United States government. The CISET
Working Group convened in December 1994 "to consider the
global threat of emerging and reemerging infectious dis-
eases."51 It produced a report in September 1995 called Infec-
tious Disease-A Global Health Threat that identified specific
actions the U.S. government could take to improve its ability to
contribute to global efforts to fight EDs5 2 The Clinton ad-
ministration also mobilized against the EID problem. On June
12, 1996, Vice President Gore announced a new national ini-
49. Emerging Infections Hearings, supra note 1. The hearings were called
to help "develop a legislative approach to support and complement the U.S.
Public Health Service and many other global efforts that are being focused on
the deadly problems of domestic and international emerging infections." Id.
at 2 (statement of Senator Kassebaum).
50. Id. at 3. Earlier in 1995, Senator Arlen Spector warned about the ad-
verse effects of budget cuts on the National Institute for Health's initiative on
EIDs, arguing for "sustained, stable funding" and "a sustained strategic ap-
proach" to EIDs. 141 CONG. REC. S7459, 7461 (daily ed. May 25, 1995) (state-
ment of Sen. Spector). During the impasse in Congress over the federal
budget in January 1996, Senator Nunn drew the Senate's attention to the vir-
tual shutdown of the CDC because of the lack of federal funding and noted the
CDC's role in dealing with EMs as one of the reasons why the CDC should be
spared the effects of the budget impasse. See 142 CoNG. REC. S63, 64 (daily
ed. Jan. 4, 1996) (statement of Sen. Nunn).
Legislation was also proposed in the U.S. Senate that would heighten the
priority the U.S. government gives to EmDs. In January 1995, Senator Kasse-
baum introduced a bill to "strengthen the capacity of State and local public
health agencies to carry out core functions of public health." S. Res. 142,
104th Cong. § 101 (1995). Included in the bill was language that made EIDs a
priority public health issue of regional and national significance. Id. § 202.
The Foreign Relations Revitalization Act, introduced in the U.S. House of
Representatives and Senate in 1995, included a provision that made efforts
against EDs a U.S. foreign policy priority. H.R. Res. 1561, 104th Cong. § 1604(1995); S. Res. 908, 104th Cong. § 615 (1995).
51. CISET REP., supra note 28, at 1.
52. The CISET Report contains 19 specific recommendations broken down
into two major categories: (1) "improve worldwide disease surveillance, report-
ing, and response" by working with other countries, WHO, and other interna-
tional organizations; and (2) "[s]trengthen the U.S. capacity to combat
emerging infectious diseases." Id. at 7-8.
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tiative to combat EDs. 3 The new policy commits the federal
government to tackling the global problem of EIDs through de-
velopment of a global surveillance and response system, in-
creased funding requests to Congress, and tightening U.S.
quarantine regulations at U.S. ports of entry.5 4 As Health and
Human Services Secretary Donna Shalala commented, the
Clinton administration has in essence declared war on EIDs.
55
As part of its efforts, the United States has begun to pursue a
number of bilateral EID initiatives with the European Union,56
Japan, South Africa, and RussiaY
The leaders of the Group of Seven leading industrialized
nations (G7) also put EIDs onto their agenda by endorsing a
project at the 1995 Halifax Summit called 'Toward a Global
Health Network," designed "to help public health institutions
in their fight aainst infectious diseases and other major
health hazards." Infectious diseases were again on the G7's
agenda at the 1996 Lyon Summit as the G7 leaders incorpo-
rated a statement on infectious diseases in their final summit
statement.59 The states participating in the Asia Pacific Eco-
53. See Gore, supra note 4, at 1; see also Ellen McCleskey, Gore Unveils
New Initiative for Fighting Infectious Diseases, BNA HEALTH CARE DAILY
(June 13, 1996), available in LEXIS, Nexis Library, Curnws File.
54. See Fact Sheet: Addressing the Threat of Emerging Infectious Dis-
eases, White House Office of Science and Technology Policy (June 12, 1996)
(on file with author) [hereinafter Addressing the Threat of Emerging Infec-
tious Diseases].
55. See McCleskey, supra note 53 (reporting Shalala's comment that the
"Clinton Administration has made the war against infectious diseases a prior-
ity").
56. See Worldwide Network to Warn of Epidemics; Under Plan, U.S. and
European Governments Will Take Lead in Reporting Outbreaks, WASH. POST,
Nov. 28, 1996, at A19 (reporting on U.S.-European Union agreement "to es-
tablish a global early warning network to alert doctors and governments
about budding epidemics"). This agreement forms part of the U.S.-E.U.
Transatlantic Agenda, which involves many different issues. For specifics on
the EID aspect of the U.S.-E.U. Transatlantic Agenda, see The New Transat-
lantic Agenda (visited Jan. 27, 1997) <http://europa.eu.intlen/agenda/trO6ap2.
html#ii7>.
57. See Letter from Stephen M. Ostroff, Acting Deputy Director, National
Center for Infectious Diseases, Centers for Disease Control and Prevention, to
David P. Fidler, Associate Professor of Law, Indiana University School of
Law-Bloomington (Nov. 21, 1996) (on file with author) (mentioning U.S. bi-
lateral EID efforts with these three countries) [hereinafter Ostroff Letter].
58. CISET REP., supra note 28, at 4.
59. See Full Text of G-7 Chairman's Statement, Kyodo News Service, June
29, 1996, available in LEXIS, Nexis Library, Curnws File [hereinafter Group
of Seven Statement].
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nomic Cooperation forum established in 1996 a working group
on EIDs.
60
Awareness about EIDs was growing in popular culture as
well. The publication of books dealing with infectious diseases
brought to wider audiences the reality that the microbial world
represented a clear and present danger to human popula-
tions.61 Even Hollywood participated in the infectious disease
genre. Outbreak, starring Dustin Hoffman and Morgan Free-
man, built its plot around an outbreak in California of a lethal
disease imported from Africa.62 Whatever the entertainment
value of this film, one fact about the making of Outbreak helps
put the danger of EIDs and the level of preparedness for such
danger into perspective: "Dustin Hoffman made more money
last year playing a disease control scientist in the movie Out-
break than the combined annual budget for the U.S. National
Center for Infectious Diseases and the U.N. Programme on
AIDS/HIV."
63
B. FACTORS CONTRIBUTING TO EIDs
No easy answer exists to explain why infectious diseases
have returned with a vengeance at a time when mankind's sci-
entific knowledge and powers are historically unprecedented.
The emergence and reemergence of infectious diseases are
complex phenomena that touch an awesome array of scientific,
social, political, and economic problems.6" This section ana-
60. See Ostroff Letter, supra note 57.
6L See CISET REP., supra note 28, at 11; see also GARRETT, supra note 7
(providing a detailed history of the rise of the EID threat); JOE MCCORMICK &
SusAN FISHER-HOcH, LEVEL 4: ViRus HUNTERS OF THE CDC (1996) (detailing
memoirs of two well-known epidemiologists); RICHARD PRESTON, THE HOT
ZONE (1994) (discussing a near outbreak of Ebola hemorrhagic fever in Re-
ston, Virginia). Eliot Cohen, in a book review for the influential Foreign Af-
fairs, commented that although the tone of Garrets book was panicky, a note
of hysteria about EIDs may be justified. Eliot A. Cohen, Book Review: The
Coming Plague: Newly Emerging Diseases in a World Out of Balance,
FOREIGN AFF., July-Aug. 1995, at 136, 136. Foreign Affairs lended its influ-
ence to spreading the warning call about EIDs by publishing an article by
Garrett. See Laurie Garrett, The Return of Infectious Disease, FOREIGN AFF.,
Jan.-Feb. 1996, at 66 [hereinafter Garrett, Infectious Disease].
62. OUTBREAK (Warner Brothers 1995).
63. Garrett, Infectious Disease, supra note 61, at 79.
64. For example, Alan Lifson identifies no fewer than eight factors con-
tributing to dengue epidemics in different parts of the world: international
travel, urbanization, population growth, crowding, poverty, inadequate sani-
tation facilities, weak public health infrastructure, and lack of sustained sup-
port for disease-control measures. Alan R. Lifson, Mosquitoes, Models, and
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lyzes the most frequently cited factors contributing to EDs.
Because these factors vary in relative importance for different
EIms, they are not listed in order of importance or priority.
The sheer number and complexity of the factors behind EIms
demonstrates that the EID threat poses tremendous challenges
for any attempts to develop global public health and legal
strategies.
1. The Power of Nature
One of the crucial lessons learned through the ED prob-
lem is that nature is a powerful, ever-changing force. The mi-
crobial world has shown a dynamism that confirms the
strength of evolution in the natural world. This lesson may
seem obvious; Laurie Garrett observes, however, the optimistic
triumph of medicine over microbes rested on the false assump-
tion "that microbes were biologically stationary targets."65 The
EID threat drives home that "mutation and change are facts of
nature ... and that human health and survival will be chal-
lenged, ad infinitum, by new mutant microbes, with unpredict-
able pathophysiological manifestations."66 For Nobel Laureate
Joshua Lederberg, the power of nature's evolutionary forces
make disease plagues "natural, almost predictable" phenom-
ena.
67
Microbial adaptation and evolution take two forms: change
as a natural process and change as a result of pressure exerted
by antimicrobial drugs.68 "Te ability to adapt is required for
the successful competition and evolutionary survival of any mi-
crobial form," notes the Institute of Medicine, "but it is particu-
larly crucial for pathogens, which must cope with host defenses
Dengue, 347 LANCET 1201, 1201 (1996). Even more sobering is the under-
standing that many of the factors identified by Lifson as important in den-
gue's reemergence can also be factors in the spread of other infectious dis-
eases. A team of physicians studied the emergence or reemergence in Djibouti
City, Republic of Djibouti, of malaria, HIV/AIDS, tuberculosis, dengue, chol-
era, hantavirus, gonorrhea, and shigella, concluding that factors like poverty,
urbanization, and poor sanitation played into the increasing presence of the
diseases. See G.R. Rodier et al., Recurrence and Emergence of Infectious Dis-
eases in Djibouti City, 73 BULL. WORLD HEALTH ORG. 755, 758 (1995).
65. Garrett, Infectious Disease, supra note 61, at 67.
66. Alison Jacobson, Emerging and Re-Emerging Viruses: An Essay (visited
March 10, 1997) <http'//www.uct.ac.za/microbiology/ebolaess.htm]> (quoting Don-
ald A. Henderson) (citation omitted).
67. Barbara J. Culliton, Emerging Viruses, Emerging Threat, 247
SCIENCE 279, 279 (1990) (quoting Joshua Lederberg).
68. See IOM REP., supra note 13, at 85, 92.
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as well as microbial competition."69 Even absent efforts from
humans to kill them or prevent their replication, pathogenic
microbes constantly adapt and compete with host immune sys-
tems and with other microbes.
Microbes exhibit a similar evolutionary drive when con-
fronted by antimicrobial drugs. One of the most worrying as-
pects of the reemergence of some infectious diseases is the de-
velopment of antimicrobial resistance in some disease agents. 0
The list of diseases that have developed antimicrobial resis-
tance is disturbingly long.71 The development of antimicrobial
resistance in disease agents might not be as troubling if the
resistant microbes had to confront a new arsenal of effective
drugs. But the pharmaceutical industry has been slow to re-
search and market new drugs to combat resistant strains of
bacteria, viruses, and parasites. 2 Although some new drugs
are being developed,73 they will not appear on the market for
another five to fifteen years because of lengthy clinical trials
69. Id. at 84.
70. See id. at 92 (stating that the "emergence of resistance in a known
infectious agent may be a greater threat to public health than the emergence
of a new disease"); Linda F. McCraig & James M. Hughes, Trends in Antimi-
crobial Drug Prescribing Among Office-Based Physicians in the United States,
273 JAMA 214, 214 (1995) (stating that persons infected with drug-resistant
microbes require more hospitalization, have longer hospital stays, and are
more likely to die).
71. Bacteria that have shown resistance to antibiotics include streptococ-
cus pneumonia, staphylococci, enterococci, pseudomonas aeruginosa, and tuber-
culosis. See IOM REP., supra note 13, at 93-97. Viruses with antiviral resis-
tance include herpes simplex virus and HIV-1. See id. at 99-100. Resistance to
antimalarial treatments such as chloroquine and mefloquine is also apparent in
the parasite that causes malaria, plasmodium falciparum. See id. at 100-01.
The development of resistance in the malaria parasite is particularly frighten-
ing because the disease "is endemic in 91 countries, with about 40% of the
world's population at risk." WORLD HEALTH REP. 1996, supra note 2, at 47.
72. See Garrett Infectious Disease, supra note 61, at 68 (quoting James
Hughes, Director of the National Center for Infectious Diseases at the CDC,
who asserts that "[tihe pipeline is dry. We really have a global crisis."); see
also CISET REP., supra note 28, at 10 (concluding that "[iln the race between
drug-resistant bacteria and new drugs, the resilient bacteria are winning");
Nancy McVicar, Infectious Diseases Fight Back; Old Cures Don't Work on Re-
sistant Organisms, SUN-SENTINEL (Fort Lauderdale), July 24, 1994, at 1A
(quoting Dr. Stephen Ostroff of the CDC stating that "organisms appear to be
developing resistance faster than the industry can make new drugs"); Robert
F. Service, Antibiotics That Resist Resistance, 270 SCIENCE 724, 724 (1995)
(stating that in some areas there is agreement that drug resistance is near
crisis proportions).
73. See Service, supra note 72, at 724 (reporting on a dozen new promis-
ing antibiotic treatments).
7871997]
MINNESOTA LAW REVIEW
and regulatory approval procedures. 74 Further, pharmaceuti-
cal companies are reluctant to invest in research on drugs to
combat pathogenic microbes that are found mainly in develop-
ing countries because the anticipated return on investment is
poor.7 5 The Institute of Medicine warns of "potentially cata-
strophic consequences if the development process is left en-
tirely to free enterprise."7 6 The state of antimicrobial research
and development undermines WHO's call for "urgent action" on
drug resistant diseases.7 The warnings about a crisis created
by antimicrobial resistance contain the lesson about the mi-
crobial world's immense power to adapt and survive. Even if
pharmaceutical companies develop new antimicrobial treat-
ments, resistance will once again develop, and the process
would begin again. In nature, microbial change is constant.
2. Complacency and the Breakdown of Public Health Systems
As well as underestimating the resilience of microbes, the
public health, medical, and scientific communities around the
world have contributed directly to the EID problem in other
ways. A key reason almost universally cited as a cause behind
the EID threat is complacency about infectious diseases. Those
now struggling to respond to the EID threat bluntly describe
the consequences of this complacency among scientists, physi-
cians, pharmaceutical companies, and public officials. 9
After surveying the quality of infectious disease surveil-
lance in the United States, a group of CDC and state public
health officials concluded: "Our ability to detect and monitor
74. See id. at 726.
75. See Garrett, Infectious Disease, supra note 61, at 68; see also Drug
Firms: Limited Imagination, EcONOMIST, Sept. 28, 1996, at 80, 85 (noting
that pharmaceutical research on antimalarial drugs is not undertaken be-
cause "[mlost of the victims... are too poor to pay").
76. IOM REP., supra note 13, at 11.
77. World Health Organization, WHO Calls for Action on the Spread of
Drug-Resistant Diseases, WHO Press Release, WHO/95 (Dec. 5, 1994) <http
//www.who.ch/press/1994/pr94-95.html> [hereinafter WHO Calls for Action].
78. See McCraig & Hughes, supra note 70, at 219.
79. See IOM REP., supra note 13, at vi (noting complacency toward the
danger of EIDs in the scientific and medical communities, the public, and the
political leadership of the United States). Not all public health experts fell
victim to complacency. Neville Goodman, who worked for both the Health
Committee of the League of Nations and WHO, wrote in 1971 "that the Pale
Horse of the Apocalypse has by no means been broken to bit and halter."
NEVILLE GOODMAN, INTERNATIONAL HEALTH ORGANIZATIONS AND THEIR
WORK 247 (2d ed. 1971).
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infectious disease threats to health is in jeopardy. False per-
ceptions that such threats had dwindled or disappeared led to
complacency and decreased vigilance regarding infectious dis-
eases, resulting in a weakening of surveillance ... .80 Simi-
larly harsh conclusions were published about the poor condi-
tion of infectious disease preparedness in Great Britain.81
Outbreaks of Ebola hemorrhagic fever in Zaire in 1995 and
plague in India in 1994 demonstrated the lack of preparedness
in those two countries and internationally in dealing with
EMs
Lack of preparedness for EID outbreaks was not, however,
the only consequence of complacency. With complacency came
the misuse of antimicrobial drugs. WHO has argued that an-
tibiotics have been excessively and inappropriately used in de-
veloped and developing countries.8 3 Such widespread use and
misuse of antimicrobial drugs has contributed to the develop-
ment of drug resistance in many diseases.84 Compounding the
misuse of antimicrobial drugs, the pharmaceutical industry
believed the predictions that infectious diseases were con-
quered and thus shifted attention and resources into other ar-
eas, like the treatment of chronic diseases. 85 As a result, the
industry's past complacency has made it difficult to respond
rapidly to the present EID crisis.
Complacency has also had an impact on public health law
in the United States, in other countries, and at the interna-
tional level. Terry O'Brien, Assistant Attorney General for the
80. Ruth L. Berkelman et al., Infectious Disease Surveillance: A Crum-
bling Foundation, 264 SCIENCE 368, 368 (1994); see also IOM, FUTURE OF
PUBLIC HEALTH, supra note 24, at 19 (describing the poor condition of the
U.S. public health system).
81. See J. Michael O'Brien et al., Tempting Fate: Control of Communica-
ble Diseases in England, 306 BRIT. MED. J. 1461, 1461 (1993) (arguing that
Britain's system of infectious disease surveillance "is out of date and needs
substantial reform").
82. See Emerging Infections Hearings, supra note 1, at 21 (statement of
Dr. David Heymann on Ebola'outbreak in Zaire); D.T. Dennis, Plague in In-
dia: Lessons for Public Health Everywhere, 309 BRIT. MED. J. 893, 894 (1994)
(commenting on plague outbreak in India).
83. See WHO Calls for Action, supra note 77.
84. See CDC STRATEGY, supra note 26, at 2 (stating United States faces
emergence of drug-resistant pathogens from widespread use and misuse of
antimicrobial drugs); WHO Calls for Action, supra note 77 (stating that mis-
use of antibiotics is largely responsible for drug-resistance crisis).
85. See Service, supra note 72, at 724-25 (noting sources suggesting that
bacterial disease research should be subjugated to research for chronic dis-
eases).
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State of Minnesota, has argued that public health law, devel-
oped mainly in the pre-antibiotic era, did not change after the
advent of antimicrobial treatments because the treatments
were successful. The treatments' success reduced the need for
state intervention to control diseases.86 With the arrival of
AIDS, public health law in the United States has come under
pressure to conform with modern principles of due process and
civil rights. O'Brien raises the question whether U.S. public
health law can balance sufficient public health powers to com-
bat EMs and strict restrictions on interfering with individual
rights. 8
8
At the international legal level, the World Health Assem-
bly has not substantially revised the International Health
Regulations (IHR), the main source of international law on in-
fectious diseases, since 1973.89 In 1975, a WHO publication as-
serted that it was reasonable to believe that the IHR will "no
longer serve any purpose and will eventually lapse" as national
systems of infectious disease control and international coop-
86. Terry P. O'Brien, Emerging and Re-Emerging Infectious Diseases:
The State Law Perspective, Address Before ABA Panel on Law and Emerging
and Re-Emerging Infectious Diseases (Aug. 5, 1996), in PROGRAM MATERIALS
FOR LAW OF EMERGING AND RE-EMERGING INFECTIOUS DISEASES, 1996 ABA
ANNUAL MEETING, at 32-33 [hereinafter PROGRAM MATERIALS].
87. See id. at 33; see, e.g., Lawrence 0. Gostin, The Resurgent Tuberculo-
sis Epidemic in the Era of AIDS: Reflections on Public Health, Law, and Soci-
ety, 54 MD. L. REV. 1, 90-129 (1995) (discussing use of compulsory power to
prevent the spread of tuberculosis); Larry Gostin, The Politics of AIDS: Corn-
pulsory State Powers, Public Health, and Civil Liberties, 49 OHIO ST. L.J.
1017, 1026-57 (1989) (discussing the use of state power to reduce HIV trans-
mission); Larry Gostin, Public Health Strategies for Confronting AIDS: Legis-
lative and Regulatory Policy in the United States 261 JAMA 1621, 1621-29
(1989) (surveying state legislative efforts to combat the spread of HIV); Larry
Gostin, The Future of Communicable Disease Control: Toward a New Concept
in Public Health Law, 64 MILBANK Q., 1986 Supp. 1, at 79, 80 (discussing the
use of state power to stop the spread of disease).
88. See O'Brien, supra note 86, at 39. Similar questions have surfaced
about the outdated condition of public health law in Great Britain. See, e.g.,
O'Brien et al., supra note 81, at 1463 (arguing for the passage of new legisla-
tion on infectious disease control in the United Kingdom).
89. See WORLD HEALTH ORGANIZATION, INTERNATIONAL HEALTH
REGULATIONS 5 (3rd ed. 1983) [hereinafter INTL HEALTH REG] (describing
IHR amendment history). According to WHO, the IHR are "the only interna-
tional health agreement on communicable diseases that is binding on Member
States" of WHO. Division of Emerging and Other Communicable Diseases
Surveillance and Control, Emerging and Other Communicable Diseases Stra-
tegic Plan 1996-2000, at 10 (WHO/EMC/96.1), World Health Org. (1996)
[hereinafter EMC Strategic Plan).
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eration became sufficiently advanced. 90 As the EID threat
grew, it became apparent that such optimism about the IBR
was unwarranted. In the face of the EID problem, the IHR
look increasingly ineffective for infectious disease control. 91
For example, only three diseases are subject to the current
HR: yellow fever, plague, and cholera.92 These are the same
diseases that the delegates to the first international conference
on infectious disease addressed in 1851.93 WHO member states
have not kept the IHR relevant to the global problems EIDs
have caused.
Another factor in the EID problem is the poor condition of
public health systems around the world, which only partly
stems from the complacency analyzed above. Public health ca-
pabilities are suffering globally, nationally, and locally, and in
developed as well as developing countries. The first crucial
step in dealing with infectious diseases is identifying the
pathogenic agent, which is entrusted to public health surveil-
lance systems. At global, national, and local levels, infectious
disease surveillance capabilities are in bad shape. According
to the CISET Working Group, currently "an infectious disease
surveillance system does not exist on an international scale."95
The current global surveillance network for infectious diseases
is informal, rudimentary, and limited to a few diseases.96 The
90. P.J. DELON, THE INTERNATIONAL HEALTH REGULATIONS: A PRACTICAL
GUIDE 23 (1975).
9L See Fidler, supra note 8, at 79-80.
92. See INTL HEALTH REG., supra note 89, at 8. As Dr. David Heymann,
Director of WHO's Division of Emerging and Other Communicable Diseases
Surveillance and Control, observes, many EDs have the same potential for
spreading internationally as the three diseases currently subject to the IHR,
but are not included in the Regulations. David L. Heymann, The Interna-
tional Health Regulations: Ensuring Maximum Protection with Minimum Re-
striction, Address Before ABA Panel on Law and Emerging and Re-Emerging
Infectious Diseases (Aug. 5, 1996), in PROGRAM MATERIALS, supra note 86, at
12.
93. See N. Howard-Jones, Origins of International Health Work, BRIT.
MED. J., May 6, 1950, at 1032, 1034 (listing the diseases discussed at the In-
ternational Sanitary Conference in 1851).
94. See infra Part V for a discussion of the proposed revision of the IHR.
95. CISET REP., supra note 28, at 23; see also IOM REP., supra note 13,
at 6 (noting that [t]here has been no effort to develop and implement a global
program of surveillance for emerging diseases or disease agents"); Donald A.
Henderson, Surveillance Systems and Intergovernmental Cooperation, in
EMERGING VIRUSES 283, 285 (Stephen S. Morse ed., 1993) (noting that "we are
not today well-structured or staffed on a global level to detect either new or
emerging viral diseases").
96. See CISET REP., supra note 28, at 18, 21. Further, what passes as a
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Clinton administration has made building a global surveillance
system one of the fundamental objectives of its policy on
EmDs.97
As the specialized U.N. agency for international health is-
sues, WHO is an important part of any global surveillance sys-
tem. Yet WHO's financial limitations hinder its ability to im-
prove global surveillance. 98 Further, WHO depends on its
member states making infectious disease surveillance a prior-
ity, which has not occurred for decades. 99 If WHO member
states have deficient national surveillance systems, then the
prospects for a global surveillance network are grim indeed.
The same story has played out at the state and local levels
in the United States as well. The CISET Working Group re-
ported that over the last decade, "state and local support for in-
fectious disease surveillance has diminished, largely as a re-
global surveillance system has suffered as the network has deteriorated and
laboratories have declined in capabilities. See Ruth L. Berkelman et al., Ad-
dressing Emerging Microbial Threats in the United States, 275 JAMA 315, 315
(1996) (noting reduced global capacity to detect and respond to emerging dis-
eases). WHO conducted a survey in 1993 of its global network of laboratories.
The survey "highlighted the urgent need for improving global surveillance ca-
pacity." Id. at 369. For a more detailed discussion of the WHO survey, see
James W. LeDuc, World Health Organization Strategy for Emerging Infectious
Diseases, 275 JAMA 318, 320 (1996).
97. See Gore, supra note 4, at 6 ("[W]e must create a global surveillance
system.").
98. See Leon Gordenker, The World Health Organization: Sectoral Leader
or Occasional Benefactor?, in U.S. POLICY AND THE FUTURE OF THE UNITED
NATIONS 167, 176 (Roger A. Coate ed., 1994) (noting that "reluctance of WHO
member states to provide increased funding places real constraints on the or-
ganization's ability to fund its broad agenda of health activities").
99. A case in point is the United States, the biggest contributor to WHO's
budget. See id. at 174. Dr. Michael Osterholm, State Epidemiologist for the
Minnesota Department of Health, tried to put American commitment to in-
fectious disease surveillance in perspective in testimony to a U.S. Senate
committee when he compared the $42 million in federal dollars spent annu-
ally on national surveillance with the approximately $225 million the U.S.
military spends maintaining musical bands. See Emerging Infections Hear-
ings, supra note 1, at 33 (statement of Dr. Michael Osterholm). Dr. Oster-
holm predicted that if Congress did not appropriate more money for EID sur-
veillance and control, the United States would suffer large economic costs
from the adverse effects of EIDs on the population. Id.
Under its new EID policy initiative, the Clinton administration will ask
Congress to more than double the CDC's budget for EIDs. See Gore, supra
note 4, at 5. Other budgetary decisions also affect control of infectious dis-
eases. The American Public Health Association predicts, for example, that
cuts in federal Medicare and Medicaid programs will produce widespread in-
creases in infectious diseases. See Garrett, Infectious Disease, supra note 61,
at 77.
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suit of budget restrictions."l1 0 Such budget pressures at the
state and local level have produced understaffed surveillance
systems, underreporting of reportable infectious diseases, lim-
ited follow-up on reported cases, and reluctance to add new
diseases to the list of reportable diseases." 1 In 1995, twelve
U.S. states or territories had no personnel responsible for food
or water-borne disease surveillance, and thirty-four states had
fewer than one person per million population with responsibil-
ity for food or water-borne disease surveillance.1" 2 The tubercu-
losis epidemic in New York City, for example, resulted partly
from "the collapse of the local public health infrastructure.
One EliD expert observed that American "surveillance and
public health systems had reached states of inaccuracy and
chaos that rivaled those in some of the world's poorest coun-
tries."
104
If infectious disease surveillance eroded in the United
States, one of the world's most affluent countries, then the
state of infectious disease surveillance in developing countries
is not hard to imagine. The CISET Working Group observed
that in Africa, for example, "[i]nfectious disease surveillance is
nearly non-existent, and emerging and reemerging diseases
frequently go unreported."1 5 Given the higher incidence of all
100. CISET REP., supra note 28, at 41.
10L See id.; see also Berkelman et al., supra note 80, at 368 (noting skele-
tal staffing levels, reluctance to add new diseases, underreporting, and limited
follow-up). Dr. Osterholm observed that the condition of state and local in-
fectious disease surveillance was so bad in the 1993 outbreak of cryptosporidi-
osis, which infected an estimated 400,000 people in Milwaukee, Wisconsin,
that the outbreak was not detected until drug stores ran out of anti-diarrheal
medicine and grocery stores ran out of toilet paper. Emerging Infections
Hearings, supra note 1, at 45 (statement of Dr. Michael Osterholm).
102. See Emerging Infections Hearings, supra note 1, at 32 (statement of
Dr. Michael Osterholm).
103. GARRETT, supra note 7, at 76-77. Dr. Margaret Hamburg, Health
Commissioner of New York City, told a U.S. Senate committee that the sever-
ity of the tuberculosis problem could be traced back to the 1970s when severe
cutbacks accompanied block grants from Congress for public health activities.
Emerging Infections Hearings, supra note 1, at 35 (statement of Dr. Margaret
A. Hamburg).
104. GARRETT, supra note 7, at 512. The Institute of Medicine observed in
1988 that the U.S. public health care system was in disarray. See IOM,
FUTURE OF PUBLIC HEALTH, supra note 24, at 19. It commented in 1992 "that
there has been little positive change in the U.S. public health system since the
release of that report." IOM REP., supra note 13, at 7.
105. CISET REP., supra note 28, at 17. The CISET Working Group notes
that the 1995 outbreak of Ebola in Zaire probably occurred as early as Decem-
ber 1994, but the international community did not learn about it until May
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kinds of EIDs in the developing world, the poor condition of in-
fectious disease surveillance there spells trouble for not only
the peoples of the developing world but also the peoples of de-
veloped countries vulnerable to EIDs through global travel and
trade. Inadequate surveillance in the developing world dra-
matically limits the prospects for a global surveillance system
as well. Although the World Bank has called for more invest-
ment in public health in developing countries, 10 6 developing
countries do not have the resources to so invest, WHO does not
have the money to rebuild national public health infrastruc-
tures, and the United States is unlikely to fund such health in-
frastructure investments in other countries.
10 7
One commentator accurately sums up the condition of the
current U.S. infectious disease surveillance system as the
equivalent of trying to operate O'Hare International Airport,
one of the busiest airports in the world, with tin cans and
string.08 More daunting still is the thought that many devel-
oping countries-critical parts of a global network-cannot
even afford the tin cans and string.
3. Global Travel and Trade
The speed, volume, and scope of global travel stand high
on the list of factors contributing to the EID threat for virtually
all experts examining the subject. In 1993, approximately 500
million persons crossed international borders on airplane
flights.'0 This vast movement of people across borders every
year has inevitable consequences for the spread of infectious
1995. The CISET Working Group concluded that "[t]his delay reflects the
weak health care systems and the poor state of infectious diseases surveil-
lance in most of Africa." Id.; see also Emerging Infections Hearing, supra note
1, at 21 (statement of Dr. David Heymann commenting on Zaire's lack of an
early detection system necessary to detect the Ebola outbreak).
106. See GARRETT, supra note 7, at 69; see also WORLD BANK, WORLD
DEVELOPMENT REPORT 1993: INVESTING IN HEALTH 158 (1993) (advocating
investment in public health activities).
107. See CISET REP., supra note 28, at 43.
108. See Emerging Infections Hearings, supra note 1, at 32 (statement of
Dr. Michael Osterholm).
109. See WHO Meeting Memorandum, supra note 44, at 848 (summarizing
data on international travel). In 1951, only 7 million passengers flew inter-
nationally; by 1967, the number had grown to 51 million. See P. Dorolle, Old
Plagues in the Jet Age, 23 WHO CHRONIcLE 103, 104 (1968) (discussing the
increase in international air travel between the 1940s and 1960s). From 1951
to 1993, the number of international air passengers has grown 3,500 times.
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diseases. As Mary Wilson has noted, "Travel is a potent force
in disease emergence and spread."'10
Travel is not a new factor in the global spread of infectious
diseases."' Diseases have traveled with their human hosts
and spread to new populations from the beginning of human
history.'12 According to Wilson, "Human migration has been
the main source of epidemics throughout recorded history."11
3
Further, governments have long considered travel and trade as
a conduit for diseases. The Italian city-states of the fourteenth
century first introduced quarantine1 4 measures because, as
hubs for commerce between Europe and the Orient, they felt
the impact of disease spread.1 5 In the age of sea travel, infec-
tious diseases usually manifested themselves during the long
voyage, making quarantine at the port of arrival a sensible
strategy for preventing their spread."
6
Even before the advent of the airplane, travel increased so
much that quarantine practices became ineffective. The ex-
pansion of international travel that took place during the nine-
teenth century encouraged the spread of infectious diseases." 7
The threat from infectious diseases spread by international
travelers provided a catalyst for the convening of the first In-
ternational Sanitary Conference in 1851."' The impact of
travel led some people to argue as early as 1866 that infectious
diseases should be limited at their source rather than subject
110. Mary E. Wilson, Travel and the Emergence of Infectious Diseases, 1
EMERGING INFECTIOUS DISEASES 39, 39 (1995).
111 See Dorolle, supra note 109, at 103 (stating that the observation that
diseases could be transmitted by man or goods transported by ships is an-
dent).
112. See MCNEILL, supra note 5, at 14-68 (discussing the transport of dis-
eases and parasites by ancient humans).
113. Wilson, supra note 110, at 40.
114. "Quarantine" comes from the Italian word for "forty," the number of
days the Italian city-states detained ships, travelers, and cargoes in the four-
teenth century. See Dorolle, supra note 109, at 103 (discussing the history of
quarantines).
115. See Sidney Edelman, International Travel and Our National Quaran-
tine System, 37 TEMP. L.Q. 28, 28-40 (1963) (discussing the historical use of
quarantines); Howard-Jones, supra note 93, at 1032 (discussing early quaran-
tine measures).
116. See Garrett, Infectious Disease, supra note 61, at 69.
117. See Frank Gutteridge, The World Health Organization: Its Scope and
Achievements, 37 TEMP. L.Q. 1, 1 (1963).
118. See Howard-Jones, supra note 93, at 1034.
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to ineffective quarantine measures. 119 The speed, volume, and
global scope of travel undermined the state's ability to protect
its citizens through quarantine laws and regulations. In 1918-
1919, before air travel had even begun, swine flu circumnavi-
gated the planet five times in eighteen months, killing 22 mil-
lion people worldwide.
120
With the introduction of air travel, the trends manifested
in the nineteenth century accelerated. The speed of travel and
average distances traveled have increased one thousand times
over the last two hundred years. 121 The opportunities for travel
to spread disease have likewise increased. Travel has contrib-
uted to the spread of many diseases, including malaria, yellow
fever, plague, cholera, tuberculosis, influenza, HIVAIDS,
Lassa fever, smallpox, hepatitis, hantaviruses, gonorrhea,
syphilis, herpes, and others. 122 The potential for global pan-
demics fueled by the ease of travel is illustrated by the AIDS
virus. The opportunities offered a virulent airborne pathogen
by air travel are perhaps even more frightening. Garrett notes
the 1918-1919 global influenza pandemic that killed 22 million
people and asks: "How many more victims could a similarly le-
thal strain of influenza claim in 1996, when some half a billion
passengers will board airline flights?"
23
The role of travel in the international spread of infectious
diseases raises questions about how to deal with the EID
threat exacerbated by the explosion in global travel. The
choices seem to be to restrict travel through quarantine meas-
ures or improve health conditions and infectious disease sur-
veillance within countries. In 1966, exactly one hundred years
after the efficacy of quarantine measures were first seriously
119. See Gutteridge, supra note 117, at 2 (noting the conclusions of the
Third International Sanitary Conference in 1866).
120. See Garrett, Infectious Disease, supra note 61, at 69.
121. See The International Response to Epidemics and Applications of the
International Health Regulations: Report of a WHO Informal Consultation 5,
WHO/EMC/IHR/96.1, World Health Org. (Dec. 11-14, 1995) [hereinafter Re-
port of a WHO Informal Consultation] (comments of Prof. P. Haggett of the
University of Bristol).
122. Travel by itself does not usually produce new disease outbreaks. Wil-
son observes that most infectious agents introduced through travel do not re-
sult in disease. See Wilson, supra note 110, at 40. Conditions in the arrival
country have to be right for infectious agents to spread disease through a
population. Although travel may introduce a pathogenic virus, bacterium, or
parasite, transmission involves other factors like poverty, environmental deg-
radation, and inadequate sanitary or health infrastructures. See id. at 40-42.
123. Garrett, Infectious Disease, supra note 61, at 69.
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questioned, a U.S. Public Health Service advisory committee
concluded that "it is no longer possible to have confidence in
the idea of building a fence around this country against com-
municable diseases, as is the traditional quarantine con-
cept."124 Unfortunately, as quarantine has declined in impor-
tance, U.S. federal and state public health officials have not
maintained the next line of defense against importation of dis-
ease-public health surveillance and intervention capabili-
ties. 1
25
The international movement of goods also contributes to
the EID problem. Since the end of the Cold War, free trade
dominates thinking about international economic relations, as
evidenced by the World Trade Organization, the North Ameri-
can Free Trade Agreement, and the continued building of the
common market in the European Union. Trade is, of course,
not a new phenomenon in international relations, but the na-
ture of international trade today is historically novel since it is
truly universal and involves the movements of unprecedented
quantities of food.
Today, up to seventy percent of fruits and vegetables con-
sumed in some U.S. states is imported from developing coun-
tries.126 The Institute of Medicine states that "[ilnternational
trade has become so pervasive that it is virtually impossible to
screen most of the food entering the country for known micro-
bial hazards, let alone for new microbiological threats."127
While international trade agreements typically reserve a coun-
try's powers to inspect, and even prohibit the entry of imported
food under so-called sanitary and phytosanitary provisions,128
124. IOM REP., supra note 13, at 22 (quoting Advisory Committee on For-
eign Quarantine, 1966). United States policy since 1966 has relied less and
less on quarantine. For example, the United States operated 55 domestic
quarantine stations in 1967, but today has only 7. See CISET REP., supra
note 28, at 21; IOM REP., supra note 13, at 23. In contrast, the United States
has approximately 50 international airports and more than 150 other legal
points of entry. See CISET REP., supra note 28, at 21.
125. See CISET REP., supra note 28, at 21; see also supra note 99 and ac-
companying text (discussing the weakness of the U.S. public health system
and its problems funding emerging infectious disease surveillance and con-
trol).
126. See Emerging Infections Hearings, supra note 1, at 44 (statement of
Dr. Michael Osterholm).
127. IOM REP., supra note 13, at 68.
128. See, e.g., Agreement on the Application of Sanitary and Phytosanitary
Measures, Dec. 15, 1993, GATT Doc. MTN/FA H-AIA-4 (stating that members
have the right to take certain sanitary and phytosanitary measures to protect
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the Institute of Medicine believes that the momentum of free
trade will result in decreased inspections of imported food.129
In the United States, increasing occurrence of food-borne
infectious disease outbreaks underscores the dangers inherent
in the global food trade. 3 ° In 1996, an outbreak of cyclospora13 1
caught U.S. public health officials by surprise. 132 Health offi-
cials believe that imported strawberries were contaminated
with cyclospora, but little is actually known about the parasite,
its host, and means of transmission. 133 U.S. officials suspected
a link to imported food and consulted the Pan American Health
Organization, a unit of WHO, about testing for cyclospora in
the water of Latin American countries that export to the
United States. 134 Other reports suggest that imported Guate-
malan raspberries were the source of the cyclospora out-
break.135
human, animal, and plant life health); North American Free Trade Agree-
ment, Dec. 17, 1992, U.S.-Can.-Mex., arts. 709-724, 32 I.L.M. 289, 377-83(1993) (discussing discretionary actions each country may take with respect to
sanitary and phytosanitary measures for protecting human, animal, and plant
life); TREATY ESTABLISHING THE EUROPEAN COMMUNITY, Feb. 7, 1992, art. 36,
O.J. (C 224) 48 (1992) [hereinafter EC TREATY] (noting that Member States
are not precluded from restricting the import or export of goods on grounds of
protecting humans, animals, and plants).
129. This situation alarms Dr. Michael Osterholm, chief epidemiologist for
the State of Minnesota, who told a Senate committee, "We have so changed
our food supply in this country today that the same fruits or vegetables that
you eat here in Washington, DC are the ones I would tell you if you went to a
developing world country to boil it, peel it, or do not eat it. And you have no
idea." Emerging Infections Hearings, supra note 1, at 44.
130. Escherichia coli 0157:H7 contaminated hamburgers at a fast-food
chain and caused a multi-state outbreak of bloody diarrhea and serious kidney
disease. See CDC STRATEGY, supra note 26, at 2. Ultimately, this killed four
children. See id. Ice cream manufactured in Minnesota was contaminated
with salmonella, causing the largest outbreak of food-borne illness in U.S. his-
tory. See O'Brien, supra note 86, at 23. Apples contaminated with cow feces
were inadequately washed before being processed into cider, which caused an
outbreak of cryptosporidiosis in New England. See Peter S. Millard et al., An
Outbreak of Cryptosporidiosis From Fresh-Pressed Apple Cider, 272 JAMA
1592, 1595-96 (1994). Scientists have increasingly raised concerns about
pathogen contamination of fish and shellfish consumed by humans. See
GARRETT, supra note 7, at 562.
131. Cyclospora is a parasite that infects the intestine, causing diarrhea,
weight loss, and fatigue. See Lawrence K Altman, Illness Outbreak Puzzles
Officials, N.Y. TIMES, June 30, 1996, at Al.
132. See id.
133. See id.
134. See id.
135. See David H. Frankel, US Bad Berries May Be From Below the Bor-
der, 348 LANCET 185, 185 (1996); Mike Cooper, Guatemalan Fruit Named as
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Trade is a significant factor in the EID problem beyond
food contamination. Means of transportation themselves-
ships and airplanes-can harbor infectious agents.136 Because
transportation offers opportunities to infectious agents, the In-
ternational Health Regulations require as many ports and air-
ports in a country as possible to have facilities for disinfecting,
disinsecting, and deratting of ships and airplanes used in in-
ternational travel.1 37 Certain internationally-traded products
are also recurring conduits for infectious diseases. The Insti-
tute of Medicine warns that the lack of effective screening of
animals imported for scientific research constitutes "[p]erhaps
the greatest problem associated with international commerce
and its relation to disease emergence." 138 The globalization of
trade in human blood, blood products, organs, and tissue rep-
resents another trade-related opportunity for infectious dis-
eases to spread. The spread of AIDS was facilitated partly
through the transfusion of commercially sold blood and blood
Likely Outbreak Cause, CHI. SUN-TIMES, July 19, 1996, at 20. Florida public
health authorities have threatened to ban imports of Guatemalan raspberries
if federal authorities do not develop a way to detect the cyclospora parasites.
Glenn Singer, Florida Talks of Banning Guatemalan Raspberries; Agriculture
Commissioner Says Hell Wait to See How CDC Fares in Cyclospora Battle,
SUN-SENTINEL (Fort Lauderdale), July 19, 1996, at 3A. Guatemala has, how-
ever, defended its raspberry exports, and argued that U.S. public health
authorities have not scientifically confirmed the cyclospora parasite is linked
to any Guatemalan products. See Guatemala Defends Its Raspberries, REUTERS,
July 19, 1996, available in LEXIS, News Library, Curnws File.
136. Bilge water from ships sailing from East Asia introduced a new strain
of cholera to South America when the ships released contaminated waters
into a Peruvian harbor. Stephen S. Morse, Examining the Origins of Emerg-
ing Viruses, in EMERGING VIRUSES 10, 20 (Stephen S. Morse ed., 1993). Aedes
albopictus, a mosquito capable of infecting humans with dengue, yellow fever,
and eastern equine encephalitis made its way from Asia to the United States
in a cargo of water-logged tires. See Wilson, supra note 110, at 43. Rats, car-
riers of the fleas that host the plague, often find their way to new destinations
as stowaways on ships. See id. at 40-41.
137. See INTL HEALTH REG., supra note 89, art. 15, at 15.
138. IOM REP., supra note 13, at 83. Since 1989, the international trade in
wild primates captured for scientific research and development has been the
source of six recorded outbreaks of the Asian strain of the Ebola virus in the
United States. See David Brown, Exporter's Monkeys Tested for Ebola Virus,
WASH. POST, Apr. 20, 1996, at A6. The African strain of the Ebola virus is le-
thal to humans, while the Asian Ebola strain has not yet caused illness in
humans. See id.; see also PRESTON, supra note 61, at 251-54 (recounting the
outbreak of the Asian strain of Ebola in research primates in Reston, Vir-
ginia). The Marburg virus, another lethal virus that causes hemorrhagic fe-
ver, killed primate researchers and handlers in Marburg, Germany in 1967.
See GARRETT, supra note 7, at 53-59 (describing the outbreak of the Marburg
virus in Germany).
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products. 139  Hepatitis B, Chagas' disease, syphilis, and ma-
laria can also be spread through contaminated blood and blood
products.1 40  No international legal protections for blood and
organ safety currently exist.
1 4 1
4. Socio-Economic and Environmental Factors
a. Social Unrest and Civil War
Historically, war has been conducive to infectious diseases
by creating conditions ripe for outbreaks. While the prospects
for traditional interstate war are probably smaller in the post-
Cold War era, social unrest and civil war are currently promi-
nent issues in international relations. With civil unrest and
war come the breakdown of political authority, public health
services and facilities, and large movements of refugees that
generate a rich environment for infectious diseases.' 42 Infec-
139. See Katarina Tomasevski, Health, in 2 UNrTED NATIONS LEGAL
ORDER 859, 886-87 (Oscar Schachter & Christopher C. Joyner eds., 1995).
140. See id. at 886.
141. See id. at 888.
142. See Anthony A. Marfin et al., Infectious Disease Surveillance During
Emergency Relief to Bhutanese Refugees in Nepal, 272 JAMA 377, 377 (1994)
(commenting that "[riefugees and internally displaced persons, especially
those living in temporary camps, suffer from high mortality rates compared
with nondisplaced persons"). WHO observes that civil war complicates control
of infectious disease epidemics by making it difficult for public health officials
to have safe access to refugees. World Health Organization, Emergency Vac-
cination Campaign in Liberia to Control Yellow Fever Outbreak, WHO Press
Release, WHO/83 (Nov. 24, 1995) <http:.//www.who.clhpress/1995/pr95-83.htmbl>;
see also World Health Organization, Suspect Cases of Ebola in Liberia, WHO
Press Release, WHO/90 (Dec. 11, 1995) <http//www.who.ch/press/1995/pr95-
90.html> (noting that the WHO team had to receive permission from warring
factions in order to carry out an investigation of Ebola infections in Liberia).
Recent events contain classic examples of how civil unrest and war pro-
mote the reemergence of infectious diseases. For example, the civil war in
Rwanda forced hundreds of thousands of refugees into neighboring Zaire in
1994. See Wilson, supra note 110, at 41. In the first month that the refugee
camps existed, disease exploded in the camps and approximately 50,000 refu-
gees died from cholera or shigella. See id. Similarly, a cholera epidemic also
broke out in Sierra Leone, where a civil war raged and threatened to create
other epidemics of diarrheal diseases, malaria, and acute respiratory infec-
tions. See World Health Organization, Threat of Epidemics in Sierra Leone,
WHO Press Release, WHO/49 (June 23, 1995) <http'//www.who.ch/press
/1995/pr-95.html>. The civil war in Liberia has caused widespread displace-
ment of populations within that country and neighboring states, starting a
yellow fever epidemic in Sierra Leone that threatens to spread throughout
that region of West Africa. See World Health Organization, Yellow Fever Out-
break in Liberia, WHO Press Release, WHO/81 (Nov. 15, 1995) <http//www.
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tious diseases do not require, however, actual military conflict
to cause epidemics in unsettled countries. For example, the
harsh economic and social transitions to democracy and capi-
talism underway in the newly independent states of the former
Soviet Union triggered a diptheria epidemic that, according to
WHO, threatened to spin out of control into a global public
health emergency.143
b. Environmental Degradation
Man-made changes to the natural environment are often
factors in the EIfD problem.'" Human manipulation or de-
struction of the environment increases the potential for EIDs
by bringing humans into closer contact with host organisms,
making transmission into human populations easier, or by al-
tering an ecosystem so that conditions are favorable for the
growth of the microbe or its host organism. Scientific research
demonstrates that changes to the natural environment can
produce conditions conducive to the emergence and reemer-
gence of infectious diseases.1
45
Scientists have identified many infectious diseases that
have spread after environmental changes. These include Ar-
gentine hemorrhagic fever,' 46 Bolivian hemorrhagic fever,
147
Lassa fever, 4 8 Lyme disease, 149 La Crosse encephalitis, 50 and
who.ch/press/1995/95 81.html>. WHO has also reported outbreaks of hemor-
rhagic fever with renal syndrome in war-torn Bosnia and Herzegovina. See
World Health Organization, Disease Outbreaks Reported-Previous Bulletins
(visited Jan. 21,1997) <http://www.who.ch/programmes/emc/oldnews.htm>.
143. See World Health Organization, Diphtheria Epidemic-International
Health Emergency, WHO Press Release, WHO/48 (June 19, 1995) <http//www.
who.ch/press/1995/ pr95-48.html>.
144. See Morse, supra note 136, at 25-26 (noting the role of environmental
degradation in emergence of viruses).
145. See Ann Gibbons, Where Are Wew" Diseases Born?, 261 SCIENCE 680,
680-81 (1993) (reporting on two projects providing evidence that environ-
mental change leads to the emergence or reemergence of infectious diseases).
146. See Walter Dowdle, The Origins of Plagues, 261 SCIENCE 1610, 1611
(1993) (mentioning that Argentine and Bolivian hemorrhagic fevers emerged
because of changes in agricultural practices).
147. See id.
148. See MCCORMIcK & FISHER-HOCH, supra note 61, at 90-91 (noting
diamond mining as factor in Lassa fever in Sierra Leone).
149. See Paul Salopek, Latest Hot Zone for Diseases May Be Right Out
Your Window, Ci. TRB., Apr. 21, 1996, at Al (reporting that outbreaks of
Lyme disease are associated with the growth of suburbs).
150. See id. (reporting that outbreaks of La Crosse encephalitis are associ-
ated with the growth of suburbs).
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ehrlichiosis. 151 Although the natural host or reservoir for Ebola
virus has yet to be identified, some experts suspect that de-
struction of rain forests in Africa has brought humans into con-
tact with this almost always fatal virus. 15' Human manipula-
tion of the environment can also increase the populations of
organisms that host infectious agents thus increasing the
likelihood of transmission to humans. 5 Predictions about
global warming also have ominous portents for control of in-
fectious diseases. Scientists have predicted that global warm-
ing could significantly increase the habitats of key infectious
disease vectors, such as mosquitoes, leading to more cases of
malaria, yellow fever, and dengue.1 54  Global warming could
also fuel further growth of algae blooms in the world's oceans
and the pathogens those blooms harbor. 55
Ironically, some efforts to improve environmental protec-
tion may help the spread of infectious diseases. The Institute
of Medicine notes with concern, for example, that U.S. regula-
tions on pesticide use may make it difficult to deal with an out-
break in the United States of a vector-borne disease like ma-
laria or dengue.
1 56
151. See id. (reporting that outbreaks of ehrlichiosis are associated with
the growth of suburbs).
152. See PRESTON, supra note 61, at 287 (stating that emergence of Ebola
"appears to be a natural consequence of the ruin of the tropical biosphere").
153. Experts believe that the construction of dams and irrigation systems
have increased the prevalence of Rift Valley fever. See Morse, supra note 136,
at 18. Marine pollution has produced fertile conditions for cholera growth in
algae blooms that feed off nitrogen-rich, sewage-laden pollution. See GAR-
RETT, supra note 7, at 563-67 (discussing relationship of cholera epidemics to
algae blooms in the ocean and noting cholera can lie dormant and incubated
within algae until the virus has direct contact with humans); see also Paul R.
Epstein et al., Marine Ecosystems, 342 LANCET 1216, 1216 (1993) (noting the
relationship between algae blooms and infectious diseases like cholera).
154- See Richard A. Kerr, Greenhouse Report Foresees Growing Global
Stress, 270 SCIENCE 731, 731 (1995) (describing warnings from UN-sponsored
Intergovernmental Panel on Climate Change about potential spread of tropi-
cal diseases because of global warming); Jonathan A. Patz et al., Global Cli-
mate Change and Emerging Infectious Diseases, 275 JAMA 217, 218 (1996)
(identifying potential for increase in vector-borne infectious diseases as a re-
sult of global warming); David Brown, Infectious Disease May Rise As the
World Gets Warmer, WASH. POST, Jan. 17, 1996, at A2 (reporting that re-
searchers at Johns Hopkins, Harvard, and George Washington universities
found malaria, dengue, cholera, and other diseases could spread because of
global warming).
155. See Patz et al., supra note 154, at 220.
156. See IOM REP., supra note 13, at 13-14. The Institute of Medicine
specifically commented on: (1) the likelihood that U.S. pesticide regulations
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The close relationship between environmental degradation
and the emergence and reemergence of infectious diseases
greatly increases the difficulty in containing and preventing
EID outbreaks. Some experts believe that the environment's
link to EMIs forces public health officials and scientists to
broaden their approach to EMs to include sensitivity to and
surveillance of ecological conditions around the world.157 Con-
versely, some experts view global health surveillance and
monitoring as important in shaping environmental protection
strategies. 58 The intertwined nature of environmental protec-
tion and infectious disease control in the global village poses
profound questions for formulating international legal strate-
gies against EDs. As Thomas Lovejoy comments, "All of the
major environmental problems, population, deforestation, loss
of biological diversity, global pollution, are really all part of one
great inter-connected problem and, in many senses, represent
the greatest challenge that faces human society."
159
c. Changes in Human Behavior
New patterns of human behavior comprise additional
pieces of the EID puzzle. Changing sexual practices have re-
ceived the most attention. Sex has long been a method of
transmission for infectious diseases.1 60  Changes in human
have forced many effective pesticides to become unavailable in the United
States, see id. at 13; (2) the inefficient procedures that must be followed before
pesticides can be applied in emergency situations in enviromnentally-
protected areas, see id. at 13-14; and (3) the lack of incentives created by U.S.
regulations as well as by market conditions for the development of new pesti-
cides. See id. at 14. The report concluded that pesticide development for
public health applications needs to be given priority. See id.
157. See Patz et al., supra note 154, at 221.
158. See Andrew Haines et al., Global Health Watch: Monitoring Impacts
of Environmental Change, 342 LANCET 1464, 1469 (1993) (arguing that
"[gjreater integration of efforts to collect data on health and global environ-
mental change is needed").
159. Thomas E. Lovejoy, Global Change and Epidemiology: Nasty Syner-
gies, in EMERGING VIRUSES 261, 264 (Stephen S. Morse ed., 1993).
160. The growth of urban areas in all civilizations created an environment
conducive to multiple-partner sex and increased the chances that sexually-
transmitted diseases would spread. See GARRETT, supra note 7, at 235, 245
(commenting that city dwellers throughout the history of urbanization "built
centers for sexual activity that allowed microbes to exploit another method of
transmission" and noting that "[s]ince ancient times urban centers had been
hubs of profligacy in the eyes of those living in small towns and villages").
Epidemics of sexually-transmitted diseases are not twentieth century phe-
nomena. For example, a syphilis epidemic broke out in Europe in 1495 and
spread worldwide within two years. See id. at 245.
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sexual practices in the late twentieth century have, however
resulted in new epidemics of sexually-transmitted diseases.161
Garrett identifies the 1970s, at least as regards many developed
countries, as "a time of sexual liberation and experimentation"
for heterosexuals and homosexuals alike. 62 While multiple-
partner sex was not new, the sexual liberation trend combined
with rapid urbanization and global travel made the "scale of
multiple-partnering during the late twentieth century... un-
precedented."163 In this fertile environment, pathogenic mi-
crobes had an orgy. Between 1965 and 1975, cases of gonor-
rhea and syphilis in the United States tripled and quadrupled
respectively.' In the 1970s and 1980s, cases of Chlamydia
steadily increased in the United States. 165 Genital herpes,
caused by the herpes simplex type H virus, experienced a nine-
fold increase in the United States between 1966 and 1981.166
From 1975 to 1987, reports of chancroid increased tenfold in
the United States. 167 A similar story of sexually-transmitted
diseases on a rampage could be told in developing countries as
well. 168
161. This section focuses on changes in sexual behavior perceived by ex-
perts to be contributing to new epidemics of sexually-transmitted diseases.
Sexual behavior changes are complex because they reflect many other socio-
economic phenomena. Factors contributing to new patterns of sexual behav-
ior in the developed world are likely to differ from those affecting the develop-
ing world. For example, changes in cultural and societal attitudes towards
sex (i.e., the sexual revolution) may factor more prominently in the increase in
sexually-transmitted diseases in Europe and the United States than in Africa,
where urbanization may play a bigger role in sexually-transmitted disease
epidemics. Exploring these different socio-economic contexts of the global in-
crease in sexually-transmitted diseases is beyond the scope of this Article.
162. GARRETT, supra note 7, at 262-63.
163. Id. at 263; see also WORLD HEALTH REP. 1996, supra note 2, at 17
("Increases in the number of sexual partners have been the main factor in the
spread of HIV infection and other sexually transmitted diseases.").
164. See GARRETT, supra note 7, at 264; see also IOM REP., supra note 13,
at 54-55 (noting cases of syphilis in the United States nearly doubling from
1985 to 1990); WORLD HEALTH REP. 1996, supra note 2, at 33 (recording an
estimated 62 million new cases of gonorrhea and 12 million new cases of
syphilis worldwide in 1995).
165. See GARRETT, supra note 7, at 265; see also WORLD HEALTH REP.
1996, supra note 2, at 33 (noting WHO estimate of 89 million new cases of
chlamydial infection worldwide in 1995).
166. See GARRETT, supra note 7, at 267.
167. See id.; see also WORLD HEALTH REP. 1996, supra note 2, at 24
(recording 7 million new cases worldwide of chancroid in 1995).
168. See GARRETT, supra note 7, at 268 (discussing the rise of various
sexually transmitted diseases, such as Pelvic Inflammatory Disease, in devel-
oping countries); see also WORLD HEALTH REP. 1996, supra note 2, at 33
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Infectious diseases did more than just explode in terms of
numbers of cases. Strains of gonorrhea developed resistance to
penicillin, ampicillin, spectinomycin, and finally to all tetra-
cycline antibiotics. 169 The bacterium causing chancroid also
developed antibiotic resistance.170 The changes in human sex-
ual behavior produced a chain reaction: more cases of sexually-
transmitted diseases resulted in more frequent use of antimi-
crobial drugs, which in turn triggered microbial adaptation and
drug resistance.
The sexual revolution also helped spread a new virus
and disease: HIV and AIDS. Multiple-partner sex, particularly
amongst homosexual men, was a key factor in the spread of
AIDS in the United States and Europe.1 71 In Africa, another
epicenter of the AIDS disaster, heterosexual activity fueled the
spread of IIIV. 172 The history of sexually transmitted diseases
in this century shows that microbes are supreme opportunists
and that human behavior is dangerously intertwined with the
power of the microbial world.
The sexual revolution was not the only change in human
behavior to create opportunities for the emergence and ree-
mergence of infectious diseases. The explosion in the use of
such drugs as heroin and cocaine in developed countries in the
second half of the twentieth century has provided infectious
diseases, particularly AIDS, with new opportunities to spread;
sharing contaminated needles has been an effective mode of
transmission for HIV.
1 73
(noting that "WHO estimates that at least 333 million new cases of sexually
transmitted diseases, other than HIV infection, occurred in 1995").
169. See GARRETT, supra note 7, at 266 (indicating that treatment of gon-
orrhea became terribly complicated because of a strain that was resistant to
the entire tetracycline family of antibiotics); see also WORLD HEALTH REP.
1996, supra note 2, at 20 (noting that the bacterium Neisseria gonorrhoaea
has acquired resistance to penicillin and tetracyclines).
170. See GARRETT, supra note 7, at 267 (asserting that the chancroid bac-
terium developed resistance to ampicillin, sulforamides, chloramphenicol, and
tetracyclines).
171. See IOM REP., supra note 13, at 55 (indicating that high-risk sexual
practices of some male homosexuals contributed to the early spread of HIV,
particularly in the United States and Europe).
172. See id. (indicating that the transmission of HIV in Africa occurred
primarily among heterosexual populations).
173. See GARRETT, supra note 7, at 326 (commenting on CDC's efforts to
understand transmission of HIV through sharing of needles by drug users);
WORLD HEALTH REP. 1996, supra note 2, at 32 (noting that HIV spreads
through contaminated needles).
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Other changes in human behavior also created opportuni-
ties for infectious diseases. For example, circumstances rang-
ing from personal satisfaction to economic necessity have led
many women into the workplace since the late 1960s. One
consequence of this change in female behavioral patterns has
been the increased use of child care facilities by families with
younger children. This increased use of daycare centers and
other facilities is directly linked to the dramatic increase in
childhood ear infections in the United States. The CDC reports
that childhood ear infections increased 150% from 1975 to
1990.174 Evidence exists that the bacteria causing childhood
ear infections are acquiring drug-resistance to the traditional
antibiotic treatments as well. 7 5 Once again, human behavioral
changes have encouraged the reemergence of an infectious dis-
ease and its development of antimicrobial resistance.
d. Urbanization
Urbanization has always been a factor in the spread of in-
fectious diseases. In the last fifty years, though, urbanization
around the world has become "irrepressible and breathtakingly
rapid."76 More importantly, most of the growth seen in ur-
banization has taken place and is taking place in the develop-
ing world.17 7 Garrett reports that by the year 2000, twenty-four
cities will have populations of 10 million or more, and most of
them will be in developing countries.178 Megacities of 10 mil-
lion or more residents are only the tip of the iceberg; the fastest
growing cities are smaller metropolises, which suffer the same
problems as larger urban areas. r 9 Population growth and mi-
gration to urban areas explain much of the urbanization phe-
nomenon. The Institute of Medicine noted that "the size and
density of many cities are.., increasing, in part because of the
overall population growth rate-each year the population of
174. See CDC STRATEGY, supra note 26, at 9.
175. See id. at 12 (noting that drugs are losing their effectiveness against
pneumococcal infections, which include childhood ear infections).
176. GARRETT, supra note 7, at 247.
177. See id. at 248; cf Eugene Linden, The Exploding Cities of the Develop-
ing World, FOREIGN AFF., Jan.-Feb. 1996, at 52, 53 (noting the United Na-
tions' prediction that 5 billion people, or 61% of humanity, will be living in
cities by the year 2025).
178. See Garrett, Infectious Disease, supra note 61, at 71.
179. See Linden, supra note 177, at 54-55 (positing that the fastest growing
urban areas are not the giant metropolises but "anonymous secondary cities").
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the world grows by approximately 70 million."180 Moreover, the
world's rural populations are increasingly migrating to cities.
181
Migration patterns tend to follow a disturbingly familiar for-
mat: from rural areas in developing countries to secondary ur-
ban areas, then onto the megacity, and finally to the developed
world.18 2 Most frequently, immigrants from developing coun-
tries end up in large cities in developed countries, which offer
opportunities for transmission not unlike those found in the
megacity of a developing country. This linkage between ur-
banization and migration represents a powerful combination
that fosters the emergence and reemergence of infectious dis-
eases.
Urbanization has been linked to emergence or reemer-
gence of air-borne diseases (e.g., tuberculosis), blood-borne dis-
eases (e.g., HIV/AIDS), water-borne diseases (e.g., cholera),
vector-borne diseases (e.g., malaria and dengue), virtually
every kind of sexually transmitted disease, and the develop-
ment of drug-resistant strains of diseases.183 In the eighteenth
and nineteenth centuries, urbanization nurtured infectious
diseases in North America and Europe as well;&I4 but im-
provements in sanitation and hygiene made a tremendous im-
pact in North American and European cities before the intro-
duction of antimicrobial treatments.1 8 5  Most cities in
developing countries lack, however, the resources to build ade-
quate sanitation and hygiene infrastructures. According to
Garrett, most urban centers in developing countries "are
squalid sites of destitution where hundreds of thousands live
180. IOM REP., supra note 13, at 49.
181. See id. (noting that in 1970 more than one third of the world's popu-
lation lived in cities and that by 2000 this will increase to one alf).
182. See Garrett, Infectious Disease, supra note 61, at 71-72.
183. See GAPR=, supra note 7, at 240-41 (discussing the rise of tubercu-
losis in Europe); id. at 255-50 (discussing link between dengue and urbaniza-
tion); Cities as Disease Vectors, 270 SCIENCE 1125, 1125 (1995) (suggesting
that rapid urban growth in Peru caused a cholera outbreak there); Garrett,
Infectious Disease, supra note 61, at 72 (discussing the link between HIV and
African urbanization); id. (noting black market access to antimicrobial drugs
in urban centers leading to overuse and misuse of the drugs and the emer-
gence of drug-resistance); Lifson, supra note 64, at 1201 (describing the suc-
cessful exploitation of urban areas by dengue mosquito vector); Linden, supra
note 177, at 56 (attributing the spread of malaria to urbanization); id. at 57
(detailing the spread of the cholera epidemic in South America).
184. See GARRET, supra note 7, at 234-47 (describing the history of infec-
tious diseases in urban areas).
185. See id. at 242-43 (discussing social reform campaigns aimed at im-
proving urban sanitation and hygiene).
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much as they would in poor villages, yet so jammed together as
to ensure astronomical transmission rates for airborne, water-
borne, sexually transmitted, and contact-transmission mi-
crobes."18 6 Urbanization in developing countries will continue
to create incubators for infectious diseases. Given the speed,
volume, and ease of global travel, such incubators are an
alarming prospect. As Linden succinctly noted, "The developed
world ignores at its peril the problems of Third World cities."8 7
e. Poverty
Closely related to urbanization as a factor contributing to
EfDs is poverty. People living in poverty suffer a multitude of
conditions that create opportunities for pathogenic microbes.
88
Poor people tend to live in crowded housing that often lacks
proper ventilation and adequate sanitation,189 generally have
worse diets than the affluent, making their weakened immune
systems more vulnerable to infectious diseasesf190 typically
have limited or no access to primary health care, 19 and tend to
make up the majority of economic migrants, whether the mi-
gration is from rural areas to cities within a country 92 or from
developing countries to the developed world.193 As the Direc-
tor-General of WHO stated, poverty remains the main obstacle
186. Garrett, Infectious Disease, supra note 61, at 71.
187. Linden, supra note 177, at 53.
188. See Gostin, The Resurgent Tuberculosis Epidemic in the Era of AIDS,
supra note 87, at 39 (arguing that a wide variety of health conditions, includ-
ing stress, alcoholism, overcrowded housing, air pollution, and low infant
birth weight produce an "association between poverty and respiratory disease"
that disproportionately impacts the poor).
189. See WORLD HEALTH REP. 1996, supra note 2, at 10-11 (reporting that
"[in the developing world, a shortage of affordable housing for the majority of
low-income urban dwellers has caused a proliferation of slums and squatter
settlements" in which sanitation services are "non-existent and opportunities
for connecting to city water, sewerage and power supplies are poor").
190. See Gostin, The Resurgent Tuberculosis Epidemic in the Era of AIDS,
supra note 87, at 39 (noting that malnutrition is one health condition that af-
fects the immune system disproportionately among the poor).
19L See GARRETT, supra note 7, at 511 (contending that for the urban poor
in the United States "the only point of access to the health care system was
the public hospital emergency room").
192. See WORLD HEALTH REP. 1996, supra note 2, at 10 (noting that in
Latin America many poor people have migrated to cities).
193. See id. at 4 (noting migration patterns from developing to developed
countries).
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to health development worldwide. 194 Poverty is the faithful
squire of pestilence.
195
Not only does poverty itself generate a fertile environment
for infectious diseases but it also contributes to other factors
behind the spread of EDs. Poverty, for example, compels
many people to seek a better life in a city or in another, more
affluent country. Thus, it increases both urbanization and
global migration. Once the migration to a city or separate
country is complete, most economic migrants do not escape
poverty. Economic migrants usually swap rural for urban pov-
erty.196 Urban areas are very good places for disease spread;
197
migration from rural to urban poverty benefits pathogenic mi-
crobes. Urban poverty creates opportunities for poor people to
survive economically in ways that encourage transmission of
infectious diseases, like prostitution, sales of illegal drugs, and
black market sales of antimicrobial treatments. Poverty also
encourages agricultural and other economic practices that de-
grade the environment such as deforestation and marine pol-
lution, and thus creates more chances for transmission of in-
fectious diseases.
194. See World Health Organization, World Summit on Social Develop-
ment 11-12 March, Copenhagen, Denmark: Health Is Central to Social Devel-
opment, WHO Press Release, WHO/18 (Mar. 6, 1995) <http'//www.who.ch
/pressf1995/pr95-18.html> [hereinafter Health is Central to Social Develop-
ment).
195. The reemergence of tuberculosis offers a specific example of the influ-
ence of poverty on the emergence and reemergence of infectious diseases. Tu-
berculosis is far more prevalent in developing countries than in developed
states, suggesting that the difference in economic wealth plays a role in the
prevalence of tuberculosis. See GARRETT, supra note 7, at 243 (discussing the
enormous decline in tuberculosis cases in the Northern Hemisphere in the
twentieth century even though the disease continued to rage across Africa,
Asia, and South America). Within developed countries, the poor suffer tuber-
culosis more than the rich. See Gostin, The Resurgent Tuberculosis Epidemic
in the Era of AIDS, supra note 87, at 38 (contending that those groups that
fall below the poverty line "are precisely those groups that are most affected
by the tuberculosis epidemic"). Others have made similar conclusions about
other infectious diseases. See, e.g., Diane Seligsohn, The New Underclass and
Re-Emerging Diseases, WORLD HEALTH, Nov.-Dec. 1994, at 25, 25 (arguing
that the "resurgence in infectious diseases observed during the 1990s appears
to be linked to the growing poverty and deprivation of a new underclass in
many European and North American cities").
196. See WORLD HEALTH REP. 1996, supra note 2, at 10-11 (noting prob-
lems that migrants to urban centers face, including overcrowding, inadequate
sanitation, polluted water and air, and increased risks of infectious diseases).
197. See supra text accompanying notes 176-187 (discussing urbanization
as a factor in the spread of infectious diseases).
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Just as poverty contributes to EIDs, infectious diseases are
clearly factors in causing and/or perpetuating poverty.19 Such
synergy is most obviously at work in developing countries
where infectious diseases exact a huge toll economically. Ma-
laria hurts, for example, economic development in areas where
it is endemic. WHO reports that malaria is endemic in ninety-
one countries, undermines the health of hundreds of millions,
and "is closely linked to poverty and contributes significantly to
stunting social and economic development."199 According to the
U.S. Department of State, AIDS is a very serious economic
threat in developing countries because it kills productive work-
ers and skilled professionals, decreases output and income, en-
courages inefficient business and government operations,
threatens tourism, and scares off much-needed foreign invest-
ment and business.20  As WHO has observed, diseases are
likely to continue to exact their heaviest burdens on the peo-
ples of the developing world for the foreseeable future, crip-
pling their socioeconomic development.20'
I1. EIDS AS A PROBLEM IN INTERNATIONAL RELATIONS
Analyzing the factors shaping the EID problem demon-
strates the seriousness and complexity of the EID problem.
Part II briefly discusses how pathogenic microbes interact with
and affect the structure and dynamics of international rela-
tions. The objective of this analysis is not only to measure the
impact infectious diseases have on international relations, but
also to consider how the nature of the international system it-
self contributes to the global problem of EIDs.
198. See Health Is Central to Social Development, supra note 194 (noting
WHO Director-General's comment that ill-health causes and perpetuates pov-
erty); WORLD HEALTH REP. 1996, supra note 2, at 11 (indicating that in-
creased risks of infectious diseases perpetuate poverty by causing sickness,
which produces absences from work and lost earnings).
199. WORLD HEALTH REP. 1996, supra note 2, at 47; see also Emerging In-
fections Hearings, supra note 1, at 24 (reporting Dr. Kragstad's statement
that "meaningful economic development is simply not possible when 80 to 90
percent of a population has malaria for five to 6 [sic] months of the year or
more").
200. See U.S. INVL STRATEGY ON HIV/AIDS, supra note 39, at 37.
201. See WORLD HEALTH REP. 1996, supra note 2, at 9.
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A. MICROBES AND THE STRUCTURE OF THE INTERNATIONAL
SYSTEM
International relations occur within a system dominated
by independent states. Sovereignty has been the organizing
principle of international relations since the European Peace of
Westphalia in 1648.202 Under a system of sovereign states,
populations, territory, and resources are divided up and placed
under distinct political authorities. The international system
is, thus, full of boundaries. International efforts to deal with
infectious diseases continually confront issues of state sover-
eignty and control. Initiatives by the United States and other
developed countries to improve infectious disease surveillance
in developing countries must acknowledge that disease surveil-
lance is currently the responsibility of each sovereign state.2 °3
Neither WHO nor CDC can assist a country in the midst of an
infectious disease epidemic unless that country invites WHO or
CDC to provide assistance.2° In addition, as WHO's financial
problems suggest, WHO's authority and resources remain lim-
ited by the political and economic priorities of its member
states. As Allyn Taylor has observed, "The ability of WHO to
affect national health decisions ... is limited by a world order
dominated by independent nations."2
0 6
The structure of the international system is, however, ir-
relevant to the microbial world. Slogans like "germs know no
frontiers" and "germs carry no passports" have been used since
the founding of WHO.2 °7  In international relations terms,
202. See Ali Mazrui, Africa Entrapped: Between the Protestant Ethic and
the Legacy of Westphalia, in THE ExPANSION OF INTERNATIONAL SOCIETY 289,
306 (Hedley Bull & Adam Watson eds., 1984) (stating that the sovereign state
was "very much a legacy of the Treaty of Westphalia of 1648").
203. See CISET REP., supra note 28, at 12 (noting that surveillance must
be the responsibility of each sovereign nation); U.S. INT'L STRATEGY ON
HIV/AIDS, supra note 39, at 7 (arguing that national governments have the
primary responsibility for AIDS surveillance, control, and prevention).
204. See CISET REP., supra note 28, at 18 (stating that U.S. participation
in an investigation in another country is dependent upon a formal request for
assistance from that country).
205. See Gordenker, supra note 98, at 176 (commenting on budget con-
straints created by WHO member states' reluctance to provide more funds).
206. Allyn L. Taylor, International Public Health Law, 86 AM. Soc'Y INT'L
L. PROC. 574,574 (1992).
207. See Walter R. Sharp, The New World Health Organization, 41 AM. J.
INT'L L. 509, 514 (1947) (commenting on these slogans from the conference
that established WHO). For recent pronouncements on the same idea, see
Emerging Infections Hearings, supra note 1, at 5 (relating Dr. Robert Shope's
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pathogenic microbes constitute nonstate actors with transna-
tional power. The consequences are threefold. First, the
spread of infectious diseases throughout the international sys-
tem undermines sovereignty when a state cannot protect the
health of its public. As numerous commentators have ob-
served, the distinction between national and international
health policy is no longer helpful. °8 When pathogenic microbes
combine with global travel and international trade, infectious
diseases become part of the globalization process.20 9 The EID
problem accentuates the extent to which microbes in this
global era denationalize health and health policy.210
Second, the irrelevance of the structure of the interna-
tional system to microbes requires that states cooperate to ad-
dress infectious diseases. As the CISET Working Group ob-
served, international cooperation is critical.211 The need for
such cooperation is evident in the statements of political lead-
ers,21 2 the activities of WHO in establishing international pro-
grams on malaria,213 cholera,214 tuberculosis, 215 and AIDS,2 16
statement that "infections do not recognize national borders"); Gore, supra
note 4, at 2 (stating that diseases do not stop at the border, respect treaties,
or carry passports or visas).
208. See CDC STRATEGY, supra note 26, at 12 (suggesting that the "concept
of 'domestic' as distinct from 'international' health is outdated"); Berkley, su-
pra note 39, at 3369 (indicating that the distinction between domestic and in-
ternational health is obsolete); George A. Gellert et al., The Obsolescence of
Distinct Domestic and International Health Sectors, 10 J. PuB. HEALTH POLY
421, 421 (1989) (arguing that "traditional and historical bases for differentiat-
ing domestic and international health in Western nations have . . . lost
meaning"); LeDuc, supra note 96, at 318 (proposing that national health has
become an international challenge).
209. Globalization has been defined as the "process of denationalization of
markets, laws and politics." Jost Delbrdick, Globalization of Law, Politics,
and Markets-Implications for Domestic Law-A European Perspective, 1 IND.
J. GLOBAL LEGAL STUD. 9, 11 (1993).
210. See Fidler, supra note 8, at 78 (stating that public health policy has
been denationalized because a country cannot tackle EIDs by itself).
211. See CISET REP., supra note 28, at 11.
212. See Gore, supra note 4, at 10 (stating that the international challenge
of EDs must be met with international solutions); Group of Seven Statement,
supra note 59 (listing new epidemics as one of several challenges which inter-
national leaders must face together).
213. See World Health Organization, Malaria Outbreak in India, WHO
Press Release, WHO/82 (Oct. 25, 1994) <http'//www.who.clhpress/1994/pr94-
82.html> (noting establishment of global malaria strategy in 1992).
214. See World Health Organization, Cholera Outbreak in Ukraine, WHO
Press Release, WHO/57 (Aug. 8, 1995) <http//www.who.ch/press/1995/pr95-
57.html> (quoting Dr. Maria Neira of the WHO Global Cholera Task Force).
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and regional efforts against infectious diseases.217 Interna-
tional cooperation on infectious disease control is, of course, not
new.218 The EID problem does, however, give new urgency to
the age-old recognition that international cooperation is
needed to combat pestilence.
Third, the need for international cooperation makes the
structure of the international system an obstacle to global in-
fectious disease strategies. While microbes simply bypass sov-
ereignty, states must adhere to the limitations, procedures,
and inefficiencies created by an international system. Put an-
other way, "globalization jeopardizes disease control nationally
by eroding sovereignty, while the need for international solu-
tions allows sovereignty to frustrate disease control interna-
tionally."2 9 The structure of the international system thus
helps pathogenic microbes by creating obstacles to effective in-
ternational disease control. To evaluate the extent to which
this is true, we need to examine how microbes affect the dy-
namics of international relations.
B. MICROBES AND THE DYNAMICS OF INTERNATIONAL
RELATIONS
To evaluate the effect of EDs on international relations,
we must understand whether EIDs and their consequences in-
crease or decrease international order, cooperation, and com-
munity. Proponents of both views exist. Some believe that the
EID threat offers the international community an opportunity
to strengthen common interests, values, and institutions
through global cooperation on public health policy. William
Mock notes, for example, that public health law is no longer
within the exclusive domain of the state but has become a
subject of international law.220 Mock believes that interna-
215. See Raviglione et al., supra note 31, at 225 (noting WHO's declaration
in 1993 that tuberculosis was a global health emergency).
216. See Jonathan Mann et al., Global Coordination of National Public
Health Strategies, 18 L. MED. & HEALTH CARE 20 (1990) (describing WHO's
global strategy for AIDS).
217. See World Health Organization, Epidemic Dengue and Dengue Haem-
orrhagic Fever in the Americas, WHO Press Release, WH0/72 (Sept. 28, 1995)
<http'J/www.who.ch/press/1995/pr95-72.html> (describing emergency plan to
control dengue fever epidemics adopted by Central American health authori-
ties with assistance from the Pan American Health Organization).
218. See Howard-Jones, supra note 93, at 1032-36 (describing the history
of international cooperation on public health matters).
219. Fidler, supra note 8, at 83.
220. See The Global Challenge of HIV/AIDS: The Future of World Health
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tional health law now addresses basic issues of human rights,
like the right of access to health care and freedom of move-
ment, and issues concerning the internal governance and
structure of national public health systems.2 2 1 He further be-
lieves that the AIDS pandemic will influence international law
positively in the areas of human rights, global governance, and
global development. 2 Because international law is evidence
that an international society exists,223 the growth of interna-
tional health law can be understood as a positive development
for global public health by representing the growth in the
common interests, values, and rules among states. The deci-
sion by member states of the European Community to grant
authority to the European Community in the area of public
health through the 1992 Treaty on European Union 224 is per-
haps the best expression of this sentiment.
The incorporation of public health matters into international
law and supranational institutions does not, however, necessarily
affect the dynamics of international relations in a positive way.
The recent controversy within the European Community concern-
ing the banning of British beef exports because of fears of so-called
Law, 87 AM. SOC'Y IN'L L. PROC. 534, 535 (1993) (remarks by William B.T.
Mock).
221. See id.
222. See id. at 546.
223. See HEDLEY BULL, THE ANARCHICAL SOCIETY 140 (1977) (stating that
the first function of international law is to identify the idea of a society of sov-
ereign states).
224. See Christopher Bartlett & Noel Gill, Communicable Disease Control
After Maastricht: Germs and Subsidiarity, 341 LANCET 997, 997 (1993)
(discussing the treaty and suggesting priorities for joint action across the
European Community to control communicable disease). The Treaty on Euro-
pean Union inserted into the Treaty Establishing the European Community
Title X on Public Health providing that "ltlhe Community shall contribute to-
wards ensuring a high level of human health protection by encouraging coop-
eration between the Member States and, if necessary, lending support to their
action." EC TREATY art. 129.
The activity of the European Community after the Treaty of European
Union on infectious disease surveillance is summarized in European Com-
mission Communication Concerning Communicable Disease Surveillance
Networks in the European Community, COM(96)78, at 9-12. The European
Commission issued in March 1996 a Proposal for a European Parliament and
Council Decision Creating a Network for the Epidemiological Surveillance and
Control of Communicable Diseases in the European Community, 1996 O.J. (C
123) 10. In November 1996, the European Parliament offered amendments to
this proposal. See EP Modifies Proposals on a Network for Surveillance of
Communicable Diseases and AIDS in Developing Countries, Agence Europe,
Nov. 22, 1996, available in LEXIS, Nexis Library, Txtnws File (detailing the
Parliament's amended recommendations).
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"mad cow disease" illustrates how infectious diseases can ad-
versely affect even the most interdependent and peaceful relations
between states.ns Unfortunately, history suggests that infec-
tious diseases tend to cause friction in international relations
rather than build community. As this Article discusses more
thoroughly below, n 6 the major set of international legal rules
on infectious disease control-the International Health Regu-
lations-have not been successful. n 7 Historically, states have
tended not to report serious disease outbreaks to other coun-
tries or WHO because they fear such reporting will reduce
tourism and trade.28  For instance, Garrett reports that
"nearly every country initially denied or covered up the pres-
ence of the HIV virus within its borders" and that "at least ten
nations known to be in the midst of HIV epidemics refuse to
cooperate with WHO, deliberately obfuscating incidence re-
ports or declining to provide any statistics. "2 Egypt denies
that the Nile contains cholera bacteria, Saudi Arabia does not
want to warn pilgrims traveling to Mecca about mosquitoes
carrying the dengue virus, and Serbia canceled an interna-
tional epidemic alert concerning the deadly Crimean-Congo
hemorrhagic fever when it learned that WHO planned to send
American scientists to investigate.230 In recent years, several
countries in the Caribbean did not notify other countries of
dengue epidemics, believing that news of the epidemic would
225. See, e.g., Paul Mylrea, Britain's Links to EU at Risk over Mad Cow
Crisis, REUTER EUR. CoMMUITy REP., Mar. 26, 1996, available in LEXIS,
Nexis Library, Curnws File (discussing strained relations between the British
government and the European Community over the ban on British beef ex-
ports imposed out of fear of spread of "mad cow disease"); Case C-180/96R,
United Kingdom v. Commission, 3 C.M.L.R. 1 (1996) (European Court of Jus-
tice rejecting Britain's application for the annulment of the E.C. Commission's
decision imposing a worldwide ban on the export of British beef and beef
products).
226. See infra note 374 and accompanying text (noting WHO officials' ac-
knowledgment of the inadequacy of the IHR as early as 1968).
227. See Allyn Lise Taylor, Making the World Health Organization Work: A
Legal Framework for Universal Access to the Conditions for Health, 18 AM. J.
L. & MED. 301, 343-44 (1992) (noting that WHO's law-making efforts in tradi-
tional areas of international public health regulation have been acknowledged
a failure by senior WHO health legislation officials).
228. See CISET REP., supra note 28, at 12 (noting that national govern-
ments may not share disease surveillance information because of feared losses
in trade, tourism, and national prestige).
229. Garrett, Infectious Disease, supra note 61, at 74.
230. See id.
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hurt their tourist industries.231 The outbreaks only came to the
attention of other countries after tourists returning home fell
sick.23
2
Another example of how infectious diseases adversely af-
fect international relations comes in states' reactions to epi-
demics in other countries. Fears of lost trade and tourism ap-
pear to be well-founded. The cholera outbreak in Peru in 1991
resulted in an estimated loss in trade and travel of $700 mil-
lion for that country.233 Estimates of lost trade and travel in
the wake of the 1994 plague epidemic in India run as high as
$1.7 billion.234 As indicated in a 1975 WHO publication on the
IER, states often enact measures to keep diseases breaking out
in other countries at arm's length, and "[i]nstances of excessive
and useless measures have been numerous in the history of the
application of the Regulations since 1951." 235 Relations be-
tween states are strained, international trade and travel suf-
fer, and diseases continue to spread; none of which can be seen
as a positive influence on international relations.
Pathogenic microbes also exacerbate tensions in interna-
tional relations that have long existed for other reasons. The
most prominent of these tensions is the inequality between rich
and poor states. Infectious diseases threaten all states, but
they exact the greatest toll in developing countries. 23 In short,
the burden of infectious diseases makes poor states poorer. For
example, the U.S. Department of State fears that H1V/AIDS
"threatens the sustainable economic development of many
countries."237 Not only does HIV/AIDS threaten the domestic
231. See CISET REP., supra note 28, at 19 (describing the spread of dengue
fever from continent to continent). Under the IHR, dengue is not a disease
subject to the notification requirements. See INTL HEALTH REG., supra note
89, art. 1, at 8.
232. See CISET REP., supra note 28, at 19 (explaining the failure of Carib-
bean countries to report dengue epidemics due to concerns about potential
losses in tourism). In 1994, India failed to report outbreaks of plague until
after the international press had widely disseminated news of the epidemics.
See Heymann, supra note 92, at 13. Plague is a reportable disease under the
HU. See INT'L HEALTH REG., supra note 89, art. 1, at 8.
233. See Heymann, supra note 92, at 12 (describing misapplications of the
IHR).
234. See id. at 13; see also Garrett, Infectious Disease, supra note 61, at 74.
235. DELON, supra note 90, at 24.
236. See WORLD HEALTH REP. 1996, supra note 2, at 15 (reporting that
most deaths caused by infectious diseases occur in Africa and southeast Asia).
237. U.S. INTL STRATEGY ON HIV/AIDS, supra note 39, at 1; see also Con-
fronting a Calamity, supra note 39 (stating that AIDS "threatens to under-
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resources of an economy, but it also has the potential for slow-
ing foreign trade with and investment in developing coun-
tries.2 8  These fears about the poverty-enhancing power of
HIV/AIDS are magnified in the context of more wide-spread in-
fectious diseases. Long a source of conflict in international re-
lations, the EID problem will deepen the inequality between
rich and poor states.
The importance developed countries give to EIDs, espe-
cially outbreaks in the developing world, is an indication of the
gulf between developed and developing countries. The lan-
guage of the current discourse on infectious diseases reveals a
clearly developed world bias. The concept of "reemergence" in
connection with some diseases has little meaning in the devel-
oping world. For instance, tuberculosis is considered a ree-
merging disease in the United States, but in many developing
countries it has long been endemic.239 Moreover, a major rea-
son why infectious diseases have reemerged as a serious inter-
national issue in the 1990s is because developed nations feel
threatened. 240 Parochial thinking on international infectious
disease control has a long pedigree. Examining the origins of
international efforts on infectious disease control, Howard-
Jones observed that implicit in all the conferences and diplo-
matic activities from 1851 on was "not a wish for the general
betterment of the health of the world, but the desire to protect
certain favoured (especially European) nations from contami-
nation by their less-favoured (especially Eastern) fellows."241
The attitude towards disease threats from less wealthy states
mine development efforts, depleting workforces and striking many sectors of
the economy").
238. The U.S. Department of State believes that "U.S. and other multina-
tionals will be forced to consider HIV/AIDS in foreign investment and trade
discussions." U.S. INT'L STRATEGY ON HIV/AIDS, supra note 39, at 4.
239. See WORLD HEALTH REP. 1996, supra note 2, at 27 (reporting that
"C[albout 95% of [tuberculosis] sufferers are in the developing world"); Paul
Farmer, Social Inequalities and Emerging Infectious Diseases, 2 EMERGING
INFECTIOUS DISEASES 259, 263 (1996) (noting that outside the industrialized
world, tuberculosis infection rates did not decrease despite the availability of
effective therapies).
240. The CISET Working Group asserted, for example, that "diseases that
arise in other parts of the world are repeatedly introduced into the United
States, where they may threaten our national health and security." CISET
REP., supra note 28, at 11.
241. Howard-Jones, supra note 93, at 1035; see also Michel Blanger, The
Future of International Health Legislation, 40 INT'L DIG. HEALTH LEG. 1, 5
(1989) (stating that international health law in the nineteenth century corre-
sponded "primarily to the requirements of European countries").
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that prevailed in 1851 is the same attitude that permeates
global infectious disease action plans today.
The tension in international relations between the have
and the have-not nations has other potentially malignant fea-
tures. The growth of awareness about the EID problem has
renewed worries in the United States and other developed
countries about the possible use of biological weapons by ter-
rorists.242 The harnessing of pathogenic microbes by terrorists
would heighten the problem terrorism poses in today's inter-
national system.
The EID problem may also play a role in undermining in-
ternational order and regional balances of power. The U.S.
Department of State has expressed concern that AIDS may
begin to undermine the military capabilities of countries in
Africa, Asia, and Latin America by degrading manpower re-
sources and military preparedness. Additionally, it may be-
gin to hamper international peacekeeping operations by forcing
the United Nations to deal with HIV-infected national contin-
gents from militaries with high infection rates.24 HIV/AIDS,
in combination with other infectious diseases, could alter mili-
tary power and preparedness in ways not witnessed since dis-
eases killed more soldiers than actual combat.245
The undermining of military capabilities in the developing
world is linked to-the economic problems infectious diseases
cause. Increasing economic instability combined with eroding
military capabilities could produce volatile conditions within
many nations. The U.S. Department of State posits that as
HIV/AIDS undermines economies and military capabilities in
certain countries "it may be a potential 'war-starter' or 'war-
outcome-determinant.' " 24 6 The adverse impact of other infec-
242. See CISET REP., supra note 28, at 4, 11 (commenting that an effective
global surveillance system could help detect terrorist incidents involving bio-
logical weapons); CDC STRATEGY, supra note 26, at 22 (noting that biological
warfare is an area of increasing international concern); Garrett, Infectious
Disease, supra note 61, at 75-76 (discussing how the threat of bio-warfare has
arisen in connection with the emergence and reemergence of infectious dis-
eases).
243. See U.S. INT'L STRATEGY ON HIV/AIDS, supra note 39, at 41.
244. See id. at 4 (enumerating new issues raised by HIV/AIDS that indus-
trialized nations must address).
245. For example, during the American Civil War, "twice as many Civil
War soldiers died of disease as were killed and mortally wounded in combat."
JAMES M. MCPHERSON, BATTLE CRY OF FREEDOM 485 (1988).
246. U.S. INVL STRATEGY ON HI/AIDS, supra note 39, at 40. The U.S.
Department of State reports that the impact of AIDS on military forces is
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tious diseases on economic and military capacities would only
amplify the ravages of HIV/AIDS. Infectious diseases have the
potential, therefore, to contribute not only to individual misery
and death but also to social disintegration that triggers civil
and perhaps even interstate war.
In sum, infectious diseases have a significant adverse ef-
fect on the dynamics of international relations. The idea that
states can cooperate and use the EID problem to build com-
munity among people and states is based more on hope than a
serious assessment of the effect of infectious diseases on inter-
national relations. The proposed solutions to deal with EIms
must address not only a sobering array of causes but also the
malignant effect of infectious diseases on international rela-
tions. Whether these proposals adequately face these daunting
challenges is the question to which this Article turns next.
III. GLOBAL PLANS FOR DEALING WITH EIDS
In response to the EID problem, scientists, public health
officials, and political leaders have been formulating plans to
address its many challenges. The Institute of Medicine, CDC,
CISET Working Group, Clinton administration, and WHO
have produced the major policy documents to date.247 The ef-
forts of the Institute of Medicine, CDC, CISET Working Group,
and Clinton administration focus on the United States and
thus do not take into account the national interests of other
states except to the extent that all states face analogous risks
from EDs. In contrast, WHO's plan is expressly global in that
it is not seeking to change the foreign and public health poli-
most severe in Africa, with the potential of the same degradation of military
capabilities affecting Asia, and to a lesser degree, Latin America. See id. at
41.
247. All the various plans are related, and thus have similar substantive
content. The seminal document was, as mentioned earlier, the 1992 report
from the Institute of Medicine. See generally IOM REP., supra note 13. The
CDC's plan responded to the Institute of Medicine's call for action and con-
tains many of the same objectives. See generally CDC STRATEGY, supra note
26. The CISET Working Group also relied on the work of both the Institute of
Medicine and CDC. See generally CISET REP., supra note 28. The new Clin-
ton administration policy follows the path already blazed by the Institute of
Medicine, CDC, and CISET Working Group. See generally Gore, supra note 4;
Addressing the Threat of Emerging Infectious Diseases, supra note 54.
Likewise, the WHO plan has benefited from the work of the Institute of
Medicine and CDC. See generally EMC Strategic Plan, supra note 89.
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cies of one state.248 Each of the U.S.-centered plans, however,
has a global perspective, making them not only national
strategies but international plans for confronting EDs.
Moreover, action by the United States is critical to global ef-
forts because it has power, influence, and resources.249
A detailed description of the major plans drafted to date is
beyond the scope of this Article, and, to a large extent, unnec-
essary because the plans share fundamental objectives and ex-
hort the adoption of common approaches. In this part, the Ar-
ticle provides a synthesis of the plans to locate the core
features and policy options of a global approach to the EID
threat.
A. THE FUNDAMENTAL OBJECTIVES
The plans share four fundamental objectives: to improve
international and national infectious disease surveillance ca-
pabilities; prevention and control strategies and resources;
public health infrastructures; and applied research on infec-
tious diseases.25 0 All these objectives are interrelated. Surveil-
lance addresses the identification of an infectious agent, which
is the critical first step to any containment strategy for infec-
tious diseases. Once an infectious disease is identified, public
health officials can institute control and prevention measures
to minimize disruption to social and economic activities. Sur-
veillance activities and prevention and control measures de-
pend on adequate public health systems; trained personnel,
equipment, facilities, and resources are needed to identify out-
breaks and to implement procedures that prevent and control
the spread of infectious diseases. Finally, public health offi-
cials rely on research from the scientific community in the fight
248. This approach is in keeping with WHO's objective to promote "the at-
tainment by all peoples of the highest possible level of health." WHO CONsT.
art. 1.
249. See CISET REP., supra note 28, at 3-4 (noting need for U.S. leader-
ship).
250. See id. at 23-24 (listing surveillance, diagnostic tests, response capa-
bilities, and research as objective of global strategy); CDC STRATEGY, supra
note 26, at 1 (listing surveillance, applied research, prevention and control,
and infrastructure as goals of CDC strategy); EMC Strategic Plan, supra note
89, at 2 (listing surveillance, infrastructure, prevention and control, and re-
search as goals of WHO). The European Community also seeks to improve
surveillance in its regional strategy. See Proposal for a European Parliament
and Council Decision Creating a Network for the Epidemiological Surveillance
and Control of Communicable Diseases in the European Community, 1996
O.J. (C123) 10.
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against pathogenic microbes. Good scientific data produced by
applied research can help improve surveillance, prevention and
control, and public health infrastructures. The four fundamen-
tal objectives fit together as integral parts of an overarching
"grand strategy."251
The four objectives address to varying degrees the factors
bearing on the ElD problem. Most directly, the grand strategy
takes aim at the complacency that has plagued infectious dis-
ease efforts for decades and at the deterioration of public
health systems resulting largely from such complacency. 52 As
stated at a WHO meeting, "We must.., concentrate first on
rebuilding our foundations in communicable diseases, if we are
to have the capability of meeting the new challenges of emerg-
ing and reemerging diseases."253 The grand strategy also offers
a way for public health officials to control infectious diseases
without restricting global travel and international trade. With
enhanced surveillance and prevention and control capabilities,
diseases that travel through migrants or goods can be identi-
fied and largely controlled without resorting to quarantine or
other trade-restricting measures. Better public health systems
can educate people about the dangers of certain types of behav-
ior, and improved surveillance can help public health authori-
ties intervene more effectively when diseases related to
changes in individual behavior appear. Finally, improved re-
search capabilities can help scientists and public health offi-
cials keep pace with the changes constantly occurring in the
microbial world.
The grand strategy has more limited potential in connec-
tion with civil unrest and war, environmental degradation, ur-
banization, and poverty. Nothing in the four objectives ad-
dresses the underlying causes of these allies of pestilence.
Experts formulating approaches to the E)ID threat understand
the importance of confronting these root causes of infectious
disease spread,254 but the grand strategy does not attempt to do
251. In the rest of this Article, reference to the "grand strategy" means
reference to the four fundamental objectives of the EID plans just outlined.
252. See supra Part I.B.2 (discussing complacency towards E)ID dangers
and resulting breakdown in public health systems).
253. WHO Meeting Memorandum, supra note 44, at 845-46.
254. See CISET REP., supra note 28, at 43-44 (noting that political and
economic instability and civil strife provide fertile breeding grounds for mi-
crobes, and that "[w]orldwide efforts to promote good governance, economic
development and resolution of conflicts are not out of place in a discussion of
how to deal with new and re-emerging diseases").
19971
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so." 5 Strengthened surveillance, prevention and control, pub-
lic health infrastructures, and applied research may well help
public health officials react more effectively against infectious
diseases fostered by civil war, environmental degradation, ur-
banization, and poverty. Because the grand strategy does not
attempt to address the root causes of these social problems,
though, the plans will constantly be under threat from infec-
tious diseases because socio-economic conditions will continue
to foster disease emergence and reemergence.
256
B. THE FOUR OBJECTIVES EXAMINED INDIVIDUALLY
1. Surveillance
Each plan makes infectious disease surveillance the most
important element of its respective strategy.257 Surveillance is
255. The failure to address the root cause of the conditions that help create
the EID problem may be explained by the focus in the plans on practical, im-
mediate actions to take against EIDs. Another reason is that the research on
EDs to date has not been informed by probing the socio-economic context of
the EID problem. One commentator writes: "Standard epidemiology, nar-
rowly focused on individual risk and short on critical theory, will not reveal
these deep socioeconomic transformations, nor will it connect them to disease
emergence." Farmer, supra note 239, at 265. At least one policy proposal at-
tempts to connect the spread of infectious diseases with environmental degra-
dation. Dr. Edward McSweegan has proposed the development of an Infec-
tious Diseases Impact Statement (IDIS), which would be similar to
Environmental Impact Statements used in the United States. Edward
McSweegan, The Infectious Diseases Impact Statement: A Mechanism for Ad-
dressing Emerging Diseases, 2 EMERGING INFECTIOUS DISEASES 103, 103
(1996). McSweegan believes that "[eimbedding an IDIS requirement into the
planning and execution of large-scale projects likely to alter local environ-
ments could prevent new epidemics and reduce infectious disease-associated
morbidity and mortality." Id. at 104. None of the proposed plans incorporates
or even refers to the IDIS idea.
256. See generally Farmer, supra note 239 (arguing for development of a
critical epistemology of EIDs that will confront socio-economic transforma-
tions that contribute to disease emergence).
257. See IOM REP., supra note 13, at 2 (stating that the "key to recognizing
new or emerging infectious diseases, and to track the prevalence of more es-
tablished ones, is surveillance"); CISET REP., supra note 28, at 18-28 (making
surveillance the first step in its strategy for preventing disease outbreaks and
discussing ways to build a global disease surveillance network); CDC
STRATEGY, supra note 26, at 12 (stating that "[s]urveillance is the single most
important tool for identifying infectious diseases that are emerging, are
causing serious public health problems, or are diminishing in importance");
EMC Strategic Plan, supra note 89, at 4 (stating that strengthening global
surveillance is WHO's first goal in its EID strategy); Gore, supra note 4, at 6
(stating that the first component of the Clinton administration's new policy is
the creation of a global surveillance system).
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the "systematic collection, analysis and public health response
to the occurrence of infectious disease conditions in our com-
munities" and "encompasses both the report and investigation
of cases and the submission of clinical specimens when needed
for testing at a... public health laboratory."2 8 As Frederick
Murphy puts it, "[Tlhere is a universal agreement that we
must first know 'what the hell is going on out there?'" 2 9 Sur-
veillance is vital because scientists cannot identify infectious
agents if they have no information on outbreaks. Similarly,
public health officials are handicapped in designing and im-
plementing prevention and control measures if they do not
know which pathogenic microbe is on the rampage. Surveil-
lance provides the baseline information public health officials
need to respond to infectious disease threats and to assign pri-
orities to prevention and control efforts concerning different
diseases.
260
The importance of surveillance reaches beyond the scien-
tific and public health arenas to affect international and do-
mestic politics. The history of ineffective state responses to
disease outbreaks in other countries illustrates261 that poor
surveillance information promotes travel and trade restric-
tions, and results in increased international tension. The
breakdown in surveillance fuels a vicious cycle: bad surveil-
lance produces excessive reactions in other states, which in
turn encourages states not to improve surveillance for fear of
more lost trade and tourist revenue.262 Poor surveillance also
258. Emerging Infections Hearings, supra note 1, at 30-31 (statement of
Dr. Michael Osterhohn).
259. Frederick A. Murphy, Problems in the Surveillance and Control of Vi-
ral Diseases with Special Reference to the Developing World, Address presented
at the FVi International Congress on the Impact of Viral Diseases in the De-
veloping World, Johannesburg, South Africa (July 1995) <http'//www.uct.ac.za
/microbiology/icumurp.html>; see also Emerging Infections Hearings, supra
note 1, at 31 (statement of Dr. Michael Osterholm that "[wlithout the ability
to know with accuracy when, where, and why infectious diseases are occur-
ring, we cannot begin to prevent them").
260. See Berkelman et al., supra note 80, at 368; see also IOM REP., supra
note 13, at 2 (noting that poor surveillance handicaps public health officials in
the development and implementation of disease control policies).
261. See infra text accompanying note 390 (discussing WHO's inability to
prevent states from imposing excessive and unnecessary quarantine meas-
ures).
262. See Dorolle, supra note 109, at 109 (noting that states that impose
irrational quarantine measures discourage other states from reporting accu-
rate disease information, which in turn further perpetuates irrational quar-
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hampers WHO's efforts to better world health through the con-
trol of infectious diseases.
Surveillance also concerns sovereignty. The power to
monitor a population for infectious diseases flows from the sov-
ereignty exercised over such population. For WHO or any
other state to monitor the health of a population through sur-
veillance techniques, the state within which such population
resides must give its consent and cooperate. Thus, any global
surveillance system will be made up of many parts controlled
independently by sovereign states.
Surveillance also relates to domestic and foreign policies.
Surveillance information is important in evaluating whether
public health regulations are in fact effective.23 The CISET
Working Group states that surveillance on a global basis pro-
tects the health of American citizens at home and promotes
U.S. foreign policy objectives of promoting international politi-
cal stability through sustainable economic development as well
as helping the United States respond to biological or chemical
weapons attacks.
26
All these scientific, public health, and political reasons
demonstrate that "[tihe importance of surveillance to the de-
tection and control of emerging microbial threats cannot be
overemphasized."265 Because surveillance is so vital to effective
disease detection and control, and because the current condi-
tion of national and international surveillance capabilities is so
atrocious,266 the grand strategy particularly emphasizes this
objective. Surveillance breaks down if any one step-reporting,
collecting, investigating, and evaluating-is not undertaken
properly. 67 Currently, local, national, and global surveillance
capabilities are breaking down or are broken, giving the em-
phasis on improving surveillance at every level in the grand
strategy a sense of urgency. 268
antine measures); see also DELON, supra note 90, at 24 (noting this cycle in
connection with lack of disease reporting under IHR).
263. See Berkelman et al., supra note 80, at 368.
264. See CISET REP., supra note 28, at 11.
265. IOM REP., supra note 13, at 2.
266. See supra note 95 and accompanying text (discussing the current lack
of an effective disease surveillance system at the international level).
267. See Berkelman et al., supra note 80, at 368 (noting that surveillance
systems break down if testing, reporting, or investigating is not accom-
plished); Emerging Infections Hearings, supra note 1, at 31 (statement of Dr.
Michael Osterholn that surveillance system can break down at any step).
268. The various plans also contain specific proposals to strengthen infec-
tious disease surveillance. The CDC and the CISET Working Group propose,
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Notable in the grand strategy's emphasis on surveillance is
its critical linkage of national surveillance systems to an over-
arching global surveillance system. Improving national sur-
veillance capabilities requires creating an effective global sur-
veillance network.269  The interdependent nature of national
and international surveillance underscores that infectious dis-
eases undermine sovereignty by weakening a state's power to
protect the health of its citizens by constantly threatening na-
tional capabilities. This interdependence reinforces sover-
eignty and makes it an obstacle to global surveillance capabili-
ties by necessitating each state's agreement to cooperate with
global efforts.
The reconstruction of national and international surveil-
lance systems poses a formidable task, given how poorly sur-
veillance systems all over the world currently operate. New
electronic and telecommunications resources, however, have
the potential to extend and simplify surveillance. All the plans
stress the need to utilize electronic links to improve the speed
and quality of surveillance data.270 Examples of electronically-
for example, that the United States take four steps to improve the American
surveillance system: (1) strengthen the existing national notifiable disease
system, see CISET REP., supra note 28, at 41-42; CDC STRATEGY, supra note
26, at 15; (2) establish "sentinel surveillance systems" that link groups of par-
ticipating physicians, clinics, hospitals, and laboratories to a central data re-
ceiving and processing center, see CISET REP., supra note 28, at 42; CDC
STRATEGY, supra note 26, at 16; (3) establish specific public health centers fo-
cusing on EIDs within strategically located sites across the United States, see
CISET REP., supra note 28, at 42; CDC STRATEGY, supra note 26, at 17; and
(4) develop an enhanced global surveillance system, see CISET REP., supra
note 28, at 23; CDC STRATEGY, supra note 26, at 20-21. The new Clinton
administration policy on EIDs also stresses the importance of strengthening
domestic and global surveillance capabilities. See Addressing the Threat of
Emerging Infectious Diseases, supra note 54, at 2. WHO also has made spe-
cific proposals to create a global surveillance system for infectious diseases.
See LeDuc, supra note 96, at 341 (noting WHO efforts to lead and coordinate
the effort to create global surveillance program). WHO has four specific tasks
to undertake in creating a global surveillance system according to its EID
strategic plan: revise the hR, monitor antimicrobial resistance, monitor viral
and bacterial diseases, and disseminate information as widely as possible. See
EMC Strategic Plan, supra note 89, at 4.
269. See Berkelman et al., supra note 80, at 369 (noting the need to estab-
lish effective global surveillance in addition to strengthening domestic surveil-
lance).
270. See IOM REP., supra note 13, at 4-5 (recommending the development
of a comprehensive, computerized infectious disease database); CISET REP.,
supra note 28, at 5, 23 (advocating application of information technology to
disease control programs); CDC STRATEGY, supra note 26, at 21 (advocating
use of the Internet to facilitate exchange of information in global surveillance
system); EMC Strategic Plan, supra note 89, at 6 (proposing to disseminate
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linked public health surveillance systems already exist,271 and
some commentators believe that expanding such electronic
surveillance capabilities will facilitate "the rapid collection,
analysis, and dissemination of vital public health information"
and promote "the establishment of effective international pub-
lic health policies."272 Experts who are less sanguine about the
will or ability of governments to fund improved surveillance
systems find hope in the telecommunications revolution be-
cause it may empower individuals across the world to build
and operate a private global infectious disease network. 3
information on the World Wide Web); Gore, supra note 4, at 7 (advocating use
of the information superhighway).
271. In the United States, the CDC operates the National Electronic Tele-
communications System for Surveillance and the Public Health Laboratory
Information System. T. Demetri Vacalis et al., Electronic Communication and
the Future of International Public Health Surveillance, 1 EMERGING IN-
FECTIOUS DISEASES 34, 34-35 (1995). In the European Community, electronic
surveillance networks track salmonella and Legionnaire's disease. See id. at
34. WHO operates WHONET, an integrated electronic system for surveil-
lance of antimicrobial resistance at local, national, and global levels. See
WHO Calls for Action, supra note 77.
272. Vacalis et al., supra note 271, at 35. Garrett reports on "a hopeful
revolution" in the form of the on-line satellite connection to medical libraries
in the United States and Canada created for the University of Zambia Medical
Library and other electronic connections between developing countries and
medical data bases in the developed world. See GARRETT, supra note 7, at
615.
273. See Murphy, supra note 259 (noting in 1995 the failure of govern-
ments to adequately fund infectious disease surveillance and control programs
and the prospects for a private "Global Infectious Disease Network"). Such a
private infectious disease surveillance effort does exist in the form of the Pro-
gram for Monitoring Emerging Diseases, which the Federation of American
Science started in 1993 "to create a global system of early detection and
timely response to disease outbreaks." The Program for Monitoring Emerging
Diseases Homepage (visited March 10, 1997) <http'//www.healthnet.org/pro-
grams/ promed.html.>. Efforts to create private public health surveillance
networks emulate pathogenic microbes in that they attempt to bypass the
state.
Another interesting private initiative is SatelLife, which electronically
connects developing country physicians and scientists to electronic resources
and colleagues in developed countries. See GARRETT, supra note 7, at 615-16
(describing achievements of SatelLife). For a skeptical view of the promise of
cyberspace in infectious disease control strategies, see David P. Fidler, Mis-
sion Impossible? International Law and Infectious Diseases, 10 TEMP. INT' &
COMP. L.J. 493, 502 (arguing that "[wihat should be remembered about the
promise of cyberspace is that it only spreads information about the continuing
ravages of infectious diseases more quickly").
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2. Prevention and Control
Surveillance systems are designed to provide public health
officials with sufficient information to prevent and control the
spread of infectious diseases. The EID plans advocate
strengthening the ability of public health authorities to pre-
vent and control infectious diseases. According to the Institute
of Medicine, successful intervention against EIDs "necessitates
coordinated efforts by a variety of individuals, government
agencies, and private organizations."274 Similar coordination is
needed at the international level as well as among local physi-
cians, different governments, and WHO.
As the United States illustrates,275 national public health
systems are in bad shape and therefore weaken the ability of
public health authorities to act effectively. One obstacle con-
fronting U.S. efforts to improve prevention and control capa-
bilities involves the federal system. Under the federal system,
individual states have primary responsibility for infectious dis-
ease control, and the federal government's powers are limited.
The CDC, for example, cannot respond to a disease outbreak
unless it is invited to do so by state health authorities.276 In
addition, the CDC has no regulatory powers to implement pre-
vention and control measures outside the national quarantine
system, as those powers reside with the states.277 The nature
of the federal system and the division of public health powers
provides an "increased likelihood of uncoordinated approaches"
to multistate disease outbreaks.278 Thus, improved prevention
and control of infectious diseases will require more national co-
ordination and oversight to prevent jurisdictional divisions
274. IOM REP., supra note 13, at 7.
275. See supra text accompanying note 100 (discussing diminished state
and local support for disease surveillance systems in the United States).
276. See Stephen M. Ostroff, Law and Emerging and Re-Emerging Infec-
tious Disease: A View from the CDC, Address Before ABA Panel on Law and
Emerging and Re-Emerging Infectious Diseases), in PROGRAM MATERIAlS,
supra note 86, at 19.
277. See id. The Foreign Quarantine Regulations delegate to the CDC pri-
mary responsibility for administering the U.S. foreign quarantine system. See
42 C.F.R. § 71.31 (1995) (empowering Director of CDC to order inspection and
detention of a carrier); id. § 71.32 (empowering CDC Director to detain, iso-
late, or place under surveillance any arriving person).
278. Ostroff, supra note 276, at 19.
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from compromising public health reactions to infectious dis-
ease outbreaks. 9
The importance of prevention and control measures in
other countries to public health in the United States has led to
proposals that Congress expand CDC's mandate to include
authority to investigate and respond to disease epidemics in
other countries.280 The call for such an expanded mandate for
CDC is further evidence of the interdependent nature of public
health in the contemporary international system. It is also
evidence that any strategy for dealing with EIDs is likely to be
expensive and complex as national public health authorities
are forced to think and act globally.
The weaknesses at the national level complicate efforts by
WHO to provide global leadership in preventing and control-
ling diseases. WHO responded to the growing EID threat by
creating a new division-the Division of Emerging and Other
Communicable Diseases Surveillance and Control (EMC)-to
spearhead its strategy against EIDs.281 The EMC proposals to
improve prevention and control capabilities cluster around (1)
developing rapid response capacities at the national, regional,
and international level so that resources can be mobilized
swiftly when disease outbreaks occur;282 (2) formulating guide-
lines for communicable disease surveillance and control, han-
dling new diseases, quality assurance and proficiency testing
for laboratories, improving antimicrobial prescribing practices,
stockpiling equipment and supplies for disease outbreaks, and
279. See Emerging Infections Hearings, supra note 1, at 35 (statement of
Dr. Margaret A. Hamburg, Health Commissioner for New York City).
280. See CISET REP., supra note 28, at 19 (noting that the authority of the
CDC does not cover international disease control and prevention); Addressing
the Threat of Emerging Infectious Diseases, supra note 54, at 4 (proposing to
include in CDC's mandate surveillance and response activities in connection
with epidemics overseas).
281. See EMC Strategic Plan, supra note 89, at 2-3 (describing creation of
EMC).
282. See id. at 8-9 (describing EMC's proposals for epidemic preparedness
and response). EMC's mandate includes establishment of "a new rapid re-
sponse unit to control and prevent the growing incidence of new and re-
emerging diseases around the world, with a view to improving containment of
outbreaks." World Health Organization, WHO Establishes New Rapid-Response
Unit to Combat Growing World-Wide Threat of Emerging Diseases, WHO
Press Release, WHO/75 (Oct. 17, 1995) <http'//www.ch/press/1995/pr95-
75.html>. The EMC rapid-response team went into action for the first time in
December 1995, when WHO was informed of a suspected case of Ebola hemor-
rhagic fever in C~te D'Ivofre. See Ebola Case Confirmed in C6te D'Ivolre, su-
pra note 19.
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protocols for intra-epidemic research;283 and (3) providing train-
ing in basic epidemiology, training materials explaining new
diseases, and advanced training in immunology, vaccinology,
biotechnology, and biosafety."
3. Infrastructure Development
285As discussed above, complacency and budget constraints
have eroded public health systems all over the world. In re-
sponse, the grand strategy calls for revitalized national and in-
ternational public health infrastructures. 28 6 Both surveillance
and prevention and control capabilities depend on an adequate
public health infrastructure, which in turn requires human
and physical resources, cooperation, and leadership in making
infectious disease a priority.287
Reconstructing public health infrastructures to support
surveillance, prevention, and control programs will be an ex-
pensive undertaking.288 The most glaring omission in the EID
283. See EMC Strategic Plan, supra note 89, at 7-9 (discussing strategy for
strengthening prevention and control capabilities).
284. See id. In the United States, the CDC operates an Epidemic Intelli-
gence Service (EIS) that trains health professionals in public health epidemi-
ology. See IOM REP., supra note 13, at 148 (describing operation of EIS pro-
gram). EIS officers participate in the investigations of disease outbreaks in
the United States. See id. The IOM and CDC have both asserted a need for
additional support in training and investigation. See IOM REP., supra note
13, at 148 (recommending domestic and global expansion of EIS); CDC
STRATEGY, supra note 26, at 19 (stating that the CDC must strengthen its
field investigation program in response to emerging infectious disease
threats).
285. See supra notes 79-82 and 98-100 and accompanying text (observing
that complacency and financial constraints have eroded the quality of public
health systems globally).
286. See IOM REP., supra note 13, at 7 (noting poor condition of U.S. public
health system); CISET REP., supra note 28, at 27 (recommending that the
U.S. public health infrastructure be rebuilt); CDC STRATEGY, supra note 26,
at 33 (stating that a goal of CDC disease prevention strategy is to
"[sltrengthen local, state, and federal public health infrastructures to support
surveillance and implement prevention and control programs"); EMC Strate-
gic Plan, supra note 89, at 2 (stating EMC's second goal is "to strengthen [the]
national and international infrastructure necessary to recognize, report, and
respond to emerging communicable diseases"); Addressing the Threat of
Emerging Infectious Diseases, supra note 54, at 2 (stating goals of Clinton
administration s policy to be the strengthening of federal and state laboratory,
epidemiological, training, and technological resources).
287. See CISET REP., supra note 28, at 45 (stating that public health in-
frastructure includes a complex set of skills and resources already available in
industrialized countries).
288. See Garrett, Infectious Disease, supra note 61, at 79 (quoting Nobel
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plans is the absence of discussion about funding. The CDC es-
timates that full implementation of its strategy would cost
$125 million annually,289 yet Congress only appropriated $7.7
million in 1995.290 The Clinton administration will ask Con-
gress for $45 million to support the CDC's efforts under the
new EID policy,291 which represents only 36% of estimated
costs.
As difficult as adequate funding is to achieve in the United
States, the financial problems in the developing world are of an
entirely different magnitude. As the CISET Working Group
noted, many of the resources needed to build a public health
infrastructure are simply not available in developing coun-
tries.292 The poverty of developing states creates practical and
political problems for strengthening public health infrastruc-
tures globally. The practical problem is the lack of money to
pay for the building and maintenance of adequate public
health care systems. The political problem looms in the possi-
bility that developing countries use the inequality of wealth in
the international system as an argument to complicate inter-
national cooperation on EmDs.293 No global strategy is likely to
be successful if developed countries do not provide money to
improve public health infrastructures in the developing world. 94
While the basic configuration of financial power has not
changed in thirty years, the experiences of previous aid cam-
paigns cast a dark shadow across the prospects of more money
Laureate Joshua Lederberg as stating that while the solutions to the EID
threat are straightforward and common-sensical, "the bad news is they will
cost money").
289. See Berkelman et al., supra note 96, at 315 (estimating costs for CDC
prevention plan).
290. See id. (citing priority activities identified in CDC STRATEGY, supra
note 26, at 5).
29L See McCleskey, supra note 53 (reporting that the Health and Human
Services budget request will help the CDC respond to the threat of EIDs).
292. See CISET REP., supra note 28, at 43 (stating that "[in many develop-
ing countries... health resources are extremely scarce").
293. See Fidler, supra note 8, at 81 (noting that wealth disparities have
potential implications for treaty negotiations).
294. This reality was apparent nearly 30 years ago when the Deputy Di-
rector-General at WHO wrote the following:
Allow me, therefore, to conclude that, in this age of jet planes and
soon of supersonic transport, the only way of preventing the old
plagues, and some new ones, from spreading from continent to conti-
nent and from country to country is to help the poorest nations of the
world to reach such a level of economic and technical development
that it will be possible for them to combat the evil at its source.
Dorolle, supra note 109, at 111.
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flowing from North to South. As Garrett writes, "[B]y 1990 the
world's major donor institutions would be forced to conclude
that modernization efforts seemed only to have worsened the
plight of the average individual in the Third World, while en-
hancing the power, wealth, and corruption of national elites
and foreign-owned institutions."295 Even if money were avail-
able in large quantities for public health infrastructure recon-
struction in the developing world, the grand strategy is silent
as to how aid funds would be used to avoid the tragic mistakes
of past modernization efforts.
4. Research and Development
The final objective of the grand strategy is to reinvigorate
research and development on infectious diseases.296  Noted
earlier was the lack of new research and development by
pharmaceutical companies on antimicrobial treatments,297 but
the need extends beyond the creation of new drugs. The CDC
proposes, for example, to expand epidemiologic and prevention
effectiveness research, to improve laboratory and epidemiologic
techniques for the rapid identification of new pathogens or
syndromes, to develop diagnostic tests and reagents for dis-
eases, and to develop vaccines and vaccine development pro-
grams. 298 EMC wants to stimulate research on "new and more
cost-effective disease surveillance and control strategies, in-
cluding research on new epidemiological tools."299 The breadth
of this research agenda indicates that national and interna-
tional public health authorities are not depending solely upon
295. GARRETT, supra note 7, at 8.
296. See IOM REP., supra note 13, at 8 (recommending expansion of re-
search on EMIs); CISET REP., supra note 28, at 27, 53-55 (recommending the
strengthening of the infectious disease research infrastructure in the United
States); CDC STRATEGY, supra note 26, at 1 (listing applied research as major
goal of infectious disease control strategy); EMC Strategic Plan, supra note
89, at 2 (listing support and promotion of research in communicable disease
control as a major goal); Addressing the Threat of Emerging Infectious Dis-
eases, supra note 54, at 3 (making enhancement of research efforts part of
Clinton administration's EID policy).
297. See supra notes 72-77 and accompanying text (noting reluctance of
pharmaceutical companies to invest in research and development of drugs to
combat pathogenic microbes).
298. See CDC STRATEGY, supra note 26, at 25-29 (identifying strategies for
integrating epidemiology and laboratory science techniques).
299. EMC Strategic Plan, supra note 89, at 9-10. Specific research areas
include hepatitis 0, hepatitis E, Ebola, and the new variant of Creutzfeldt-
Jacob Disease. See id. at 10.
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the development of antimicrobial drugs to combat EIDs. The
research agenda could perhaps be expanded further to include
investigations into how urbanization, poverty, and environ-
mental degradation factor into the EID problem.
The key variable for better infectious disease research is
money. Again, none of the EID plans confront the funding is-
sue. Pharmaceutical companies cite lack of market incentives
to develop antimicrobial products for use primarily in the de-
veloping world.00 Whether national governments in developed
states prove any more willing to expend large sums of money
on infectious disease research remains to be seen.
C. SUMMARY OF THE GRAND STRATEGY
The major EID plans proposed to date share four funda-
mental objectives. These common goals might make integra-
tion of national and global efforts easier because governments
and international organizations will be working towards the
same ends. 30 1 The grand strategy suffers, however, from two
serious problems. First, the plans noticeably avoid the finan-
cial concerns raised by their suggestions for creating better
surveillance, prevention and control capabilities, public health
infrastructures, and research and development. Second, the
grand strategy does not address many of the factors shaping
the EID threat, which suggests that these factors will continue
to fuel EIDs and put pressure on public health resources na-
tionally and internationally.
IV. INTERNATIONAL LAW ON INFECTIOUS DISEASE
CONTROL: THE INTERNATIONAL HEALTH
REGULATIONS
The global nature of the EID threat combined with the
structure of the international system mean that international
300. See Garrett, Infectious Disease, supra note 61, at 68 (noting that "lack
of profitability has stifled the development of drugs to combat organisms that
are currently found predominantly in poor countries").
301. For an example of an effort to promote integration of national and
global efforts, see DIVISION OF EMERGING AND OTHER COMMUNICABLE
DISEASES SURVEILLANCE AND CONTROL, WORLD HEALTH ORGANIZATION,
WHO POsrrION PAPER ON COLLABORATION IN GLOBAL SURVEILLANCE OF
COMMUNICABLE DISEASES: FOR CONSIDERATION WITHIN THE FRAMEwORK OF
THE EU-US TRANSATLANTIC AGREEMENT ON COMMUNICABLE DISEASES 8
(1996), in which WHO states its willingness to "make available its resources
and long experience to assist" European Union-United States collaboration on
infectious diseases.
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law will have to play a prominent role in dealing with the
threat.30 2  The need to utilize international law for interna-
tional infectious disease control is, of course, not new. Since
the first international public health conference in 1851, states
have attempted to negotiate, and have negotiated, international
treaties on infectious disease control.30 3 The EID problem most
directly implicates the International Health Regulations (IFIR),
which constitute the "only international health agreement on
communicable diseases that is binding on Member States."
3 4
According to WHO, which administers the IFIR, a fundamental
purpose of the regulations is to provide a universal code for in-
fectious disease control. 30 5 This Article analyzes the IHR to de-
termine how effectively these regulations currently address the
threat posed by EDs.
A. DEVELOPMENT OF THE IR
The HIR are progeny of the long line of international ef-
forts to formulate international rules on infectious disease con-
trol dating back to 1851. Before international efforts to de-
velop international rules, infectious disease control was
entirely within the power of each sovereign state.30 6 Quaran-
tine measures dominated the national responses to the threat
of infectious diseases spreading from other countries. 30 7 This
system of disparate quarantine measures eventually proved
harmful because it disrupted expanding international travel
and trade.08 The medical effectiveness of quarantine was,
302. See Fidler, supra note 8, at 79 (stating that international law is im-
portant to emerging infections control because states will have to agree on
many issues and translate such agreement into rules or guidelines).
303. See generally Howard-Jones, supra note 93, at 1033-34 (providing a
history of international negotiations on infectious disease control).
304. EMC Strategic Plan, supra note 89, at 10.
305. See Lindsay Martinez & Jean-Charles Alary, World Health Organiza-
tion, International Health Regulations 1 (Mar. 19, 1996) (unpublished docu-
ment, on file with author).
306. See Edelman, supra note 115, at 28-30 (detailing early national re-
sponses to threat of disease).
307. See Nancy E. Allin, The AIDS Pandemic: International Travel and
Immigration Restrictions and the World Health Organization's Response, 28
VIR. J. INTL L. 1043, 1046 (1988) (examining methods of disease control prior
to the advent of international cooperation).
308. See id. (noting significant economic losses attendant to quarantine
measures). Great Britain's long-standing opposition to quarantine measures
probably had at least as much to do with its status as a great maritime nation
as it did with scientific or medical evidence about the ineffectiveness of quar-
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however, questioned as early as 1866.309 States (exclusively
European) thus had two incentives to engage in international
negotiations on infectious disease control: quarantine meas-
ures were not effective, and they were costly to international
trade.
From 1851 until 1944, many states participated in sixteen
international conferences on infectious disease control310 and
concluded thirteen conventions on the subject.311 Early confer-
ences failed to produce conventions largely because scientific
knowledge about infectious diseases was extremely limited.312
The breakthrough for international law came with the Interna-
tional Sanitary Conference of 1903, which updated four earlier,
more limited treaties in light of scientific discoveries,313 estab-
lished an international surveillance plan based on notifications
of outbreaks of specified diseases, and required party states to
refrain from enacting excessive measures against states that
properly notified others of disease outbreaks.314 The Interna-
tional Sanitary Convention also called for the establishment of
an international organization dedicated to international public
health.315 Subsequent treaties addressing maritime traffic and
aerial navigation were adopted and amended between 1903
and 1944.3
16
Despite the plethora of treaties, international law on in-
fectious disease control was confusing and unsatisfactory at
the end of World War H. First, the different treaties created
antine laws. See Howard-Jones, supra note 93, at 1033-34 (observing that
economic considerations compelled resistance to any limitation on shipping).
309. See Gutteridge, supra note 117, at 2 (citing delimitation of disease at
source as preferable to alternative measures, including quarantine).
310. See Howard-Jones, supra note 93, at 1034 (providing history of inter-
national sanitary conferences and conventions).
311. See Allin, supra note 307, at 1048 & n.29 (observing that the large
number of conventions produced confusion and an impetus for change).
312. See Howard-Jones, supra note 93, at 1034 (stating that "a complete
lack of agreement on the mode by which cholera and other diseases were con-
tracted entailed a corresponding lack of agreement on means of prevention).
313. See id. (noting that the 1903 Paris Conference unified the 1892, 1893,
1894, and 1897 conventions).
314. See Allin, supra note 307, at 1047-48 (summarizing results of confer-
ence).
315. See id. at 1048 (summarizing developments leading up to formation of
WHO).
316. See Howard-Jones, supra note 93, at 1034 (citing 1903 Sanitary Con-
ference in Paris that unified earlier conventions, a series of conferences re-
garding maritime traffic, and the 1933 International Sanitary Convention for
Aerial Navigation, amended in 1944).
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holes in the international regime for the control of infectious
diseases because, as the U.S. Department of State argued in
1947, "There are states, including some which occupy key po-
sitions in the stream of international maritime and aerial
commerce, bound only by the obsolete conventions of 1912,
1926, and 1933, or by no sanitary conventions at all."317 Sec-
ond, the treaties overlapped, were not kept current as scientific
knowledge developed, and were not designed to accommodate
the increases in the speed, volume, and scope of international
traffic.318 Third, international infectious disease control relied
exclusively on the treaty. In the context of infectious disease
control, the treaty process proved cumbersome, slow, and resis-
tant to amendments required by changing scientific knowledge
and/or patterns of international trade or commerce.319
International cooperation on health became one of the ob-
jectives of the new United Nations,32 0 and WHO was the first
specialized agency created under the United Nations system.2
Among WHO's undertakings was an attempt to unify the in-
ternational rules on controlling the spread of infectious dis-
eases. Article 21 of the WHO Constitution gave WHO the
authority to adopt regulations concerning, among other things,
"sanitary and quarantine requirements and other procedures
designed to prevent the international spread of disease."32
Pursuant to this authority, the World Health Assembly
adopted the International Sanitary Regulations in 1951, which
replaced the patchwork of conventions previously in force for
WHO member states.323 The world finally had a unified set of
international legal rules designed to control the spread of in-
fectious diseases. In 1969, as part of a revision effort, the
317. International Health Security in the Modern World: The Sanitary
Conventions and the World Health Organization, 17 Dep't State Bull. No. 437,
at 953, 957 (1947) [hereinafter Int'l Health Security in the Modern World].
318. See Sev S. Fluss, International Public Health Law: An Overview, in
OXFORD TEXTBOOK OF PUBLIC HEALTH (forthcoming 1997) (manuscript on file
with author).
319. See Intl Health Security in the Modern World, supra note 317, at 957.
320. See U.N. CHARTER art. 55 (stating that the United Nations shall pro-
mote, among other things, solutions to international health problems).
321. See Sharp, supra note 207, at 509 (calling the establishment of WHO
a "landmarl' in the history of international cooperation on health and medi-
cine).
322. WHO CONST. art. 21.
323. See INA HEALTH REG., supra note 89, art. 86(1), at 38-39 (listing
treaties the IHR replaced).
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World Health Assembly renamed the International Sanitary
Regulations the International Health Regulations.
B. LEGAL BASIS OF THE IHR
At the time of adoption, the authority permitting the
World Health Assembly to adopt regulations designed to pre-
vent the international spread of disease was considered a sig-
nificant advance over the treaty-based procedure.32 4  The
authority to issue regulations supposedly gave WHO the abil-
ity to keep the IHR up-to-date regarding scientific advances
without having to proceed through the cumbersome treaty
process. In addition, Article 22 of the WHO Constitution
adopted the "comparatively novel principle known as
'contracting out.'" 321 Under Article 22, the IHR and any
amendments are binding on all member states of WHO except
for those member states that notify the Director-General of a
rejection or reservations within a certain period of time.326 The
American delegation pushed the "contracting out" provision
specifically to allow WHO to apply new scientific techniques
and knowledge in the HR.32 7 The IHR also contain a provision
that makes all reservations to the IHR subject to acceptance by
the World Health Assembly.328 The quasi-legislative powers of
Article 21, the "contracting out" technique of Article 22, and
the procedure of subjecting all reservations to acceptance by
the World Health Assembly in the IHR work together in theory
to provide a robust regulatory process that is not weakened by
states refusing to join the regime or by significant reservations.
Article 19 of the WHO Constitution also granted the World
Health Assembly authority "to adopt conventions or agree-
ments with respect to any matter within the competence of the
Organization."9 This authority theoretically provided WHO
324. See Int'l Health Security in the Modern World, supra note 317, at 958(stating that Articles 21 and 22 of the WHO constitution constitute a signifi-
cant advance in the field of international health).
325. Sharp, supra note 207, at 525.
326. See WHO CONST. art. 22.
327. See Sharp, supra note 207, at 526 (quoting a report from the U.S.
Delegation). Sharp also observed that Article 22 "was the subject of warm de-
bate" as states worried about its effect on sovereignty. Id. at 525.
328. See INTL HEALTH REG., supra note 89, art. 88(1), at 39-40.
329. WHO CONsT. art. 19.
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with further power to hel member states prevent the interna-
tional spread of disease.
33P
The promise of energetic and effective use of international
law by WHO has yet to achieve its objective: "[Tlhe attainment
by all peoples of the highest possible level of health."3 ' WHO
has been reluctant to use international law to advance any of
its initiatives on world health.33 For instance, WHO has never
adopted a convention under its Article 19 powers.333 The power
to issue binding regulations has only been exercised twice, once
with respect to the IHR and once on nomenclature issues.
Moreover, Article 21 powers are limited in comparison to Arti-
cle 19 powers because Article 21 lists only five areas in which
regulations may be adopted while Article 19 refers to any mat-
ter within WHO's competence.334 Article 21 thus has circum-
scribed ability to support a broad attack against infectious dis-
eases. The authority to adopt regulations on the international
spread of disease also is not as innovative as it might first ap-
pear because efforts to control such spread had a long history
and thus had already settled into patterns of regulation found
330. One commentator thought in 1947 that WHO's power to adopt con-
ventions was important and far-reaching "for the development of an effective
international health code" and for "strengthening the provisions of world
health law." Sharp, supra note 207, at 524-25.
331. WHO CONST. art. 1.
332. See Taylor, supra note 206, at 577 (emphasizing that "WHO has not
adequately promoted or encouraged the development of national and interna-
tional law... with respect to the right to health").
333. See Fluss, supra note 318, at 5 (noting that WHO has not used Article
19 to implement "substantive areas of health policy"). Two current initiatives
might, however, make use of Article 19. First, the Executive Board of WHO
has asked the Director-General to organize a conference in late 1997 for the
purpose of adopting a health charter. See World Health Organization, WHO
Response to Global Change: Executive Board Expresses Its Satisfaction, WHO
Press Release, WHO/8 (Jan. 27, 1995) <http'/www.who.cb/press/1995/pr95-
08.htm]> [hereinafter WHO Response to Global Change]. Second, the World
Health Assembly has called upon the WHO Director-General to begin develop-
ing a framework convention on global tobacco control under Article 19 of the
WHO Constitution. See International Framework Convention for Tobacco
Control, WHA Res. 49.17, World Health Org., 49th Ass., 6th Plea mtg., WHO
Doc. A49/VEI6 (1996) <http://www.who.ch/programmes/psa/toh/Alert/4-96/E/
talO.htm>.
334. See WHO CONsT. arts. 19, 21; Fluss, supra note 318, at 5 (contrasting
WHO's authority to adopt regulations and agreements under Articles 19 and
21).
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in the previous treaties.335 Rather than utilizing its power to
make international law, WHO prefers to issue nonbinding rec-
ommendations under Article 23 of the WHO Constitution.3
6
In summary, the IHR are based on authority in the WHO
Constitution that contains fundamental tensions. The regula-
tory technique theoretically represents an advance over the
treaty process, but the "contracting out" procedure creates a
deterrent effect against innovative and swift change because of
concerns about sovereignty.3 7 In other words, states may be
unwilling to impose on themselves substantial international
legal obligations under Article 22 because of the "contracting
out" mechanism. The result has been the opposite of quick re-
visions to update the IHR that the regulatory authority in the
WHO Constitution was designed to accomplish. In 1988, the
Legal Counsel of WHO observed that the "real difficulty" under
Articles 21 and 22 "is that measures cannot be adopted quickly
enough to meet the health requirements of the moment."
318
This situation does not bode well for the current WHO's desire
to revise the IHR.
C. OBJECTIVES OF THE M
The express purpose of the IHR "is to ensure the maximum
security against the international spread of diseases with a
minimum interference with world traffic."39  The following
section examines these two objectives to determine how the
IKR are structured to achieve them.
335. See Fluss, supra note 318, at 5 (explaining that traditional treaty-
making has "severely circumscribed" any endeavors to reform treaty-making
under Article 21).
336. See WHO CONST. art. 23 (granting the World Health Assembly the
"authority to make recommendations to Members with respect to any matter
within the competence of the Organization"). WHO has addressed, among
other things, food safety, breast-milk substitutes, and human organ trans-
plants through Article 23 recommendations. See Fluss, supra note 318, at 19,
21 (discussing WHO recommendations with respect to these health concerns).
337. See Fidler, supra note 8, at 81 (commenting that "Article 22 relates to
the sovereignty problem and may deter WHO member states from agreeing to
serious revisions of the regulations").
338. Claude-Henri Vignes, The Fture of International Health Law: WHO
Perspectives, 40 INTL DIG. HEALTH LEGIS. 16, 18 (1989).
339. Nft HEALTH REG., supra note 89, at 5.
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1. Maximum Security Against International Disease Spread
The IHR do not define "maximum security against the in-
ternational spread of diseases." 340  In essence, though, the
regulations seek to provide member states of WHO with maxi-
mum protection against the importation of infectious diseases
from other countries. To achieve this objective, the regulations
establish a global surveillance system for the diseases subject
to the IR,41 require certain types of health-related capabili-
ties at ports and airports, 34 2 and set out disease-specific provi-
sions for the covered diseases.
343
a. Surveillance
The IHR require member states of WHO to report infor-
mation to WHO about the three diseases subject to the IHR-
yellow fever, plague, and cholera.3" Notification duties exist
for all three diseases that occur indigenously in a country,345
that are imported or transferred into a non-infected area
within a country,346 and that arrive by ship or aircraft.347 Arti-
cle 6 of the IHR lays out notification requirements in epidemic
situations.348 Member states also have weekly and annual no-
340. Id. art. 1, at 7 (listing definitions); see E. Roelsgaard, Health Regula-
tions and International Travel, 28 WHO CHRON. 265, 267 (1974) (discussing
IER objectives). Roelsgaard has argued that this concept "defies clear defini-
tion," because "maximum security" cannot be quantified. Id.
341. See INTL HEALTH REG., supra note 89, arts. 2-13, at 10-15.
342. See id. arts. 14-22, at 15-18.
343. See id. arts. 50-75, at 26-33.
344. See i&L art. 3, at 10 (setting out the requirement); id. art. 1, at 8 (defin-
ing diseases subject to the IHR as cholera, plague, and yellow fever). The
original International Sanitary Regulations made six diseases subject to the
Regulations: plague, cholera, yellow fever, smallpox, louse-borne typhus, and
louse-borne relapsing fever. See Roelsgaard, supra note 340, at 267. WHO
dropped the two louse-borne diseases in the 1969 revisions while smallpox
was taken off the list in 1981 after its worldwide eradication. See INTL
HEALTH REG., supra note 89, at 5 (discussing amendment of IHR excluding
smallpox); Roelsgaard, supra note 340, at 267 (explaining that the louse-borne
diseases do not cause problems for international travel).
345. See INT'LHEALTH REG., supra note 89, art. 3(1), at 10-11.
346. See id. art. 3(2), at 11.
347. See id. Member states must also notify WHO of the presence of the
yellow fever virus in humans and other vertebrates, and the plague bacillus in
any part of the country. See id. art. 4(1), at 11. Member states must supple-
ment notified cases with further epidemiological information as it becomes
available. See id. art. 4(1), at 11.
348. See id. art. 6, at 12.
19971 839
MINNESOTA LAW REVIEW
tification responsibilities under the MR.3 4  WHO then trans-
mits disease notifications and epidemiological information it
has received to all member states. Surveillance is critical to
the control of infectious diseases, and the IER notification du-
ties play an important role in WHO's global surveillance strat-
egy and thus in the strategy to provide maximum security
against the international spread of disease.351
b. Health Organizations
Another key element of the maximum security goal is the
IMR's requirements that member states maintain certain types
of health resources, programs, and organizations. 352  For ex-
ample, the maintenance of adequate health facilities at ports of
entry in member states of WHO limits the spread of infectious
diseases by eliminating conditions conducive to pathogenic mi-
crobes (e.g., poor sanitation). It also provides resources for
earlier detection of, and intervention against, infectious dis-
eases. Such health organizations are supposed to work in tan-
dem with surveillance operations to provide maximum security
against the international spread of disease.
c. Handling Specific Diseases
The provisions relating to the diseases subject to the IHR
also contribute to the maximum security objective. Part V of
the IHR contains various provisions creating specific duties in
relation to plague, cholera, and yellow fever.3  For example,
349. See id. arts. 9 & 13, at 13-14.
350. See id. art. 11(1), at 14.
351 See supra note 257 and accompanying text (discussing importance of
disease surveillance).
352. For example, every port and airport must provide safe drinking wa-
ter, food, and disposal of excrement, refuse, waste water, and other things
dangerous to health. See INTL HEALTH REG., supra note 89, art. 14, at 15. As
many ports and airports as practicable within a member state must have
health services, equipment, and services for isolating infected persons, disin-
fecting, disinsecting, and deratting ships and aircraft. See id. arts. 15 & 18, at
15-16. They must also have disease investigation and collection capabilities.
Id. Special requirements exist for rodent and mosquito control at ports and
airports. See id. arts. 16-20, at 16-17. WHO has the power to certify, at the
request of a member state, that airports in that member state meet the sani-
tary requirements of the IHR. See id. art. 21, at 17. Similar sanitary, health
service, and vector control measures shall be applied at points where inland
travel and/or navigation across frontiers reaches sufficient volume and epi-
demiological conditions require such application. See id. art. 22, at 18.
353. See id. arts. 50-75, at 26-33.
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Article 52(1) states that each member state "shall employ all
means in its power to diminish the danger from the spread of
plague by rodents and their ectoparasites."3 4 If a cholera case
is discovered on the arrival of any carrier, then the member
state may apply surveillance or isolation against the individual
for a period not to exceed the incubation period of cholera from
the date of disembarkation. 355 Member states may require the
vaccination of any person leaving a yellow fever infected area
for an international voyage.3 56 Part V contains other provisions
allowing member states to take certain actions against plague,
cholera, and yellow fever that also supposedly prevent or
minimize the international spread of disease.
2. Minimum Interference with World Traffic
The MR attempt to achieve maximum security against the
international disease spread with minimum interference with
world traffic by setting out the most restrictive health meas-
ures that a member state may take to protect its territory
against the diseases subject to the IHR.357 The HR prescribe
limits for procedures that may be taken generally against dis-
eases subject to the regulations.35 8 They also have provisions
that prevent the departure of any infected person or means of
transportation,35 9 and that limit actions taken against ships
and aircraft in route between ports of departure and arrival, 6 °
against persons and means of transport upon arrival,361 and
against cargo, goods, baggage, and mail moving in interna-
tional transport. 62 The surveillance provisions in Part II cre-
ate a deterrent effect by requiring member states to notify
WHO of all measures applied to arrivals from an infected
354. Id. art. 52(1), at 26.
355. See id. art. 62(1), at 30.
356. See id. art. 66(1), at 30.
357. See id. art. 23, at 18 (prohibiting states from requiring more stringent
health measures).
358. See id. arts. 23-29, at 18-19.
359. See id. art. 30, at 20.
360. See id. arts. 31-34, at 20-21.
361. See id. arts. 35-45, at 22-25.
362. See id. arts. 46-49, at 25-26. Provisions restricting the measures
member states may take against diseases subject to the IHR also appear in
other sections of the IHR, such as Part V on the special provisions relating to
the diseases subject to the IHR. Article 51 states, for example, that
"[viaccination against plague shall not be required as a condition of admission
of any person to a territory." Id. art. 51, at 26. In relation to cholera, "[n]o
person shall be required to submit to rectal swabbing." Id. art. 64(1), at 30.
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area.363 The IHR also regulate what health documents member
states may require from international travelers and carriers
36
and what health charges member states may assess against in-
ternational travelers and carriers. 365
All health measures authorized under the IHR "must be
initiated forthwith, completed without delay, and immediately
followed by the granting of free pratique; in other words, the
old concept of 'quarantine' is abolished for good."366 Thus, sur-
veillance or isolation of persons infected with a disease subject
to the IER may only last as long as the incubation period for
the relevant disease calculated from the date of last exposure
or the date of arrival.367 Epidemiology, rather than politics or
irrational fears, drives the authorized restrictive measures in
the iR. 3
68
The hR also restrict government interference regarding
diseases not subject to the IR. First, if a ship or aircraft is in-
fected or suspected of being infected with a disease not subject
to the IHR, a member state of WHO cannot refuse such ship or
aircraft free pratique, nor can it prevent such carrier from dis-
charging or loading cargo or stores or taking on fuel and water
except in case of an emergency constituting a grave danger to
public health.3 69 The WHO Committee on International Sur-
veillance of Communicable Diseases "has always given a very
restrictive interpretation" to the "grave danger" exception in
Article 28,370 thus limiting the potential the proviso might oth-
363. See id. art. 8(1), at 13.
364. See id. arts. 76-81, at 33-35.
365. See id. art. 82, at 35-36.
366. DELON, supra note 90, at 13. "Free pratique" is defined as "permission
for a ship to enter a port, disembark and commence operation, or for an air-
craft, after landing, to disembark and commence operation." INT'L HEALTH
REG., supra note 89, art. 1, at 8.
367. See, e.g., INTL HEALTH REG., supra note 89, art. 57(1), at 28 (outlining
surveillance for plague); id. art. 57(2), at 28 (providing isolation for pulmonary
plague), id. art. 62(1), at 30 (outlining surveillance or isolation for cholera); id.
arts. 68 & 71, at 31-32 (regarding handling of yellow fever cases).
368. One area where member states of WHO can implement more restric-
tive measures than are generally allowed by the IFIR is in connection with
"[mligrants, nomads,' seasonal workers or persons taking part in periodic
mass congregations" who "may be subjected to additional health measures
conforming with the laws and regulations of each State concerned." Id. art.
84(1), at 37-38.
369. See id. art. 28, at 19.
370. DELON, supra note 90, at 13; see also Edelman, supra note 115, at 39
(noting that, according to the Committee on International Quarantine under
the original International Sanitary Regulations, such Regulations expressly
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erwise have for interference with world traffic. Second, Article
81 of the IHR states that no health document other than those
listed in the 1-IR shall be required for international traffic.371
Article 81 thus requires that "member nations must refrain
from requiring health certificates for non-Regulation dis-
eases."
372
The IHR regulate restrictive measures in part to prevent
member states from overreacting when one of their members
notify WHO of a disease outbreak.373 Minimum interference is
thus both a counterweight and a compliment to the surveil-
lance mechanism established by the MHR. In theory, then, the
principles of maximum security against the international
spread of disease and of minimum interference with world
traffic are integrated to form the overall international legal
regime on infectious disease control.
D. EFFECTIVENESS OF THE IHR
Both WHO officials and international legal scholars agree
that the HR have failed to ensure the maximum security
against the international spread of diseases with minimum in-
terference with world traffic. While laudatory comments about
the IHR and their contributions to international infectious dis-
ease control are made periodically, the IHR have not achieved
their fundamental purpose. WHO officials acknowledged this
failure long before the current crisis over EMs erupted, 74 but
refer to the quarantinable diseases "and limit the sanitary measures to be
taken in respect of other infectious diseases").
371. See INTL HEALTH REG., supra note 89, art. 81, at 35. The health
documents required under the IHR are a Maritime Declaration of Health from
the master of a ship making an international voyage, see id. art. 77, app. 3, at
33, 46-47, the Health Part of the Aircraft General Declaration, see id. art. 78,
app. 4, at 34, 48, a Deratting Certificate, see id. art. 79, app. 1, at 34, 42-43,
and an International Certificate of Vaccination or Revaccination Against Yel-
low Fever, see id. art. 79, app. 2, at 34, 44-45.
372. Alin, supra note 307, at 1050.
373. See id. (noting that the IHR contains these provisions to prevent
countries from overreacting and to ensure accurate reporting of diseases by
member states).
374. See Dorolle, supra note 109, at 109 (noting the inadequacies of the In-
ternational Sanitary Regulations in 1968 by the Deputy Director-General of
WHO); Roelsgaard, supra note 340, at 266-67 (discussing the failure of IHR to
provide maximum security with minimum interference by Chief of WHO's
Epidemiological Surveillance of Communicable Diseases, in 1974); see also
Boris Velimirovic, Do We Still Need International Health Regulations?, 133 J.
INFECTIOUS DISEASE 478, 478 (1976) (arguing in 1976 that WHO, many gov-
ernments, epidemiologists, and shipping and air-traffic promoters understood
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the EID problem has placed the ineffectiveness of the IHR in
stark relief and created the impetus for their revision.
1. Breakdown in Surveillance
The surveillance system constructed through the notifica-
tion duties in the IHR has broken down because member states
regularly fail to notify WHO of outbreaks of diseases subject to
the IHR.375 Three reasons stand out for this failure to notify.
First, poor national surveillance systems in many member
states often mean that member states do not recognize an out-
break of a disease subject to the 1HR for a long time or even at
all.376 Here the deterioration of public health systems world-
wide undermines the effectiveness of existing international
law. Second, many WHO member states do not report for do-
mestic political reasons, either out of a concern for national
honor or prestige 377 or a "lack of sincerity on the part of na-
tional health administrations."378  Finally, many member
states fail to notify WHO because they fear excessive reactions
from other states that will produce losses in trade and tour-
ism.3
79
Even if WHO member states fulfilled their notification
duties under the M-I, the surveillance system in the R re-
mains flawed because it applies to only three diseases. Com-
menting on the diseases subject to the IHR in 1974-plague,
cholera, yellow fever, and smallpox-Roelsgaard argued that
these diseases are subject to the IHR largely for historical rea-
sons: "they are the pestilential diseases of the past."38  S
early as 1968, experts observed that the HIR did not address
many other infectious diseases that pose equivalent risks of
that "W[the IHR have become a glorious monument and a self-serving ritual as
much as a measure of protection, collective or individual").
375. See DELON, supra note 90, at 24 (noting unsatisfactory fimctioning of
notification system); CISET REP., supra note 28, at 4 (noting reluctance of
states to share surveillance information); Dorolle, supra note 109, at 104
(noting breakdown in systems of notification); Garrett, Infectious Disease, su-
pra note 61, at 74 (discussing reluctance of many nations in reporting infec-
tious diseases); Heymann, supra note 92, at 12 (noting failure of states to no-
tify WHO).
376. See DELON, supra note 90, at 24; Dorolle, supra note 109,-at 104.
377. See DELON, supra note 90, at 24; CISET REP., supra note 28, at 4.
378. Dorolle, supra note 109, at 109.
379. See DELON, supra note 90, at 24; CISET REP., supra note 28, at 4;
Dorolle, supra note 109, at 104-05; Heymann, supra note 92, at 12.
380. Roelsgaard, supra note 340, at 267.
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spreading internationally.381 With EIDs, the inadequacy of the
HIR's requirements for only three infectious diseases has been
repeatedly noted.382 In relation to one of the biggest infectious
disease crises of this century-the AIDS pandemic-the 1-IR
surveillance system has been irrelevant because HIV/AIDS
was not, and has not subsequently been made, a disease sub-
ject to the IR383 WHO proposes to expand the coverage of the
hIR in its planned revision,384 but it is troubling that in 1989
the Legal Counsel of WHO argued that "no one today seems to
seriously contemplate increasing the number of 'diseases sub-
ject to the Regulations.'" 385 This sentiment not only directly at-
tacks the proposed WHO revision of the IhR but also calls into
question any effort to use international law to create a global
surveillance system capable of handling the enormous chal-
lenge of Elms.
2. Ineffectiveness of Protection Measures
The objective of maximum security against the interna-
tional spread of disease might be fulfilled despite the break-
down of the IHR surveillance system if WHO member states'
attempts to prevent infectious disease spread were successful.
The historical record amply demonstrates, however, that those
actions, whether or not authorized by the HR, have failed to
prevent the international spread of infectious diseases. In
1968, the Deputy Director-General of WHO observed that the
International Sanitary Regulations had failed to contain the
international spread of cholera and smallpox-two of the dis-
381. See Dorolle, supra note 109, at 109 (commenting in 1968 on lack of
coverage in International Sanitary Regulations of many diseases, such as tu-
berculosis, poliomyelitis, brucellosis and others, posing risks of international
spread).
382. See, e.g., Heymann, supra note 92, at 12 (noting that new and ree-
merging infectious disease have the same potential for international spread as
the diseases subject to the IHR); Martinez & Alary, supra note 305, at 3(stating that the IHR fail to address new and reemerging infectious diseases).
383. See Fidler, supra note 8, at 80.
384- See infra note 419 and accompanying text (discussing proposed
changes to the IHR in which reporting of the three specified diseases would be
replaced by reporting of defined syndromes that correspond to occurrence of
diseases of urgent international importance).
385. Vignes, supra note 338, at 18. Vignes expressed this view because he
believed that the attempt to increase the use of binding rules by increasing
the number of duties under the IHR would not be an effective way to deal
with infectious disease control. See id.
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eases then subject to those regulations.386 The inability to stem
the international spread of cholera in particular has received
considerable attention.387  While some success has been
claimed for the IHR in relation to controlling the international
spread of the plague,388 Roelsgaard, WHO's Chief of Epidemiol-
ogical Surveillance of Communicable Diseases, argued that the
extent of the contribution from the H-IR is "highly question-
able" because ships and ports have ample economic incentive to
control rodent populations without the IHR's requirements.389
The ineffectiveness or questionable effectiveness of measures
taken against the international spread of the diseases subject
to the IHR is only compounded by the fact that the IMR do not
address many other infectious diseases of international impor-
tance and in fact expressly prohibit states from taking protec-
tive actions against other diseases except in situations of grave
danger.
3. Excessive Measures
The =-IR's practical effect is equally disappointing regard-
ing the objective of minimum interference with world traffic.
The IHR's attempt to regulate what actions WHO member
states may take in response to infectious disease outbreaks has
been generally ignored. WHO member states have regularly
applied measures far more restrictive than those permitted
under the IHR. Like the difficulty of achieving maximum se-
curity against the international spread of disease, the troubles
386. See Dorolle, supra note 109, at 105-06.
387. See DAVID LE1vE, I INTERNATIONAL REGULATORY REGIMES 89-99
(1976) (examining IHR's functioning under impact of a cholera epidemic);
Heymann, supra note 92, at 12 (noting misapplication of IHR in connection
with cholera spreading into Latin America); Roelsgaard, supra note 340, at
267 (stating that [tihe provisions of the Regulations for preventing the inter-
national spread of cholera have not been effective").
388. See, e.g., Roelsgaard, supra note 340, at 267 (commenting that spread
of diseases would have been arguably "far greater" without the HR); Report
of a WHO Informal Consultation, supra note 121, at 13 (noting that the IHR
played a role in limiting the international spread of yellow fever and plague).
389. See Roelsgaard, supra note 340, at 267. The HIR have been praised
for controlling the spread of yellow fever through the vaccination require-
ment. See id. (acknowledging the efficacy of yellow fever vaccination); Report
of a WHO Informal Consultation, supra note 121, at 13 (acknowledging the
role of the IHR in preventing the international spread of yellow fever); see
also IvT HEALTH REG., supra note 89, art. 66, at 30 (outlining the yellow fe-
ver vaccination requirement). Nevertheless, whether the control of yellow fe-
ver "is due to the effective vaccination of travelers leaving infected areas is
debatable." Roelsgaard, supra note 340, at 267.
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besetting the minimum interference principle were recognized
long before the EID problem surfaced. In 1968, the Deputy Di-
rector of WHO stated that the objective of avoiding "excessive
and unnecessary quarantine measures" has failed. In 1974,
the Chief of WHO's Epidemiological Surveillance of Communi-
cable Diseases said that the value of the IHR in ensuring
minimum interference with world traffic may be "seriously
questioned."391 In 1975, P.J. Delon, author of WHO's Practical
Guide to the IER, stated that "[ilnstances of excessive and
useless measures have been numerous in the history of the
application of the Regulations since 1951."392 With EIDs, the
problem of excessive measures has been exacerbated.393 One of
the most famous examples involving excessive measures violat-
ing the IHR occurred when many WHO member states applied
travel restrictions to travelers with or suspected of having
HIV/AfDS or who simply traveled from a country with reported
AIDS cases.
3 94
As noted earlier,395 the breakdown in surveillance fuels
WHO member states' enactment of excessive and unauthorized
health measures, and their excessive reaction to disease out-
breaks chills any incentive to notify WHO. When either of the
objectives of maximum security or minimum interference fails,
effectuating the purpose of the IMR becomes an impossible
396mission.
4. Enforcement of the IHIR
The almost wholesale lack of compliance with the HIR
raises the question whether WHO has any enforcement powers
390. Dorolle, supra note 109, at 105.
391. Roelsgaard, supra note 340, at 266-67.
392. DELON, supra note 90, at 24.
393. See Heymann, supra note 92, at 12-13 (noting recent episodes of ex-
cessive measures unduly interfering with world traffic).
394. See, e.g., Allin, supra note 307, at 1053-62 (documenting travel and
immigration restrictions adopted by countries in response to HIV/AIDS);
Leonard J. Nelson, International Travel Restrictions and the AIDS Epidemic,
81 AM. J. INTL L. 230, 231 (1987) (discussing a proposed rule by the CDC to
provide grounds for exclusion of aliens with AIDS); Tomasevski, supra note
139, at 867-68 (noting that 50 countries imposed lIY/AIDS-related restric-
tions).
395. See supra note 262 and accompanying text (discussing how a break-
down in surveillance produces excessive reactions in other states).
396. WHO Deputy Director Dorolle observed in 1968 that "with regard
both to notification and to maximum permissible measures the regulations are
very often a dead letter." Dorolle, supra note 109, at 105.
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that could have been or could be used to improve the member
states' performance under the IMR.3 9 The WHO Constitution
does not provide for any sanction against a member state that
fails to comply with a binding regulation enacted under Article
21.398 Similarly, nothing in the IHR gives any international or-
ganization enforcement powers in connection with the duties
created in the IHR. 399 The regulations do set up a dispute set-
tlement procedure that could be used to draw attention to the
lack of notifications or the use of excessive measures. 40 0 This
procedure has been used very seldomly.4 °'
WHO's decision to issue nonbinding recommendations
rather than enforceable legal rules has made the organization's
lack of formal enforcement powers less significant. *The reluc-
tance WHO has exhibited toward using international law
means, however, that "many legally binding Regulations tend
to be treated in practice almost as recommendations." 4 2 In the
IHR context, for example, the lack of enforcement powers and
the preference for WHO to operate through nonbinding rec-
ommendations and persuasion have seriously undermined the
authority of the regulations. Without formal enforcement pow-
ers, however, WHO may have no alternative to this nonlegal
approach. Some experts have rejected proposals to endow
WHO with greater power as incompatible with the public
health context in which WHO administers the IHR. A former
WHO Legal Counsel called the use of binding provisions in in-
ternational health law "unrealistic" because binding regula-
tions "cannot be adopted quickly enough to meet the health re-
397. One commentator asked, "[Ils there much sense in the maintenance of
rules if they are not observed-if they are disregarded or more or less system-
atically broken-without any consequences for those who deviate?" Velimi-
rovic, supra note 374, at 481.
398. See Sharp, supra note 207, at 526-27. The only sanction power in the
WHO Constitution resides in the World Health Assembly, which may suspend
the voting privileges and services to a member state that fails to meet its fi-
nancial obligations to WHO. WHO CONsT. art. 7.
399. See Heymann, supra note 92, at 12 (stating that no international body
has the mandate to enforce IHR reporting).
400. See INT"L HEALTH REG., supra note 89, art. 93, at 41.
401. See Roelsgaard, supra note 340, at 266 (noting the procedure was
used once between 1954 and 1974). The author could find no reference to, or
record of, the use of the dispute settlement procedure since 1974.
402. LEIVE, supra note 387, at 46 (discussing the status of WHO resolu-
tions in international law).
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quirements of the moment."40 3 He observed that WHO has ef-
fectively fought AIDS through nonbinding recommendations
rather than binding AIDS regulations through the IHR or oth-
erwise under Article 21 of the WHO Constitution.
404
This assessment also suggests that the sovereignty con-
cerns of member states often force WHO to work through non-
binding advice. This question of whether public health
authorities should coerce through law or persuade through
education arises at every level of public health policy: local,
national, and international.4 °5 WHO apparently has long be-
lieved that persuasion is more productive, than legal coercion.
Given the general lack of enforcement mechanisms throughout
international law,40 6 WHO's choice to persuade rather than
compel does not seem naive. In truth, however, WHO's per-
suasive efforts with member states have failed, and future
prospects for improved binding international law or expert
guidance and persuasion do not gleam brightly on the horizon.
5. Epidemiology as the Answer
Analyses of the IHR done in the late 1960s and early 1970s
by WHO officials share many important conclusions with the
fundamental elements of the current grand strategy to deal
with EDs. In both cases, the experts have recognized that the
presence of adequate systems of public health to detect, iden-
tify, control, and prevent infectious diseases in every country is
vital to controlling the spread of infectious diseases interna-
tionally.0 7 The notion that improved national public health
403. Vignes, supra note 338, at 18 (analyzing the future of international
health law).
404. See id.
405. See O'Brien, supra note 86, at 26 (noting that disease prevention
strategies cannot rely on legal coercion alone but must include cooperation
and voluntary compliance).
406. See Fidler, supra note 8, at 80 (noting problem of lack of effective en-
forcement of international law).
407. See DELON, supra note 90, at 7 (arguing that "[o]nly an increase in the
efficiency of national systems of epidemiological surveillance and prevention"
can achieve maximum security with minimum interference); Dorolle, supra
note 109, at 111 (arguing that the "only solution is a system of detection and
surveillance at the source.., in the countries where the diseases that consti-
tute a threat are endemic"); Gutteridge, supra note 117, at 13-14 (commenting
in 1963 that there is "no escape" from the conclusion that WHO's health ob-
jectives depend on the creation and maintenance of proper public health sys-
tems at the local and national levels); Roelsgaard, supra note 340, at 268
(arguing that "[sltrengthening the national surveillance of communicable dis-
1997] 849
MINNESOTA LAW REVIEW
capabilities provide the best answer to the international spread
of disease actually pre-dates the WHO analyses of the late
1960s and early 1970s.40 8 Despite a history of calls for reform,
the International Sanitary Regulations did not address the
need for "sound epidemiological services with reliable disease
surveillance" in WHO member states4 9 and successive
amendments producing the IHR have not done so either. The
director of WHO's health legislation program has argued that
improving national public health infrastructures, identified for
years as the best path to infectious disease control, "is a solu-
tion which cannot be obtained by an international instrument
but only by the improvement of the health conditions of the
peoples of WHO's member states."410 Under this view, inter-
national law has little to offer in fashioning a strategy for the
essentially domestic challenge of EDs.
The forces of globalization, however, have blurred tradi-
tional distinctions between domestic and international health.
The challenge of improving national public health systems now
clearly belongs in the realm of international law because
health conditions in one country can have a significant impact
on health throughout the world. Public health experts have
recognized for decades that, without financial assistance from
developed states, poverty in developing countries will keep a
final solution to the international spread of disease beyond
reach.41 1 All factors indicate that any serious strategy for in-
fectious disease control must include an agreement between
eases ... will afford greater protection against outbreaks than any interna-
tional agreement can provide"); Velimirovic, supra note 374, at 480 (noting
that WHO "has stressed repeatedly the importance of local competence to deal
with imported diseases and the correction of conditions that make persistence
of diseases possible"); see also supra note 250 and accompanying text (discussing
the need to improve surveillance, prevention and control, infrastructure, and
research).
408. Public health experts advocated a strategy of developing national
public health systems immediately after the adoption of the International
Sanitary Regulations in 1951, see Roelsgaard, supra note 340, at 268, after
World War I, and as early as 1866. See Nelson, supra note 394, at 233-34
(citing views from after World War I and in 1866).
409. Fluss, supra note 318, at 15.
410. Id.
41L See Dorolle, supra note 109, at 111 (commenting in 1968 that with
underdeveloped states "there is no hope that, with their limited means, they
can in the foreseeable future afford an efficient epidemiological service");
Roelsgaard, supra note 340, at 267 (commenting in 1974 that international
cholera control "requires a massive financial investment in relatively poor
countries").
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developed and developing states consummated through inter-
national law. As mentioned earlier,412 the grand strategy con-
spicuously avoids this thorny issue, but the proposed WHO re-
vision of the IHR offers another opportunity to grasp the nettle.
V. AMENDING THE INTERNATIONAL HEALTH
REGULATIONS: AN ANALYSIS OF WHO'S
PROPOSED REVISION
In December 1995, WHO held the Informal Consultation to
Review the International Response to Epidemics and Applica-
tion of the International Health Regulations (Informal Consul-
tation).413 WHO convened the Informal Consultation in re-
sponse to the World Health Assembly's call for a revision of the
HR. 414 According to the Director of EMC, the findings of the
Informal Consultation will serve as the basis for the revision of
the IRR.415 The Informal Consultation recommended that the
revised IKR continue to promote maximum security against
the international spread of diseases with minimum interfer-
ence with world traffic and trade.41 6 The Informal Consultation
concluded that the IHR "have served an invaluable purpose"
and "continue to serve the principles under which they were
conceived."417 These conclusions ring hollow, though, in light of
the failure of the IHR to uphold either the maximum security
or minimum interference principle analyzed above.418
A. RECOMMENDATIONS AFFECTING THE MAX[MUM SECURITY
PRINCIPLE
1. Syndrome Reporting
The Informal Consultation offers several recommendations
that address the principle of maximum security against the in-
ternational spread of disease. Several of these recommenda-
412. See supra notes 288-93 and accompanying text (discussing the chronic
lack of funding provisions in EID plans).
413. See Report of a WHO Informal Consultation, supra note 121, at 1.
414. See Revision and Updating of the International Health Regulations,
WHO Doc., WHA 48.7, World Health Assembly (May 12, 1995).
415. See Heymann, supra note 92, at 15.
416. See Report of a WHO Informal Consultation, supra note 121, at 14.
417. Id. at 13.
418. See supra note 374 and accompanying text (discussing views of public
health experts that the IHR have failed to achieve their fundamental objec-
tives).
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tions concern the IHR's surveillance system. First, "[tihe cur-
rent practice of immediate reporting of only three specified dis-
eases should be replaced by the immediate reporting to WHO"
of "defined syndromes corresponding to the occurrence of dis-
eases of urgent international importance."419 This recommen-
dation responds directly to the criticism that the IHR do not
address many infectious diseases with the potential for inter-
national spread.
Rather than increasing the number of diseases subject to
the IER, the Informal Consultation recommends a two-stage
reporting procedure: immediate reporting of disease syn-
dromes, followed by disease-specific reporting once the disease
is identified.420 Requiring the reporting of syndromes would
trigger earlier notification of disease-related events, allowing
WHO and the national health authority to combine their re-
sources to pin down the infectious agent causing the syn-
dromes.421 Syndrome notification would thus facilitate greater
cooperation between WHO and other member states on infec-
tious disease surveillance. In addition, WHO experts might
dissuade member states from taking excessive and irrational
action in response to early reports of syndrome and disease in-
formation. Syndrome reporting might also encourage needed
collaboration between other national and international authori-
ties.
Syndrome reporting would also allow the revised IHR to
include new diseases within its scope, unlike the rigid, disease-
specific approach of the current IHR. The revised requirements
could potentially catch novel pathogens, keeping the IHR rele-
vant as the microbial world evolves and surprises. In addition,
the detection and reporting of syndromes places less of a bur-
den on the public health capabilities of developing countries
than the current requirement to identify specific diseases.
Syndrome reporting eliminates the futility of asking that de-
veloping states have the expertise and technology to identify a
long list of infectious diseases with risks of international
spread.
Syndrome reporting obligations might not, however, con-
tribute to an improvement in the IER's surveillance capabili-
ties. First, member states have no greater incentive to notify
419. Report of a WHO Informal Consultation, supra note 121, at 14.
420. See id.
421. See id. at 8.
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WHO of syndromes than of specific diseases as long as the re-
vised IHR do not take a harder line on excessive measures.
Second, confusion might arise in reporting syndromes. Mem-
ber states may not know exactly what diseases the syndromes
represent, potentially encouraging WHO member states to en-
act excessive measures. Third, the Informal Consultation did
not indicate how developing states would develop the capabili-
ties to identify and notify disease syndromes in a timely man-
ner. Even if syndrome reporting requires less epidemiological
prowess, many developing states have "extremely scarce"
health resources.42 The Informal Consultation recommends
expanding notification responsibilities under the HR without
confronting the fundamental financial dilemma. Inadequate
syndrome reporting might fuel excessive measures by other
member states, which will likely discourage syndrome report-
ing, and history will have repeated itself.
2. Greater Information Flows
Another set of recommendations designed to support the
maximum security principle involves increasing the flow of in-
formation to and from WHO. The Informal Consultation rec-
ommends that the IhR allow notification and reporting by any
national authority, not just the public health administration.
The Informal Consultation also recommends a revision of Ar-
ticle 3(1) of the IHR to encourage the notification of imported
and transferred disease cases.
424
These proposals, however, will likely have little impact.
Expressly including all parts of the government of a member
state in the notification duties is cosmetic rather than sub-
stantive; it is doubtful whether the reporting problem rests
with an obstructionist health administration silencing other
parts of the government from communicating with WHO. De-
cisions not to report are probably made at very high levels,
thus applying to all parts of the government.
422. See CISET REP., supra note 28, at 43 (comparing public health infra-
structures in developing countries).
423. See Report of a WHO Informal Consultation, supra note 121, at 9.
424. See id. The Informal Consultation did, however, recommend eliminat-
ing the weekly and annual notification requirements now found in Articles 9
and 13 of the HR, respectively. See id. at 10. The Informal Consultation of-
fered no explanation for these recommendations, but presumably it believed
that such periodic notifications yield little benefit for a global surveillance sys-
tem.
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Removing the restriction in Article 3(1) that exempts im-
ported and transferred cases from disease notification merely
collapses Article 3(1) with Article 3(2), which requires the re-
porting of imported and transferred cases. Revising Article
3(1) would provide the limited benefit of requiring member
states to notify WHO of cases imported or transferred into in-
digenously infected areas.426 This technical gap, however, does
not cause the significant problems besetting the MR.
The Informal Consultation also proposes increasing the
flow of information from WHO to member states and to other
audiences. The recommendations would allow WHO to dis-
seminate information obtained from member states and other
WHO surveillance sources, as well as from agencies and non-
governmental organizations,4 27 in order to make the widest
possible stream of epidemiological information available to
member states. A closer reading of this recommendation sug-
gests that WHO will be able to provide information on disease
outbreaks to member states even if the affected member state
has refused to notify.
The Informal Consultation relies on the perceived power of
modern telecommunications technology to support its position
that, "in this age of wide media coverage, nothing can be hid-
den."428 Such a position encourages WHO to undermine the
sovereign prerogative to notify by utilizing global communica-
tions to bypass national reporting decisions. The Informal
Consultation proposal advocates that the concept of "national"
epidemiological information has no place in today's world.
Yet member states may well become very uncomfortable
with such a radical expansion of WHO's ability to notify mem-
ber states about epidemiological events. At the very least,
WHO will need to set forth guidelines as to what other sources
425. See INVL HEALTH REG., supra note 89, art. 3(2), at 11.
426. Article 3(1) requires notification of nonimported and nontransferred
cases. See id. art. 3(1), at 10-11. Article 3(2)(a) requires notification of cases
imported or transferred into a noninfected area. See id. art. 3(2)(a), at 11.
Neither provision regulates the notification of cases imported or transferred
into infected areas. The Informal Consultation's recommendation on Article
3(1) would close this gap.
427. See Report of a WHO Informal Consultation, supra note 121, at 9-10,
15. Currently, WHO can disseminate information received only from member
states. See INTL HEALTH REG., supra note 89, art. 11(1), at 14 (permitting
WHO to pass along only that information obtained through its surveillance
program).
428. Report of a WHO Informal Consultation, supra note 121, at 10.
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offer authoritative, and thus notifiable, information under re-
vised MR. Drafting such guidelines could be far more than a
technical challenge as some member states will be anxious to
limit the information stream to WHO for fear of reactions from
other states. A limited list of authoritative sources might,
however, prompt restrictive actions by states because they will
have access to information from other sources about disease
outbreaks regardless of whether WHO notifies them. Finding
the right balance in such guidelines might prove controversial.
The worst possible reaction would be for member states to re-
duce the opportunities for nongovernmental organizations to
provide health services for fear that they will report informa-
tion to WHO. Public health in these states would suffer, and
other states would be tempted to overreact to disease informa-
tion about such member states, thereby jeopardizing the fun-
damental purpose of the revised ]HR.
The Informal Consultation recommends that WHO con-
tinue to publish information on diseases at periodic intervals
but that such publication be optional so that WHO publishes
"data on infected areas when this is epidemiologically relevant
to the international transmission of disease. This recom-
mendation gives WHO discretion to disseminate information,
and it does not affect a member state's legal duty to report.
The proposal fails to advance the principle of maximum secu-
rity, however, because it removes the requirement to publish.
It leaves open the possibility that politics and bureaucratic
battles rather than epidemiology will determine whether in-
formation relates to the international transmission of disease.
Finally, the goal of increasing the flow of epidemiological
information from WHO to member states does not address the
reality that many member states do not have a public health
system that can make effective use of such epidemiological in-
formation. No amount of timely information will aid a member
state that has neither adequate facilities nor personnel to use
it. Here again, the condition of public health systems in the
developing world limits the effectiveness of an overarching in-
ternational strategy.
3. Application and Education
The Informal Consultation also attempts to bolster the
maximum security principle by proposing that WHO educate
429. Id. at 14.
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member states on the application of the revised IHR. The In-
formal Consultation recommends integrating the revised =-R
with all disease prevention, control, and research activities at
the national, regional, and global levels.430 Unfortunately, it
offers no specifics as to how to achieve this integration, nor
does it suggest that the revised IHR should mandate such in-
tegration. Presumably the Informal Consultation seeks to pre-
vent the revised IHR from becoming essentially irrelevant to
infectious disease control and prevention activities around the
world as had the current IHR. The efficacy of integrating the
revised IHR will depend, however, on whether member states
have anything in which to integrate it-the public health in-
frastructure dilemma again.
The Informal Consultation proposes a number of educa-
tional measures. First, it recommends that WHO provide
member states with guidelines for management of infectious
diseases spread through international traffic.' Member
states would find such guidelines particularly important when
faced with an unusual or unanticipated infectious disease
threat.432 Guidelines on handling internationally transmitted
diseases might help member states take epidemiologically ef-
fective steps to prevent and control disease outbreaks. Without
adequate facilities and personnel, though, member states can-
not implement and maintain epidemiologically-effective guide-
lines.
The Informal Consultation also recommends that WHO is-
sue a "practical handbook" with the revised IHR "to facilitate
the appreciation and use of the IHR.'  On the one hand, a
practical handbook might help member states adjust to a new
set of rules, thus easing a potentially difficult transition.434 On
the other hand, the problems that beset the current IH have
little to do with member states not understanding them. After
all, WHO published a Practical Guide to the IHR in 1975 with-
out demonstrable improvement in their application. The prac-
430. See id.
431. See id.
432. See id.
433. Id.
434. See H.S. Gear & Z. Deutschman, Disease Control and International
Travel: A Review of the International Sanitary Regulations, 10 CHRON. OF THE
WHO 273, 326-28 (1956) (describing some of the difficulties member states
had adjusting to the International Sanitary Regulations during their first four
years of application).
856 [Vol. 81:771
INFECTIOUS DISEASES
tical handbook proposal assumes the existence of a public
health audience that can effectively use the handbook, an as-
sumption simply not credible given the condition of public
health systems around the world.
4. Health Organization Requirements
The Informal Consultation recommends removing many of
the provisions laying down requirements for health organiza-
tion and capabilities at ports and airports from the IHR and
replacing them with references to other international agree-
ments that have the same or similar requirements.435 This
change presumably seeks to avoid redundancy in member
states' international legal obligations. It suggests retaining
only those provisions regarding health care services for manag-
ing arriving sick persons and those regarding equipment nec-
essary for disinfection, disinsection, and control of animal-
borne diseases.
436
The recommendation to rely on other international agree-
ments is questionable because these other agreements may
have objectives beyond, or even in opposition to, the maximum
security principle of the IHR. If the full set of health organiza-
tion requirements currently in the IhR still further the maxi-
mum security principle, then the IHR should retain them in
full as binding obligations, regardless of whether international
agreements also have similar requirements. Moreover, the
practice of states under other international agreements con-
cerning such requirements might not have the control of infec-
tious diseases as the top priority, making such practice less
than helpful to the maximum security principle. The maxi-
mum security principle should not be weakened merely to re-
duce the number of provisions in the IHR.
B. RECOMMENDATIONS AFFECTING THE MINIMUM
INTERFERENCE PRINCIPLE
The Informal Consultation also made recommendations to
strengthen the principle of minimum interference with world
traffic. The change to syndrome reporting, as the Informal
Consultation points out, would significantly affect many as-
pects of the current IHR that seek to limit interference with in-
ternational travel and trade. As a result, those parts of the
435. See Report of a WHO Informal Consultation, supra note 121, at 10.
436. See id.
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IHR would need revision to accommodate syndrome report-
ing.4
37
An immediate question arises as to whether syndrome re-
porting complicates the achievement of minimum interference
with world traffic. Presumably, the revised IER will authorize
member states to take specified actions in connection with a
large number of syndromes. Perhaps more interference is in-
evitable given the EID threat. To minimize interference under
current circumstances, the revised IIR will need to confront
directly the tendency of member states to take excessive meas-
ures when disease outbreaks occur in other states. The Infor-
mal Consultation's report contains a number of recommenda-
tions addressing the problem of excessive measures.
1. Defining "Excessive Measures"
The Informal Consultation recommends including in the
revised IHR "descriptions of inappropriate or unnecessary in-
terventions with clear indications why these actions are not
required." 43  Such descriptions of excessive measures may not
represent a substantive change from the current situation.
The footnote to Article 8 of the current IHR states that WHO
alread has the authority to publish measures it finds exces-
sive. 43 Moreover, the frequency of the application of excessive
measures by member states does not seem driven by a lack of
understanding about what the IHR authorizes. Including de-
scriptions of excessive measures in the revised IHR might de-
ter resort to such measures, but this recommendation really of-
fers a technical rather than substantive solution, because
member states apparently understand the definition of exces-
sive measure under the current IHR.
2. Limitations on Member States
The Informal Consultation makes some recommendations
that seek to reinforce limitations on member states in taking
actions beyond those authorized by the IHR. First, it recom-
437. The Informal Consultation notes that Chapters II, I1, IV, and V of
Part IV on health measures and procedures, Part V on special provisions re-
lated to the diseases subject to the IHR, and Part VI on health documents
would require revision in light of the recommendations on syndrome report-
ing. See Report of a WHO Informal Consultation, supra note 121, at 10-12.
438. Id. at 15.
439. See INT'L HEALTH REG., supra note 89, art. 8, at 13 n.a(2) (regulating
member states' ability to respond to health risks).
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mends deleting Article 28, which allows member states to take
measures in excess of those permitted by the IEIR in situations
of grave danger to public health."0 The deletion of Article 28
would bolster Article 23's mandate that the measures permit-
ted by the IHR are the maximum measures that can be ap-
plied." 1 Anticipating that deleting the Article 28 escape clause
might prove too controversial with member states, the Informal
Consultation advises that, if retained, Article 28 should in-
clude a clear definition of what constitutes "grave danger.""
2
In theory, the removal of Article 28 would represent a
radical revision of the IHR, because it would eliminate the
flexibility Article 28 gave to the exercise of sovereignty in tak-
ing health measures against the international spread of infec-
tious diseases. In practice, however, neither deleting Article 28
nor clearly defining "grave danger" would have a radical im-
pact because WHO has long interpreted "grave danger" re-
strictively with little effect on member states."3 The lack of
sanctions in the THR, and the absence of any recommendations
from the Informal Consultation on enforcement, make violating
the current Article 23 or a reinforced Article 23 painless for a
member state of WHO. Member states would likely continue to
view a revised Article 23 as a recommendation rather than a
legally-binding requirement.
The Informal Consultation also proposes that the revised
IHR restrict the application of measures on departing indi-
viduals "to those persons who are clearly ill and who present
one or more of the symptoms or syndromes that will be adopted
in the modified Regulations."4" This recommendation reduces
the discretion now available to national health authorities to
take health measures on departure under Article 30. From the
perspective of the maximum security principle, reducing the
discretion in Article 30 might seem dubious because extra
measures on departure might help prevent and control inter-
national disease spread. Retaining Article 30's allowance for
discretion would serve the epidemiological preference for stop-
ping diseases at their source. Member states are unlikely to
440. See Report of a WHO Informal Consultation, supra note 121, at 11.
441. See id.
442. See id.
443. See DELON, supra note 90, at 13 (noting in 1975 that WHO's Commit-
tee on International Surveillance of Communicable Diseases "has always
given a very restrictive interpretation" to Article 28).
444. Report of a WHO Informal Consultation, supra note 121, at 11.
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abuse this discretion because international travel and trade by
their nationals produce economic benefits for their countries,
therefore providing incentives to keep departure measures
minimal. The Informal Consultation's proposal, therefore, does
not significantly alter the standard for departure measures be-
cause of the existing economic incentives to keep such meas-
ures to a minimum. Thus, the proposal contributes little to the
minimum interference principle while removing discretion that
might in certain circumstances work in favor of the maximum
security principle.
The Informal Consultation additionally recommends
making Article 34, which limits the application of health
measures to passengers and carriers in transit, "more positive
in order that health administrations be made responsible for
extending health services to passengers in transit, sometimes
for long periods." 5 Apparently, the Informal Consultation be-
lieves the duties of member states under the current IHR to
care for passengers in transit who manifest symptoms of infec-
tious diseases are inadequate. Requiring member states to
provide health care to infected passengers would serve as a
prudent epidemiological control and prevention measure. This
proposal ignores, however, three problems: (1) many member
states could not provide the required adequate care; (2) many
passengers might resist compelled treatment in some public
health care systems as more dangerous than completing the
journey or returning home immediately; and (3) member states
might oppose the inclusion of such explicitly positive obliga-
tions in the revised IHR because of the costs they might have
to bear to fulfill them.
Finally, the Informal Consultation recommends reinforc-
ing Article 81,446 which prohibits member states from requiring
any health document in international traffic beyond those
provided for in the IHR.44' The AIDS crisis saw many member
states openly violate Article 81 by requiring AIDS-free certifi-
cates or similar health documents; Article 81 thus plays an im-
portant role in support of the minimum interference principle.
The Informal Consultation does not, however, say how Article
445. Id. This recommendation suggests that the revised IHR should im-
pose afrmative duties on member states to provide health services to pas-
sengers in transit.
446. See id. at 12.
447. See INT'L HEALTH REG., supra note 89, art. 81, at 35 (preventing
member states from exceeding the documentation provisions of the IH).
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81 should be reinforced. Its prohibition on nonauthorized
health documents is very clear, so the problem cannot be ad-
dressed by better drafting. More importantly, the Informal
Consultation offers no revisions providing enforcement any-
where, so Article 81 will not be reinforced by sanctions. There-
fore, the Informal Consultation's recommendation to reinforce
Article 81 rings hollow without any further explanation.
3. More Power for WHO
In one of the more radical proposals relating to the mini-
mum interference principle, the Informal Consultation recom-
mends additional power for WHO. The Informal Cdnsultation
urges that the revised HIR include a graduated series of health
responses for member states to follow that would be propor-
tionate to the assessed risk posed by the syndrome or disease
in question.4 8 This series would take the form of a response
ladder with five rungs, starting at Grade 0 and culminating at
Grade 4.49 A Grade 0 event involves no risk of international
transmission of disease,450 while a Grade 4 event presents risks
"of such global health importance that severe measures, includ-
ing modifications to international travel, may be considered."4"
The Informal Consultation further recommends that WHO
have the power to prohibit member states from applying health
measures in response to Grade 3 or 4 events "until such meas-
ures are approved by a specific expert group convened at ex-
tremely short notice under the auspices of WHO."45 -
This proposal to give WHO veto power over national health
measures to be enacted in response to the most serious disease
outbreak events is the most radical suggestion of the entire In-
formal Consultation report. It is a bold attempt to deal with
the recurrent problem of member states taking excessive ac-
tions in response to serious disease outbreaks. The fact that
the Informal Consultation would even consider such a dra-
matic change in the IHR is evidence of how seriously excessive
measures by member states have undermined the ]IR. The
veto power suggestion also contains a realistic outlook in ex-
448. See Report of a WHO Informal Consultation, supra note 121, at 10.
449. See id.
450. See id. (describing a Grade 0 event as "an event of significance for
public health practices which requires immediate action by other health ad-
ministrations").
451. Id. at 10-11.
452. Id. at 11.
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pecting member states to continue to overreact in the future.
The proposal is at odds with WHO's historical ethos and ap-
proach to the IRR that has stressed moral persuasion over le-
gal coercion. The recommendation to subject acts of member
states to a procedure approximating review by a supranational
body is perhaps unprecedented in WHO's existence.
The radical nature of this recommendation is also its
greatest liability because member states will certainly eye with
skepticism such a limitation on sovereignty. Even if member
states agreed to the restriction, the proposal has no enforce-
ment procedures or sanctions if a member state decides to ig-
nore the decision of the WHO expert group. Nothing in WHO's
history suggests that it is repared to go head-to-head with re-
calcitrant member states.4B
C. SUMMARY OF THE INFORMAL CONSULTATION'S REPORT
The recommendations of the Informal Consultation as a
whole do not promise to invigorate the IHR substantially.
Many of the proposals, such as the move from reporting only
three diseases to a wider range of disease syndromes, are
needed, but do not address the underlying problem that public
health infrastructures in most member states are not equipped
to undertake expanded responsibilities. Some Informal Con-
sultation recommendations contain radical changes, like the
ability of WHO to use global telecommunications to inform
member states of epidemiological events, and the proposal to
give WHO veto power of certain national health -measures.
These proposals will be controversial, and may force a com-
promised, watered-down version in a revised set of IHR. Quite
a few of the proposals represent only cosmetic or technical
changes, such as the recommendations to describe excessive
453. A second occasion where the Informal Consultation recommends giv-
ing WHO more power appears in its discussion of revising-Article 36, which
addresses medical examinations on arrival. The Informal Consultation rec-
ommends that medical assessments of arriving passengers be conducted ac-
cording to procedures approved by WHO. See id. at 11. Again, this recom-
mendation suggests that the Informal Consultation seek to subject the
authority of member states to binding procedures for certain health measures.
The radical potential of this recommendation is lessened, however, when the
Informal Consultation adds that medical assessment procedures for arriving
passengers should be available as guidelines rather than binding rules. See
id. This attitude is more consistent with the traditional ethos of WHO than
the veto power recommendation, and thus offers as much hope as can be de-
rived from the history of member states heeding the advice of WHO and its
experts.
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measures and define "grave danger" more clearly. Finally,
some of the recommendations represent little more than re-
heated old ideas, like the "practical handbook" suggestion, or
contain no specifics to indicate how a change can be made, as
with the absence of details on how to reinforce Article 81.
Readers should not view the critical analysis of the work of
the Informal Consultation presented in this Part V as a dis-
paragement of the efforts of WHO experts. Rather, the analy-
sis points to the difficulty WHO faces in trying to devise an in-
ternational legal strategy for the EID problem. Reconciling the
dynamics of the international system, the epidemiological and
scientific requirements for infectious disease control and pre-
vention, the need for a balance between binding rules and per-
suasion in public health endeavors, and the challenges
amassed by the myriad causes behind EIIs is a most daunting
task.
Likewise, in this critical analysis of the Informal Consul-
tation's work, readers should not lose sight of the fact that such
work addresses only the IHR, which forms only part of a larger
grand strategy for addressing the ED threat. An analysis of
recommendations to revise the IHR represents only a small
portion of the entire challenge to international law posed by
EEDs. The many difficulties to confront in revising the IR
may be minuscule compared to figuring out how to use inter-
national law to address civil war, environmental degradation,
urbanization, poverty, and the deterioration of public health
infrastructures-some of the best allies of pestilence.
VI. BRIEF SKETCH OF AN ALTERNATIVE
INTERNATIONAL LEGAL STRATEGY
An international legal strategy composed only of limited
amendments to the HR will not produce long-run progress in
the struggle against infectious diseases.454 Revising the MR
should be accompanied by an effort to initiate global coopera-
tion in rebuilding national public health systems, which re-
main the best weapon in the fight against infectious disease.
The Informal Consultation's recommendations for amending
the HIR do not address reconstruction of public health infra-
454. See Fidler, supra note 8, at 83 (arguing that [relying on the Inter-
national Health Regulations as the centerpiece of international law on
emerging-disease control may not be the most effective international legal
strategy").
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structures, but such an objective forms a fundamental part of
the grand strategy contained in the international EID plans.
This Article briefly sketches an alternative international legal
strategy to mere revision of the IHR in order to stimulate more
thought about the international legal aspect of the overall
strategy designed to deal with EIDs.455
WHO member states should adopt a framework treaty on
international control and prevention of infectious diseases un-
der the authority in Article 19 of the WHO Constitution.
4 56
Such a treaty could (1) lay out the objective of achieving the
prevention and control of infectious diseases that pose risks of
spreading internationally; (2) set forth the principles that
would guide states in achieving the treaty's objective; and (3)
establish commitments for states to undertake that will
gradually bring the objective closer to fulfillment. An infec-
tious disease framework treaty would, thus, resemble frame-
work treaties used in connection with environmental protec-
tion.4
57
An important element of an infectious diseases framework
treaty would be commitments by party states to improve their
national public health systems. Given the financial problems
confronting many developing states, the framework treaty
should include a financial mechanism through which developed
states and WHO will provide funding for public health system
improvements in the developing world. Precedents for such a
financial mechanism also exist in treaties on environmental
protection.458
455. See id. at 81 (highlighting "the importance of thinking through the
international legal aspects of a global emerging disease plan carefully").
456. For an analysis of the utilization of the framework convention-
protocol approach in connection with global tobacco control, see Allyn L. Tay-
lor, An International Regulatory Strategy for Global Tobacco Control, 27 YALE
J. INT' L. 257 (1996).
457. See, e.g., United Nations Framework Convention on Climate Change,
May 9, 1992, 31 I.L.M. 849; Vienna Convention for the Protection of the Ozone
Layer, Mar. 22, 1985, 26 I.L.M. 1529.
458. See, e.g., United Nations Framework Convention on Climate Change,
supra note 457, art. 11, at 864-65 (establishing a means of granting financial
assistance to countries implementing projects in conformity with the Conven-
tion); Montreal Protocol on Substances that Deplete the Ozone Layer, Sept.
16, 1987, 26 I.L.M. 1550, 1557 [hereinafter Montreal Protocol] (Article 10, as
amended by the London Amendments to the Montreal Protocol in 1990
(UNEP/Oz.L.Pro.2/3 (Annex II)), providing technical assistance for developing
countries implementing the Protocol).
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The framework treaty should make funding available to
developing states after they have satisfied conditions, such as
WHO approval of proposed improvements to public health ca-
pabilities and full implementation of the revised IER. This
provision would link improvements in national public health
systems to the harmonization of infectious disease prevention
and control regulations through revised HIR. The revised HIR
would, thus, function as a mandatory side agreement to the
framework treaty. Parties to the framework treaty would risk
losing financial benefits if they fail to notify disease events as
required or take excessive measures in response to a disease
outbreak. Cutting off such funds might provide a measure of
enforcement for the revised IHR. It may also be effective to
make financial benefits under the framework treaty condi-
tional upon recipient nations implementing WHO recommen-
dations and guidelines on infectious disease control and pre-
vention. As a result, WHO could continue to respond flexibly
to public health issues through nonbinding recommendations
and guidelines; the link to the framework treaty might ensure
more widespread adoption of WHO's advice.
An additional feature of the framework treaty should be
the opportunity for states to adopt protocols that address exist-
ing or new diseases (e.g., tuberculosis, malaria, or dengue) or
functional areas (e.g., antimicrobial resistance, epidemiological
training, or epidemiological telecommunications systems). 459
An obvious subject for a protocol is detailed principles and
commitments on improving national public health systems.
Such a protocol would function as well as a mandatory side
agreement because of a requirement to adopt it as a condition
of funding under the financial mechanism of the framework
treaty. Further, WHO, through its Article 19 power, could be
the source of on-going development of the international infec-
tious disease legal regime through protocol adoption. To the
extent that a protocol tapped into the financial mechanism of
the framework treaty, the conditions for funding would remain
the same, unless the context required otherwise.
459. Some environmental protection treaties create opportunities for the
later adoption of protocols. See, e.g., Vienna Convention for the Protection of
the Ozone Layer, supra note 457, art. 2, at 1529-30 (encouraging cooperation
for the adoption of international protocols to protect the ozone layer); Mont-
real Protocol, supra note 458, at 1550 (adopting the Protocol as Parties to the
Vienna Convention); United Nations Framework Convention on Climate
Change, supra note 457, art. 17, at 869 (allowing Parties to the Conference to
adopt protocols).
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The framework treaty should also give WHO authority to
monitor the implementation of the treaty, revised ]HR, and
protocols by each state party and to publish the results of its
watch-dog activities. The monitoring power should include
periodic audits of state performance as well as the authority to
investigate individual episodes of problematic state behavior.
Such authority would likely enhance state compliance with the
treaty, revised IHR, protocols, and recommendations and
guidelines.460
The alternative international legal strategy briefly sketched
above attempts to confront directly the major problems of na-
tional public health infrastructure reconstruction, lack of fi-
nancial resources in developing countries for such reconstruc-
tion, the need for revised IHR, the need to have better
implementation of the IHR and WHO recommendations, the
need to balance WHO's work binding rules and flexibility for
persuasion and timely expert guidance, with the need for the
entire infectious disease control effort to be integrated and
evolutionary. It is more forthright and ambitious than the In-
formal Consultation's work on revising the IHR and thus more
closely reflects the scope of the grand strategy taking shape on
infectious diseases. In addition, rather than remaining within
the traditional confines of international law on infectious dis-
ease control, this alternative strategy looks at precedent from
other areas of international law, namely environmental pro-
tection, where similar needs for domestic reform, financial
support for developing nations, and global cooperation exist.
461
The proposal outlined above would certainly face substan-
tial criticisms. Requiring developed states to provide financial
resources for the financial mechanism may be politically im-
possible to achieve. Requiring developing states to take finan-
cial aid through the financial mechanism with many strings at-
tached may be politically unacceptable as well. Further, the
enforcement powers in the proposal principally affect develop-
ing nations, leaving developed nations to enact excessive
measures against a developing country suffering a serious dis-
460. See, e.g., Allyn L. Taylor, Controlling the Global Spread of Infectious
Diseases: Toward a Reinforced Role for the International Health Regulations,
32 HOUSTON L. REV. (forthcoming 1997) (advocating the inclusion in the re-
vised IHR of an effective supervisory institution to promote national compli-
ance).
46L See Fidler, supra note 8, at 83 (discussing the relevance of efforts in
international environmental law to international legal efforts in connection
with the EfD threat).
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ease outbreak with impunity. The alternative strategy re-
quires WHO to play a more active role monitoring implemen-
tation of binding rules and nonbinding recommendations-a
requirement that WHO may be unwilling or unable to under-
take. Finally, the ambition in the strategy-one of its
strengths-may also be a great weakness because it advocates
the negotiation and adoption of a framework treaty, revised
MR, and protocols, all of which would involve tremendous ef-
forts by WHO and its member states and face all the tensions
that accompany great multilateral legal endeavors.
462
In short, this proposal may be realistic in addressing the
key problems and innovative in its use of international legal
methods but unrealistic from a political perspective. 463 Never-
theless, it will hopefully invigorate discourse and deliberation
on the international legal aspects of the growing efforts to con-
struct global plans to deal with EIDs. It builds on the useful
work of the Informal Consultation and invites the scrutiny and
creativity of international public health and legal experts.
CONCLUSION
In less than three decades, scientific, medical, public
health, and political authorities around the world have gone
from proclaiming victory over infectious diseases to a full-scale
retreat in the face of EDs. This Article has analyzed the
growth of the awareness of the EID problem as well as the so-
bering list of factors behind EIms. It has examined why EDs
constitute a major problem for international relations and how
public health authorities and political leaders are devising
strategies to deal with the global crisis. Finally, this Article
has looked at the role international law has played and might
play in the global effort to turn the current retreat into a future
counter-attack.
Permeating attitudes towards the global EID crisis is a
tension between the realization that the crisis represents a
horrible collection of forces causing great misery, and the de-
462. See Bruce Jay Plotkin, Mission Possible: The Future of the Interna-
tional Health Regulations, 10 TEMP. INT'L & COMP. L.J. 503, 515 (criticizing
my framework-protocol alternative as unrealistic because of the time it would
take to negotiate it).
463. See, e.g., David P. Fidler, Mission Impossible? International Law and
Infectious Diseases, 10 TEMP. INT'L & COMP. L.J. 493, 499-501 (arguing that a
radical revision of the IHR may not be feasible because political circumstances
militate against it).
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termination to do something in the face of such a challenge.
This tension echoes Stanley Hoffmann's description of the
"stateman's difficulty": he or she must be realistic about, and
act according to, the real nature of international relations but
not lose sight of the possibility for a better world.4  The mag-
nitude of the EID problem shatters all illusions that human-
kind will ever be able to declare victory over infectious diseases
again. This struggle is perpetual. This conclusion heightens
the determination to do something about the return of the
fourth horseman of the apocalypse. Acting on this determina-
tion forces us to confront the limitations of society and human
institutions, such as the decentralized and anarchic nature of
international relations. There is dark irony, too, in that many
of the best allies of pestilence arise from a lack of determina-
tion to confront poverty, urbanization, environmental degra-
dation, the collapse of public health systems, and other man-
made causes of infectious diseases. Perhaps this irony reveals
the tragic flaw in the human protagonist in the infectious dis-
ease drama.
History demonstrates that the phenomena contributing to
EIDs will continue, to steal a phrase from Camus, to rouse up
their infectious agents and send them forth to kill in a happy
city.465 Neither the grand strategy nor various international
legal strategies offer any prospect of breaking or even challeng-
ing the root causes of infectious diseases and their global
spread. EMs may, as a result, become for the physician, public
health official, political leader, and international lawyer what
the plague in Oren was for Dr. Rieux: "a never ending de-
feat."466 Perhaps those who do battle with infectious diseases
now and in the future can find strength in Dr. Rieux's example:
in his suffering the "never ending defeat" with stamina, skill,
and compassion, the potential for humanity's integrity and de-
cency are revealed. The challenges posed by the emergence
and reemergence of infectious diseases will require the con-
stant reaffirmation of such potential.
464. See STANLEY HOFFMANN, Rousseau on War and Peace, in JANUS AND
MINERVA: ESSAYS IN THE THEORY AND PRACTICE OF INTERNATIONAL PoLrIcs
25, 47 (1987).
465. See ALBERT CAMUS, THE PLAGUE 278 (Stuart Gilbert trans., 1948) ("[Dr.
Rieux knew] that the plague bacillus never dies or disappears for good... and
that perhaps the day [will] come when ... it would rouse up its rats again and
send them forth to die in a happy city.").
466. Id. at 118.
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